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Synopsis 
In modern times we have become increasingly reliant on mammalian cell culture for the 
production of biopharmaceuticals; therefore research aimed at improving the characteristics 
of the cell-lines being used for recombinant protein production is essential. In this study I 
have examined the hypothesis that the creation of a CHO cell-line in which the expression of 
p21
CIP1 
and Bcl-2 could be combined would un-couple cell growth from cellular proliferation 
resulting in a significant increase in both the rate of production and culture viability. Analysis 
of key metabolites together with changes in cell volume, total protein and mitochondrial 
activity indicate that following the initiation of p21
CIP1
-expression cells undergo an increase 
in their protein synthesis machinery and that the energy, previously required for cell division 
may be diverted towards cell growth and product formation.  
 
In addition to the requirement of cell-lines with high production capacities, the 
biopharmaceutical industry is under constant pressure to develop growth media able to 
facilitate high yields without the need for the addition of protein or serum. This means it is 
often necessary to adapt high producing cell-lines to growth in such a defined chemical 
environment, a process which has proven to be both extremely long and costly. In this thesis I 
have successfully developed a method for the swift adaptation of commercially important 
cell-lines to growth within a chemically defined bio-processing environment. I have shown 
that the expression of p21
CIP1
 is able to reduce the need for extracellular growth factors and 
that by combining the expression of p21
CIP1
 and Bcl-2 it is possible to further reduce the time 
required for successful adaptation, supporting the well established theory that Bcl-2 plays an 
important role in apoptotic signalling pathways.  
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1. Introduction 
 
 
1.1 . Overview 
Control over the cell cycle and apoptosis is fundamentally a very important area of 
research, particularly for industrial purposes. Understanding the mechanisms that 
drive a cell through the ordered sequence of events that result in DNA replication, cell 
division and ultimately cell death has given rise to multiple endeavours by research 
groups worldwide to develop methods of modulating this cycle in order to influence 
the productivity, viability and sustainability of biologically important cell-lines. 
 
The ability to maintain genomic integrity is vital for cell survival and proliferation. 
Lack of fidelity in DNA replication and maintenance can result in deleterious 
mutations leading to cell death or, in multicellular organisms, cancer; therefore the 
most important events of the cell cycle are those concerned with replication of the 
genome and segregation of the replicated genomes into the daughter cells formed at 
division. The processes of cell division, differentiation, survival, and death are all 
governed by intricate changes in the delicate balance between the multiple regulators 
of the cell cycle, and as such are responsible for the fundamental means by which all 
living things are propagated. 
 
The cell cycle itself consists of an ordered set of events, ultimately resulting in cell 
growth and division to produce daughter cells. The eukaryotic cell cycle can generally 
be divided into four stages known as G1, S, G2 and M. G1 also known, as gap-phase 
1 is the period during which cells prepare for the process of DNA replication. S-phase 
is defined as the stage in which DNA synthesis occurs. G2 is the second gap-phase 
2 
 
during which the cell prepares for the process of division and M stands for mitosis, 
the phase in which the replicated chromosomes are segregated into separate nuclei 
and cytokinesis occurs to form two daughter cells (Figure 1.1). In addition to G1, S, 
G2, and M, the term G0 is used to describe cells that have exited the cell cycle and 
become quiescent (Johnson and Walker 1999). 
 
Figure 1.1. The mammalian cell cycle 
 
 
 
 
 
 
 
 
 
 
 
Diagrammatic representation of the mammalian cell cycle phases. Work performed previously 
by our research group have shown that p21
CIP1
 over-expression is able to halt cell cycle 
progression in the G1 phase of the cell cycle (Watanabe et al 2001 and 2002, Ibara et al 2003, Bi et 
al 2004). Bcl-2 has also been shown to be able to prevent cell death resulting from apoptosis 
(Simpson et al 1998, Perani et al 1999, Tey et al 1999 and 2000). 
 
The replication of the chromosomes is based on the double helix structure of DNA, 
which unwinds during S-phase to generate two templates that may then be used for 
the synthesis of two new complementary DNA strands. During mitosis a bipolar 
spindle is formed and the two double helix DNA molecules making up each replicated 
G0 
D'A 
synthesis 
Preparation for mitosis 
Reversible quiescent phase 
  
  Apoptosis 
Bcl-2 
 
 
cyclin 
p21 
 P 
cdk 
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chromosome become condensed and oriented towards opposite poles of the cell. The 
DNA molecules attach to microtubules emanating from the spindle poles and moves 
away from each other toward opposite poles, to be segregated at cell division. Thus 
the formation of two genomes during the cell cycle occurs at the molecular level 
during S-phase and at the cellular level during mitosis. 
 
To ensure that each newly formed daughter cell receives a complete genome the onset 
and progression of S-phase and mitosis are tightly controlled ensuring that several 
critical criteria are met before the cell is able to progress. These criteria include the 
progression through the cell cycle in the correct sequence, ensuring each event occurs 
only once per round of cell division, screening and correction of genetic errors in their 
execution, and insuring the coordination of cellular growth.  
 
Cell death may be divided into two distinct categories, either apoptosis or necrosis. 
The former describes a morphological form of cell death which is initiated via an 
inherent gene directed program that responds to a wide variety of physiological and 
toxicological stimuli (Kerr et al 1979). This forms the basis of an integral part of 
development and homeostasis within any given organism. Necrosis on the other hand 
can be considered a passive form of cell death that corresponds to random acts of 
cellular suicide as a direct result of pathological damage or injury to the cell (Wyllie 
1980). 
 
The process of apoptosis has been identified as a key feature of many disease 
pathologies, either through the resulting loss of cells or through its failure to be 
executed (Thomson 1995), for example, tumours arise from the failure of apoptosis to 
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be activated following genetic transformation within the cell, thus leading to the 
transfer of defective genetic material during the following round of replications. At 
the other end of the spectrum over activation of apoptosis has been found to be 
responsible for several neurodegenerative conditions such as Alzheimer’s and 
Parkinson’s disease. It has therefore been a long term goal of cellular biologists to be 
able to determine the exact mechanisms of apoptosis in order to manipulate the 
outcome of diseases in which it plays a key role. 
 
The use of animal cell technology for the production of biopharmaceuticals has 
resulted in an increased interest in the process of apoptosis. This is due to the fact that 
during the process of cell culture, apoptosis plays a huge role in determining the life 
span and thus productivity of the resulting culture. The need for increased culture 
viability within bioreactor environments places apoptosis as a primary target for the 
optimisation of such processes. 
 
 
1.2. Protein Production 
Proteins are essential components of all living cells and as a result make up more than 
half of the cells dry weight. They play key roles as both structural elements and active 
functional units responsible for molecular recognition and catalysis. Within the cell 
DNA serves as the genetic template from which all proteins are produced, however it 
is the proteins themselves that drive almost all of the processes within the cell. Protein 
synthesis occurs as a result of the guided polymerization of simple amino acids. In 
nature protein synthesis is closely entwined with the process of gene expression, in 
which the information in DNA is first transcribed to mRNA then translated to protein 
(Figure 1.2). 
  
Figure 1.2. Protein production within a 
 
Simplified diagram of protein production within a 
D'A are copied to produce mR'A
the nucleus and go to either free ribosomes or to ribosomes bound to the endoplasmic reticulum. 
When released from a free ribosome, a protein can become incorporated into cytoskeletal 
or into organelles such as a mitochondrion or a peroxisome. Proteins made in the endoplasmic 
reticulum leave in a vesicle and migrate to the Golgi apparatus. Proteins are sorted in the Golgi 
before they are then carried in vesicles to lysosomes, secreted or incorporated 
surface membrane.  
 
5 
mammalian cell
 
mammalian cell. In the nucleus segments of 
. These coded instructions for a protein (like a recipe) leave 
 
 
fibres 
into the cell's 
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The specific order of polymerization of a protein's amino acids has to be guided by 
the particular order of the nucleotide bases of the corresponding DNA. In nature 
proteins are expressed in living organisms according to tightly regulated mechanisms 
in order to meet the specific needs of the organism, a process known as homologous 
gene expression. In contrast the use of recombinant DNA techniques for the 
expression of genes outside their natural expression environment is described as 
heterologous gene expression.  
 
Proteins may be heterologously synthesised either in vivo or in vitro. In vivo 
expression systems include any non-native cellular system that permits the synthesis 
of the target protein, while in vitro expression systems include any non-native, 
acellular system which permits such synthesis. Over the last 35 years recombinant 
protein expression technology has developed at an astounding rate giving rise to a 
variety of in vivo and in vitro protein synthesis systems allowing for both the 
production and manipulation of the properties of almost any protein (Hillebrecht and 
Chong 2008, Swartz 2006). 
 
In order to heterologously express a desired protein within a living host, the 
corresponding sequence of DNA must be known and a suitable method for its 
transformation and selection has to be available. The ability to clone the 
corresponding DNA into a suitable vector is vital for its introduction into the selected 
host. The vector usually consists of an independently replicating DNA or DNA 
segment which may be integrated into the host genome. In order for the DNA 
encoding for the protein of interest to be expressed it has to be preceded at the 5` end 
with a transcription promoter. Depending upon the nature of the target protein either 
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prokaryotic or eukaryotic hosts may be used for the expression of the required protein. 
This however is heavily dependent on the type of protein being encoded, as the choice 
of host can have a significant effect on the nature of the expression as well as the 
transformation, selection and subsequent purification of the target protein product.  
 
1.2.1. Bacterial production systems 
There are many reasons for the popularity of bacteria as host systems including the 
fact that the genome sequence of the most popular bacteria has been well established 
and the majority of their biological processes and metabolic pathways are now well 
understood. There are also many genetic tools readily available that allow for their 
manipulation. On the down side a bacteria such as Escherichia coli will never be 
completely suitable for every application (Billman-Jacobe 1996), mainly due to 
limitations in its ability to act as an expression system. Many of the proteins used in 
modern day industrial applications are highly complex, consisting of multiple 
subunits, cofactors/prothetic groups, disulphide bonds, and post translational 
modifications, including glycosylation, that are essential in order to produce a fully 
functional protein.  
 
Extensive efforts have been made in the direction of proper understanding and 
improvement of E. coli as an expression system for heterologous proteins (Hannig 
and Makrides 1998, Hockney 1994), however if the protein being produced is to serve 
a pharmaceutical purpose, post-translation modifications such as protein folding may 
be critical for its biological activity. Prokaryotic hosts such as E. coli are unable to 
perform such complex modifications and in addition may result in the recombinant 
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protein product preparation becoming contaminated with endotoxins and pyrogens, 
both of which are difficult and costly to remove (Binnie et al 1997).  
 
In more recent years several species of both Gram-negative and Gram-positive 
bacteria have been identified as having potential for use in protein synthesis (Billman-
Jacobe 1996). Amongst the contenders the Gram Negative species including 
Pseudomonas spp., Serratia marcescens, and Erwenia herbicola have all 
demonstrated successful heterologous expression of proteins (Rangwala et al 1991). 
Despite this they are not considered to be strong rivals for the E. coli expression 
system, but do offer the potential of further development. In contrast a number of 
Gram-positive bacteria have proven to be very good alternatives to E. coli. Many are 
currently used for the production of industrial enzymes through their ability to directly 
secrete proteins through the cell envelop into the culture medium (de Vos et al 1997). 
Lactococcus lactis which is responsible for the production of lactic acid is one 
example and has successfully been used in the expression of a large number of 
heterologous proteins. Due to its classification as a food grade bacterium it, along 
with others in this category are generally regarded as safe and therefore confer this 
safety onto the resulting protein produced, thereby making it suitable for human 
consumption (Kuipers et al 1997). Actinomycetes were previously thought to be fungi 
due to their filamentous forms however it is now clear that they are not fungi but 
higher bacteria, closely related to the Mycobacterium. These bacteria surpass most 
other bacteria in their ability to synthesise protein at significantly higher levels, with 
titres of more than 300mg/L of heterologous protein being relatively common (Binnie 
et al 1997).  
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Other uses for bacterial hosts include the in situ production of recombinant protein 
through the generation of bacterial carriers that are able to produce recombinant 
proteins within their natural environments. One of the best studied examples of this 
system is the insecticidal toxin of Bacillus thuringensis which has been expressed in 
other bacteria to facilitate its delivery. For example, the cyanobacteria Agmenillus 
quadruplicatus and Clavibacter xyli have both been successfully used to deliver 
Bacillus thuringensis to mosquito larvae and corn borer, respectively, resulting in 
insecticidal effects (Billman-Jacobe 1996). 
 
An alternative use for bacteria involves the heterologous expression of proteins on the 
bacteria cell surface. In order to achieve this, the protein must cross the cytoplasmic 
membrane and the periplasm to the outer membrane of the bacteria, while still 
retaining the correct conformation and orientation to allow it to function biologically 
(Hockney 1994). This makes it possible to produce live vaccine vectors able, through 
the expression of their recombinant proteins to elicit immune responses in higher 
organisms. Such bacterial strains are usually attenuated and transformed with an 
expression vector that carries the gene for a specific antigen. When the bacteria are 
introduced into the host the expression of the antigen elicits immunisation (Hockney 
1994, Billman-Jacobe 1996). 
 
1.2.2. Fungal production systems 
The wide diversity of fungi species available for the production of recombinant 
proteins enables the selection of a host specifically to match the target proteins to be 
produced. In addition many species have the natural capacity to produce large 
quantities of primary metabolites, such as vitamins, secondary metabolites, such as 
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antibiotics, as well as extracellular enzymes, all of which can be further optimised by 
industrial production conditions.  
 
Despite the existence of around 100,000 species of fungi (Esser and Lemke 1994) 
only a handful, mainly those belonging to the yeast and mould species have been 
sufficiently studied to enable their use as hosts for the heterologous production of 
protein. Yeast species, like Saccharomyces, Pichia, and Hansenula, are well 
characterised as efficient gene expression hosts with good fermentation properties, for 
example the yeast species Pichia pastoris during fermentation has been shown to be 
capable of substantial production levels of around 65g/L (Wolf 1996). Similarly 
mould species like Trichoderma and the Aspergilli, have been shown to have high 
enzyme secretion rates that can result in the production of around 20 g/L (Kruszewska 
1999). 
 
In most cases the choice of vector used for transforming fungi is a hybrid of both 
eukaryotic and prokaryotic sequences (Lemke and Peng 1995, Van, den Hondel et al 
1991, Fincham 1989). The eukaryotic element is usually one derived from fungal 
sequences and varies according to the specific requirements of the expression vector. 
In contrast the prokaryotic section is usually derived from E. coli, thereby allowing 
the processes of replication and selection to occur within the cell. A polylinker 
containing several restriction enzyme recognition sites allows for the introduction of 
the foreign DNA sequences. This system allows cloning to be performed within E. 
coli allowing for easy manipulation. On the negative side although fungi are more 
complex than bacteria, the majority of therapeutic proteins require additional post 
translational modifications such as :-glycosylation. Eukaryotes including yeasts are 
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able to perform N-glycosylation however the resulting structures and sugar content 
vary from species to species and therefore therapeutic proteins with non human 
glycosylation patterns carry a high risk of eliciting an immune response.  
 
Recently much of the research surrounding protein expression in fungi has focused on 
the re-creation of human glycosylation patterns. In 2003 Hamilton et al reported the 
humanization of the glycosylation pathway of the yeast species Pichia pastoris in 
order to secrete a human glycoprotein with uniform complex N-glycosylation. The 
process involves the removal of the endogenous yeast glycosylation pathways while 
properly localizing five active eukaryotic proteins, including mannosidases I and II, 
:-acetylglucosaminyl transferases I and II, and uridine 5-diphosphate (UDP)–:-
acetylglucosamine transporter. The targeted localization of these enzymes enables the 
generation of a synthetic in vivo glycosylation pathway, which is then able to produce 
the complex human :-glycan :-acetylglucosamine2–mannose3-:-acetylglucosamine2 
(GlcNAc2Man3GlcNAc2). 
 
Alternative studies (Bobrowicz et al 2004) have used different methodologies for the 
engineering of an artificial glycosylation
 
pathway in Pichia pastoris blocked in 
dolichol oligosaccharide
 
assembly. In this study the PpALG3 gene encoding Dol-P-
Man:Man5GlcNAc2-PP-Dol
 
mannosyltransferase was deleted in a strain that was 
previously
 
engineered to produce hybrid GlcNAcMan5GlcNAc2 human N-glycans.
 
Employing this approach, combined with the use of combinatorial
 
genetic libraries, P. 
pastoris strains were engineered that are able to synthesize
 
complex 
GlcNAc2Man3GlcNAc2 N-glycans with a high level of homogeneity.
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More recently researchers have also turned their attention towards the production of 
human antibodies. Presently all of the clinically approved monoclonal antibodies in 
production are produced within mammalian cell-lines, which are able to secrete 
monoclonal antibodies with glycosylation structures that are sufficiently similar, 
though not identical, to their human counterparts. In 2006 Li et al reported that it was 
possible for human antibodies with specific human N-glycan structures to be 
produced in the glycoengineered yeast Pichia pastoris and that antibody-mediated 
effecter functions can be optimized by generating specific glycoforms.  
 
It is obvious that as our understanding of the glycosylation pathways in yeast 
develops there will be great potential for their use to increase the variety of 
recombinant protein products currently on the market. In addition since the scale-up 
and production potential of yeast is well-established as being significantly higher than 
its mammalian host counterparts, it is reasonable to expect the high-throughput and 
cost-effectiveness of glycoengineered yeast strains to make a significant impact on the 
biopharmaceutical industry. 
 
1.2.3. Plant production systems 
Plant expression systems potentially offer an inexpensive and convenient method for 
the large-scale production of many recombinant protein products. Over the last ten 
years, a number of successful plant expression systems have been developed, 
resulting in the production of well over 100 recombinant proteins from a range of 
different species.  
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There are several advantages to the use of plant expression systems over other 
production systems, including the ease of which agricultural production levels can be 
achieved, cost effectiveness and the existence of established methods for the 
harvesting, transporting, sorting and processing the derived products. It is estimated 
that recombinant proteins can be produced in plants at 2–10% of the cost of microbial 
fermentation systems and at 0.1% of the cost of mammalian cell cultures, although 
this very much depends on the product yield (Giddings 2001).  
 
A major advantage to plant based expression systems over other systems, comes from 
the ability to administer several types of recombinant protein in unprocessed or 
partially processed plant material, resulting in a decrease in the overall downstream 
processing costs. For example, recombinant vaccines produced in plants may be 
administered via the consumption of the resulting raw or part-processed fruits and 
vegetables (Mason et al 2002). Similarly antibodies used for passive immunization 
may be administered topically as pastes and creams following minimal purification. In 
contrast the vast majority of pharmaceutical proteins need to be purified before they 
are suitable for use, which in turn results in a significant increase in the cost and 
complexity of downstream processing. Several strategies have been developed to 
reduce downstream processing costs, including the targeted expression of the desired 
recombinant protein to specific plant parts. For example the oleosin-fusion platform 
developed by SemBioSys Genetics, for use in oil seed crops enables the desired 
recombinant protein to be fused with oleosin. The fused protein can then be recovered 
from the plants oil bodies using a simple extraction procedure and the recombinant 
protein purified via an endoprotease digestion.  
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It is also possible to utilize a plants natural ability to secrete protein products through 
its tissues, enabling the continuous production of the desired recombinant protein 
(Borisjuk et al 1999, Komarnytsky et al 2000, Drake et al 2003). This type of strategy 
is however only suitable for small-scale production and is limited in its practicality by 
the need for sealed containment facilities to prevent the resulting recombinant product 
leaching into the soil or groundwater. Another alternative approach to the use of 
whole plants is the large-scale cultivation of plant-cell suspensions. Although plant 
cells are not comparable to microbes in terms of generation time, obtainable cell 
densities or nutritional requirements they still require similar techniques and 
equipment. It has been possible to use conventional fermentor equipment, with minor 
adjustments, to successfully apply modes like batch, fed batch, perfusion and 
continuous fermentation with scales up to 100,000 litres (Fischer et al 1999). Several 
other factors can however hinder the use of plants for the production of some 
recombinant proteins, including the quality, safety and the homogeneity of the final 
product as well as the previously described inherent difficulty in processing some 
plant-derived pharmaceutical macromolecules.  
 
There is a great deal of similarity between the protein-synthesis pathways of plants 
and animals, therefore the expression of human transgenes results in the production of 
proteins with identical amino-acid sequences to their native counterparts. During post-
translational modification there are however some significant differences, including 
the inability of transgenic plants to correctly modify human collagen unless the gene 
encoding proline-4-hydroxylase is also expressed (Merle et al 2002). The most 
significant difference occurs during the synthesis of glycan side chains. Eukaryotes 
add glycan chains to proteins as they pass through the secretory pathway; however 
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differences in the expression levels of the enzymes associated with this form of 
modification results in the production of glycan-chain structures that can vary 
significantly. 
 
In general plant-derived recombinant proteins lack the terminal galactose and sialic-
acid residues, normally found in mammals, but have the carbohydrate group 
α(1,3)fucose, which has a (1,6) linkage in animal cells, and β(1,2)xylose, which is 
absent in mammals although present in invertebrates. These differences in the glycan 
structure have the potential to alter the activity, distribution and longevity of the 
resulting proteins compared with the native forms. As a result it has been suggested 
that some plant-specific glycans may be capable of inducing allergic responses in 
humans (Lerouge et al 1998). Therefore, recent attention has focused on the 
development of strategies to 'humanize' the glycosylation patterns of recombinant 
proteins (Bardor et al 2003).  
 
Despite this the last decade has seen the emergence of several plant-based expression 
systems which are able to compete with existing production systems in the large-scale 
production of recombinant proteins. As a result several plant based biopharmaceutical 
products are currently either in the late stages of development or already on the 
market including antibodies, vaccines human blood products, hormones and growth 
regulators (Hood et al 1997, Kusnadi et al 1998 Evangelista et al 1998, Fischer and 
Emans 2000, Giddings 2001).  
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1.2.4. Animal production systems  
The ability to transform animal cells through the introduction of foreign genetic 
material began in 1910 when Peyton Rous discovered that it was possible to induce 
the formation of tumours by using a filtered extract of chicken tumour cells, which 
was later proven to contain an RNA virus (Rous 1911). By the late 1950s the ability of 
viruses to transform animal cells had been well established and later in 1977 Wigler 
and associates, developed an efficient method for the introduction of single-copy 
mammalian genes into cultured cells (Wigler et al 1977). 
 
In the late 1970s interferon was the first drug derived from a cultured human 
lymphoblastoid cell-line to be licensed. In more recent years, mammalian cells have 
become the favoured expression system for industrial production of a vast multitude 
of bio-therapeutics.  More than half of the FDA license approvals for biotechnology 
products from January 1996 to November 2000 were for mammalian cell systems 
(Chu and Robinson 2001).  In addition, monoclonal antibodies produced from 
mammalian cell-lines are now becoming important drug candidates for many 
biopharmaceutical companies as there are currently over 20 approved antibodies 
already in use and about 150 in various stages of clinical studies (Reichert et al 2005).  
 
When a gene is to be expressed in an animal cell it may be either cloned into an 
expression vector or be transferred directly into the recipient cell where it may 
independently survive or integrate into the host genome (Richa and Lo 1997).  Most 
mammalian expression vectors contain a copy of the gene of interest which is placed 
downstream of a promoter sequence and is followed by a transcription termination 
signal. Some constructs may also incorporate transcription and translation enhancers 
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as well as selectable markers which enable both manipulation in E. coli and selection 
in the mammalian host. Although eukaryotic mRNA is not generally polycistronic, 
such constructs have been efficiently made using Internal Ribosome Entry Sites 
(IRES) that were identified in the single-stranded RNA genome of picorna viruses. 
These sequences provide secondary ribosome binding sites that have been shown to 
enable expression from the polycistronic messages (Ganguly and Shatzman 1999). 
 
The major difference between vectors used in the transfection of animal cell-lines and 
those used to produce transgenic animals is the process of selection. In cultured 
mammalian cells, selection is generally dependent on the presence of a drug 
resistance gene included within the expression vector. In contrast the identification of 
transgenic pre-implantation embryos prior to transfer into the recipient animals is not 
yet possible. In addition, very little is known about the fate of the transgene following 
integration into the genome of the transgenic animals (Bishop 1999).  
 
In general there are three methods utilized for the transformation of animal cell-lines 
including calcium phosphate-DNA co-precipitation which may be applied to cells 
grown as a monolayer. In this method the DNA is transfected into cells through its 
incorporation into fine calcium phosphate precipitate. An alternate method is 
Lipofection in which the DNA is adsorbed to very small spheroid lipid vesicles that 
fuse to the mammalian cell membrane. The third method is electroporation which is 
also used for transforming mammalian cells in suspension. In contrast when 
expression is required within a whole animal the expression construct must be 
delivered to the pre-implanted embryo, predominantly via the microinjection of the 
fertilised oocyte. This may then be transplanted into the uterus of a surrogate mother 
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until delivery. Currently no method exists for the selection of transformed embryos 
prior to implantation.  
 
It has been claimed that in a number of biopharmaceutical companies more protein 
species are being produced in CHO cells than in E. coli and in S. cerevisiae (Wurm 
1999). CHO cells were originally derived from a biopsy of an ovary of an adult 
Chinese hamster (Cricetulus griseus) in 1957. CHO cells posses a number of features 
which have proven to be advantageous in the process of protein production including 
the ease of which exogenous DNA may be introduced, together with a high capacity 
for large scale growth and production. Another well established cell-line is BHK. 
These cells were originally derived from 1-day-old Syrian hamster (Mesocricetus 
auratus) kidneys back in 1961 and since then they have been utilized for the 
expression of recombinant proteins such as human factor VIII for therapy of 
coagulation disorders. They have also demonstrated a susceptibility to viruses, and 
have therefore also been extensively used for vaccine production.  
 
The third type of cells that are commonly used in industry are hybridoma. 
Hybridomas are immortalised antibody secreting hybrid cells, produced through the 
fusion of malignant tumour cells (called myeloma) and spleen lymphocytes of a 
mouse immunised with a particular antigen (Kohler and Milstein 1975). They are 
primarily used in the production of monoclonal antibodies (mAb); however they have 
also proved efficient in producing recombinant mAb by constructing what are called 
heterohybridoma. The species from which they are derived can contribute to the 
variant and the constant regions of the secreted mAb in order to produce a bi-specific 
mAb that can cross react with two antigens. The myeloma cell-lines that are used for 
the production of hybridomas are themselves also suitable for the production of 
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recombinant proteins particularly because of their natural secretion capability, their 
transfection properties and their ability to grow to high cell densities (Bardouille 
1999).  
 
In contrast to the production of heterologous proteins in in vitro cultured cells, 
transgenic animal technology enables the targeting of recombinant proteins to specific 
animal tissues or secretions. The development of transgenic animals began in 1980 
when a transgenic mouse was developed through the microinjection of DNA into a 
fertilised egg (Gordon et al 1980). Currently transgenic animals may be produced 
either by microinjection of DNA into fertilised eggs or by viral transfection of 
embryonic stem cells. In both cases when the foreign DNA integrates into the 
embryo’s genome the resulting animal may then be considered transgenic. 
 
The use of tissue-specific regulatory sequences allows the expression of the gene to 
be targeted to almost into any tissue type. In one study (Janne et al 1998) a fusion 
construct between pig β globulin promoter and human β globulin coding region 
resulted in the expression of up to 24% completely human haemoglobin A (HbA) 
within the pigs blood. Interestingly the transgenic animals appeared to tolerate well 
the high levels of the human HbA in their erythrocytes and structural analysis of the 
recombinant human HbA showed it to be equivalent to the protein purified from 
human blood. Despite this the complex chemical composition of blood makes it very 
difficult to isolate and purify the resulting recombinant product. It is also obvious that 
circulating blood cannot be used as a source of biologically active recombinant 
products, such as cytokines and hormones, without creating health problems for the 
production animals. However, the technique is still valid for producing normal 
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constituents of blood such as haemoglobin, antibodies and α 1-antitrypsin (Janne et al 
1998).  
 
Recombinant proteins have also been engineered to be expressed within the mammary 
glands of animals such as mice, rabbits, goats, sheep and cows (Houdebine 1997, 
Janne et al 1998). The natural ability of these tissues to secrete the resulting products 
means that their expression into milk is expected not to create any health problems for 
the host animal even when highly bioactive peptides and proteins are being 
synthesized. In addition studies have demonstrated the resulting mammary gland-
specific secretion sequences show inter-species compatibility. It has been shown that 
transgenic sheep are able to express the human α 1-antitrypsin in their milk at 50% of 
the total proteins resulting in 35 grams of recombinant protein per litre of milk 
(Wright et al 1991). It was also found that the resulting recombinant protein was 
correctly glycosylated and therefore fully active.  
 
Despite the potential for transgenic livestock to become a source of recombinant 
proteins the technology is still relatively new and the process itself is extremely 
expensive, labour-intensive and technically difficult. The production of a single 
transgenic calf requires thousands of fertilised oocyte microinjections (Wall et al 
1992). In addition to the economic and the technical difficulties there are also ethical 
issues to consider, particularly those of a religious or culturally sensitive nature. 
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Table 1.1. A comparison of the key features of host systems used for the 
production of recombinant protein products. 
 
Host 
Overall 
cost 
Production 
timescale 
Scale up 
capacity 
Product 
quality 
Glycosylation 
Contamination 
risks 
Bacteria Low short high low none endotoxins 
Yeast Medium medium high medium incorrect low risk 
Mammalian 
cell culture 
High long very low very high correct 
viruses, prions 
and oncogenic 
DNA 
Transgenic 
animals 
High very long low very high correct 
viruses, prions 
and oncogenic 
DNA 
Plant cell 
cultures 
Medium medium medium high 
minor 
differences 
low risk 
Transgenic 
plants 
Very 
Low 
long very high high 
minor 
differences 
low risk 
 
Comparison of production costs, timescales, scale-up capacity, product quality, contamination 
risks and whether correct glycosylation occurs in the most commonly studied expression hosts. 
This table summarises the key benefits of each system described above as well as providing an 
insight into the limitations which need to be overcome in order to produce more economically 
viable production systems. 
 
 
1.3. The effect of clonal variation on cell-line stability and 
productivity 
The successful development of industrial biopharmaceuticals facilitates the need for 
the generation of stable clones with high productivity levels. At present most of the 
work performed in this area has concentrated on complete monoclonal antibodies. 
This is not surprising considering they constitute the vast majority of products 
currently in clinical use or in development. During the process of clone development, 
gene expression platforms are used to achieve high expression levels via 
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amplification. Two of the most commonly used gene expression and amplification 
systems are Dihydrofolate reductase (DHFR) and glutamine synthetase (GS) (Birch 
and Racher 2006). Both of these systems allow for the development of high 
expressing clones for the purpose of production. The ability to produce clones is vital 
to the biopharmaceutical industry. As a result strict guidelines have been produced by 
the ICH for the ‘analysis of the expression construct in cells used for production of r-
DNA derived protein products’ (1996). These guidelines define the use of a single 
clone for production purposes and limit the amount of time they can safely be in use, 
thereby reducing the amount of variability within the final product.  
 
Stable clones may be defined in one of two ways (Barnes et  al 2003). The first states 
that in order to be considered stable a clone must be able to successfully pass on the 
recombinant DNA incorporated into the host cells’ genome to the resulting daughter 
progeny.  The second definition of stability is the ability of the cloned cell-line to 
retain a constant level of recombinant protein production without a decrease in 
specific productivity during periods of long term culture. Interestingly instability 
arising due to the loss of the recombinant protein gene and the inherent chromosomal 
instability may appear as a similar process; however the latter form of instability is 
particularly significant in two of the most commonly used production cell-lines, 
Chinese hamster ovary (CHO) and NS0 mouse myeloma cell-lines.  Even without 
heterologous protein production, both cell-lines, which were immortalised artificially, 
have an inherent genetic instability which cloning may not always resolve (Barnes 
and Dickson 2006).   
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The long term culture of cell-lines, without selective pressure has often been used as a 
test for production stability of clones. Several studies into recombinant protein 
production in hybridoma cell-lines have attributed instability to the appearance of a 
non-producing population of cells, possibly due to environmental factors such as 
serum (Couture and Heath 1995, Frame and Hu 1990, Lee and Palsson 1990, Ozturk 
and Palsson 1990).  Amplification of clones using chemicals may not always be 
necessary. It has been suggested (Barnes et al 2001) that the use of growth and 
recombinant protein productivity as selection criteria is not sufficient. The study 
reported that two of the NS0 clones produced displayed unstable production levels 
when grown for extended periods of time in a medium lacking the presence of 
selective pressure.  It was theorised (Kim et al 1998a, Kim et al 1998b) that the 
observed fluctuations of productivity arise due to either chromosomal loss, mutation 
or genetic rearrangement. It is therefore possible to define clonal stability during 
protein production in terms of cellular recombinant mRNA content. Studies (Barnes 
et al 2004) of monoclonal antibody production in NS0 myeloma cells indicates the 
existence of a saturation point for the recombinant protein mRNA which defines the 
stability of protein production in long term culture.   
 
While the concentration of mRNA is an important determinant in stability, the gene 
copy number has no reflection on the protein production stability.  It has been further 
reported that even in gene amplified clones, instability still occurs and that growing 
clones without selective pressure is able to give rise to a loss of specific cellular 
productivity, either due to a loss of recombinant gene or due to mutations within the 
recombinant gene itself  (Kim et al 1998b).  The loss of protein production in some 
recombinant cell-lines can therefore be attributed to the inherent instabilities 
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discussed above, as well as several other factors such as irregularity in transcriptional 
and post-transcriptional regulation as described by Barnes et al (2003).   
 
As discussed on page 22, two of the most commonly used gene expression and 
amplification systems are glutamine synthetase (GS) and Dihydrofolate reductase 
(DHFR). The first GS is based on the Glutamine synthetase enzyme that allows for 
the biosynthesis of glutamine from the substrates glutamate and ammonia (Figure 
1.3).  
Figure 1.3. The GS expression system 
 
 
 
The over-expression of GS allows the creation of glutamine within the cell.  Methionine 
sulphoxomine (MSX) inhibits the activity of GS and therefore the addition of MSX to the culture 
medium amplifies the expression of the GS selection marker. 
 
This enzymatic reaction follows the only existing pathway for glutamine formation 
within the mammalian cell; this makes the GS gene an ideal candidate for use as a 
very successful selectable marker. The GS system may be utilised in multiple cell-
lines although not all cell-lines respond in the same way. Some mammalian cell-lines, 
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such as NS0, simply do not express sufficient GS to survive without the addition of 
glutamine to the growth medium. Therefore when these cells are transfected with the 
GS gene it is able to function as a selectable marker by only permitting growth of 
transfected cells within a glutamine-free medium. In cell-lines such as CHO, which 
express sufficient GS to survive within a growth environment lacking exogenous 
glutamine the addition of the specific GS inhibitor, methionine sulphoximine (MSX), 
can be used to inhibit endogenous GS activity and therefore allow the survival of only 
transfectants expressing the additional GS activity. 
 
In the DHFR expression system dihydrofolate reductase converts dihydrofolate into 
tetrahydrofolate, a methyl group shuttle required for the synthesis of purines, 
thymidylic acid, and certain amino acids. Using this system mammalian expression 
vectors are designed to express the DHFR gene along with the gene of interest. The 
plasmid is transfected into DHFR negative host cell-line which is unable to synthesize 
tetrahydrofolate, an important cofactor in the one-carbon metabolism. DHFR negative 
cells are only able to grow thereby in a media containing thymidine, glycine and 
hypoxanthine which are required to overcome their inherent deficiency. Cells that 
have been stably transfected are able to grow within media lacking these components, 
thereby facilitating their selection. The addition of the cytotoxic drug methotrexate 
(MTX), a powerful inhibitor of DHFR allows for the selection of cells containing an 
increased number of copies of the DHFR gene. Increasing the concentration of MTX 
over time therefore has the potential to not only amplify the DHFR gene, but also the 
co linked gene of interest within the cell-line. The productivity of any given cell-line 
can be greatly influenced by the construction of the plasmid vector used. For example 
in the GS system glutamine synthetase is usually under the control of a weak 
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promoter, whilst the heterologous protein coding sequence is usually controlled by a 
powerful promoter (Brown et al 1992) meaning that the resulting transfectants are 
constantly exposed to a positive selection.  
 
As described previously both the GS and DHFR systems rely on the cell-lines used 
expressing very low levels of endogenous GS or DHFR thereby enabling the selection 
of the desired transfectant through their growth in a medium deficient of the required 
elements. The addition of MSX inhibits the expression of endogenous GS whilst also 
allowing for gene amplification (Brown et al 1992) in much the same way as MTX in 
the DHFR system. The amount of MSX required is very much dependent on the cell-
line used, for example the NS0 cell-line generally requires 10-100µM whereas CHO 
cell-lines require anywhere between 50-500µM of MSX in order to suppress the 
expression of the cells endogenous glutamine. MSX has a powerful and irreversible 
effect on GS as a result of its phosphorylation to form MSX phosphate (Manning et al 
1969) which in turn binds to GS thus blocking its functional activity. 
 
In some cases it has been shown that the use of MTX in the DHFR expression system 
has resulted in the production of clones resistant to the amplification process that may 
not undergo any amplification to the DHFR gene copy number (Assaraf and Schimke 
1987) Such resistance to MTX may be due to the altered affinity of DHFR in these 
clones (Flintoff and Essani 1980) or to a MTX-resistant DHFR enzyme (Kim et al 
2001). Recent studies (Kim et al 2001, Griffiths et al 2002) have shown that although 
it is possible to increase gene copy number with successive rounds of amplification, 
the expression levels of the resulting recombinant protein often does not increase 
linearly with this increase in copy number. Instead it was found (Kim et al 2001) that 
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during dihydrofolate reductase mediated gene amplification as few as 1 in 23 clones 
demonstrated any increase in antibody production following  amplification, probably 
as a result of genetic rearrangement or fragmentation occurring either during or prior 
to integration within the chromosome.  
 
Similar studies have also shown a wide spectrum of productivities resulting from gene 
copy number amplification, with anything from a 5 to 50 fold increase being observed 
(Griffiths 2001, Hayduk and Lee 2005).  This has lead to the belief that beyond a 
certain gene copy number productivity levels cannot be related to the gene copy 
number. One example of this has been demonstrated by Kim et al (Kim et al 1998b). 
In their study they were able to show that gene amplification within clones resulted in 
increasing productivity up to a certain methotrexate (MTX) concentration, after 
which, posttranscriptional factors became limiting.  This has meant that process of 
producing clones can often result in significantly different and random results. 
 
 In a study of a chimeric antibody producing CHO cell-line that utilized the DHFR 
expression system, the productivity and stability of the clones during periods of 
selection pressure was correlated to changes in growth rate, gene copy number and 
mRNA levels (Kim et al 1998a).  The results once again demonstrated no correlation 
between productivity and antibody gene copy number or indeed growth rate. It was 
shown that the loss of copies of the amplified gene resulted in the majority of clonal 
instability; however reduced transcriptional efficiency and/or reduced mRNA stability 
also resulted in lower productivity levels per copy of the chimeric antibody gene 
following a non-selective culture period.   
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Several interesting observations concerning cell-line productivity and stability have 
also arisen from studies of the GS expression system, for example analysis of 17 NS0 
myeloma cells produced via limited dilution cloning revealed significant variation not 
only in productivity levels but also in growth rates (Barnes et al 2007). More 
significantly it was shown that no obvious correlation existed between growth and 
productivity. This is in agreement with work produced within our group which 
examined 31 NS0 sub clones and found that slow growth did not always equate to 
high production levels and vice versa, high growth rate did not necessarily result in 
low productivity (Carroll  2005). This would seem to contradict other results from our 
and other groups (Bi et al 2004, Watanabe et al 2001, Watanabe et al 2002, 
Fussenegger et al 1998) which show that productivity may be significantly enhanced 
by reducing or preventing cell growth. It is worth noting that the majority of the 
works demonstrating the ability to achieve higher productivities during slower growth 
were produced by comparing growth in a single clone, thus it is a comparison of 
dynamic growth rather than actual clonal variation. 
 
1.4. Regulation of the cell cycle  
As previously described the eukaryotic cell cycle may be divided into four stages 
known as G1, S, G2, and M. During the G1 phase of the cell cycle cells undergo 
preparation for the process of DNA replication, integrate mitogenic and growth 
inhibitory signals and therefore make the decision whether to proceed, stop or exit 
from the cell cycle. Within the G1 phase of both yeast and mammalian cells an 
important checkpoint exists. If a cell progresses beyond this checkpoint it becomes 
committed to DNA replication and completion of the cell cycle (Hartwell et al 1974, 
:urse 1975). Following the successful completion of the G1 phase the cell passes into 
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the S phase of the cell cycle, in which DNA synthesis occurs. This is then followed by 
a second gap phase known as G2, during which the cell prepares for the process of 
cell division. During M phase the previously replicated chromosomes are segregated 
and cytokinesis occurs resulting in the production of two daughter cells. An additional 
phase known as G0 exists in which cells may exit the cell cycle and become 
quiescent. 
 
The sequential activation and inactivation of cyclin-dependent kinases (cdks), through 
the periodical synthesis and destruction of cyclins provides the primary mechanism 
through which the cell cycle is regulated (figure 1.4). To date nine cdks and at least 16 
mammalian cyclins have been identified. All cyclins share a common region of 
homology known as the cyclin box, which is a domain used to bind and activate cdks. 
Although cyclins and cdks play crucial roles in the progression of the cell cycle, some 
have alternate functions, including the regulation of transcription, DNA repair, 
differentiation, and apoptosis. Several studies (Peng et al 1998, Rickert et al 1996, 
Roy et al 1994) have shown cyclin/cdk complexes, such as cyclin C/cdk8, cyclin 
T/cdk9, and cyclin H/cdk7, to be essential components of the basal transcription 
machinery.  
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Figure 1.4. The cyclin/cdk complexes involved in the regulation of the 
mammalian cell cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A simplified diagram of the cyclin/cdk complexes responsible for mammalian cell cycle 
progression. The cell cycle is initiated by the binding of cyclin D to cdk4 or cdk6, following which 
the binding of cyclins E and A to cdk2 results in the progression of the cell cycle. The final stage 
is catalysed by the binding of cyclin B to cdk1/cdc2. Dashed line represents the time period that 
the cyclin (circles) and cyclin dependent kinases (squares) are involved. 
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In addition to the process of cyclin binding, methods for regulating cdk activity also 
exist. It has been shown that the activity of kinases is able to be both positively and 
negatively regulated through the phosphorylation of cdk subunits (Arellano and 
Moreno 1997). In has also become increasingly apparent that ubiquitin-mediated 
proteolysis plays a critical role in the control of the cell cycle. This is made possible 
through the targeted destruction of cyclins and other regulators at key times during 
cell cycle progression (King et al 1996, Pagano 1997). The one way directionality of 
the cell cycle is provided by the irreversibility of proteolysis. Association with two 
families of proteins, the cdk inhibitors (CKI), is also an important level of cdk 
regulation. Interestingly, some CKIs appear to positively regulate the cell cycle by 
functioning as assembly factors for cyclin D/cdk complexes (LaBaer et al 1997). 
 
The D-type cyclins are the first to be induced during the G0 phase, stimulating the cell 
to enter the cell cycle (Sherr 1994). The levels of D-type cyclins do not oscillate 
during the cell cycle, unlike several of the other cyclins; instead their levels are 
controlled by the presence of growth factors. D-type cyclins are able to associate with 
and activate cdk4 and cdk6. It has previously been demonstrated that the D1, D2, and 
D3 cyclins are, for the most part, functionally redundant, however each has unique 
tissue specific functions (Sicinski et al 1995). Research has also shown that the 
primary substrate for D-type cyclin kinases is the retinoblastoma tumour suppressor 
protein (Rb). Studies of cells lacking Rb have shown that they do not require the 
activity of D-type cyclin kinases in order to undergo cycle progression (Lukas et al 
1995). D-type cyclins, as well as functioning as cdk4 and cdk6 regulatory subunits, 
also play an additional role in the targeting of Rb and Rb-related proteins for 
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phosphorylation through direct protein to protein interaction (Dowdy et al 1993, Ewen 
et al 1993, Kato et al 1993).  
 
The Rb protein also plays a crucial role in the regulation of G1 phase progression. It is 
able to bind to and regulate multiple cellular proteins, including members of the E2F 
family of transcription factors (Johnson and Schneider-Broussard 1998), which have 
been shown to be involved in the regulation of the expression of many genes encoding 
proteins involved in the cell cycle progression and DNA synthesis, such as cyclins E 
and A, cdc2 cdk1, B-myb, dihydrofolate reductase, thymidine kinase, and DNA 
polymerase α. The binding of Rb to E2F results in the inhibition of the transcriptional 
activation capacity of E2F’s and in some cases, changes their functionality from 
transcriptional activators to transcriptional repressors. Rb may become dissociated 
from E2F through its phosphorylation by D-type cyclin kinases resulting in the 
expression of E2F regulated genes (figure 1.5). Once E2F is activated, it is cyclin E 
that is  next to be induced as the cell progresses through the G1 phase of the cell cycle 
(Geng et al 1996, Ohtani et al 1995). 
 
In order for the cell to progress from the G1 to S phase of the cell cycle cyclin E is 
required to associate with cdk2, resulting in the formation of a kinase complex  
(Ohtsubo et al 1995). This complex has been shown to participate in the maintenance 
of Rb in a hyper-phosphorylated state (Hinds et al 1992) thereby providing a positive 
feedback loop allowing the accumulation of active E2F (figure 1.5). Unlike the D-
type cyclins, it has been shown that the activity of cyclin E kinase is still required 
even in cells lacking Rb. This would seem to indicate the existence of additional 
substrates for cyclin E/cdk2 (Ohtsubo et al 1995). As with many cyclin/cdk 
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complexes the cyclin E/cdk2 complex is able to phosphorylate histone H1, which may 
play an important role in the process of chromatin rearrangement which is required 
during the replication of the genome.  
 
Another cyclin which is also partially regulated by E2F is cyclin A (Schulze et al 
1995). During the G1/S phase transition cyclin A accumulates and then persists 
throughout S phase. Initially it associates with cdk2 however in late S phase it also 
associates with cdk1. Cyclin A-associated kinase activity is required for both entry 
and completion of S phase as well as entry into the M phase of the cell cycle (Girard 
et al 1991, Lehner and O’Farrell 1989, Walker and Maller 1991). Cyclin A has also 
been found to co-localize with DNA replication sites, indicating that it may be an 
active participant in DNA synthesis or have a role in preventing excessive DNA 
replication. Cyclin A is also able to negatively regulate some members of the E2F 
family; for example, E2F1, E2F2, and E2F3 all contain domains that are able to bind 
cyclin A, thereby enabling cyclin A-associated kinases to phosphorylate the E2F 
heterodimerisation partner DP1. This results in the inhibition of E2F DNA-binding 
activity (figure 1.5). Unlike cyclin E which as discussed earlier positively regulates 
E2F activity, cyclin A therefore participates in a negative feedback loop for E2F 
regulation. The G2 checkpoint responds to DNA damage by inducing a pause in the 
cell cycle that allows for DNA repair prior to the cell entering mitosis. The M phase 
of the cell cycle is regulated by cdk1 which is able to associate with the cyclins A, B1, 
and B2 (King et al 1994) to form complexes which are then able to phosphorylate a 
number of proteins including lamins, histone H1, and possibly components of the 
mitotic spindle.  
 
 Figure 
 
Two cell cycle kinases, CDK4/6
includes Rb and E2F are pivotal in controlling this checkpoint. During G1 phase, the Rb
repressor complex binds to the E2F
transcription. Phosphorylation of Rb by CDK4/6 and CDK2 dissociates the Rb
complex, permitting transcription of S
S phase switch and that are required for D'A replication
checkpoint control including TGFb, D'A damage, contact inhibition, replicative senescence, and 
growth factor withdrawal. Cell cycle progression may be halted in the G1 phase of the cell cycle 
through the expression of cyclin 
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In addition to transcriptional regulation, degradation of the activating cyclins and cdk 
inhibitors also plays a key role in the regulation of cdks. Cyclins responsible for the 
G1/S phase transition (D and E) have a relatively short life span in comparison to the 
cyclins responsible for G2/M progression (A and B), which are far more stable and 
only specifically targeted for destruction during mitosis. The cyclins A, B and E are 
degraded via ubiquitination which involves the post-translational modification of a 
protein by the covalent attachment via an isopeptide bond of one or more ubiquitin 
monomers. cdk34 is responsible for the expression of an ubiquitin conjugating 
enzyme that promotes the degradation of G1 phase cyclins and is therefore essential 
for the initiation of DNA replication (King et al 1996). It has previously been shown 
(Yew and Kirschner 1997) that the initiation of DNA replication in Xenopus embryos 
by cdc34 may facilitate the degradation of cyclin E/cdk2 inhibitor via the ubiquitin 
proteasome pathway. Cyclin E is also degraded via the ubiquitin pathway, but only 
when it is auto-phosphorylated through its association with cdk2 on Thr-380, thereby 
providing a specialized mechanism for the regulation of its own half life (Won and 
Reed 1996). 
 
In contrast cyclin B degradation is mediated by a large multi protein complex known 
as the anaphase promoting complex (APC), or cyclosome that is able to 
polyunbiqitise cyclin B and other proteins, thereby increasing their sensitivity to 
proteasome degradation. APC becomes active via phosphorylation in a cell cycle 
dependent manner and its activity is regulated by the mitotic checkpoint protein 
MAD2 which when activated blocks the activity of the ubiquitin liagase (Li et al 
1998). The targets of APC mediated degradation contain a specific nine amino acid 
sequence known as the destruction box. The above examples indicate that the 
36 
 
proteolysis of specific proteins maybe controlled via cell cycle regulated 
phosphorylation of the target proteins, by increasing their sensitivity to cdc34 
mediated ubiquitination or by the cell cycle regulated activation of ubiquitination 
machinery, which then enables the degradation of the target proteins. 
 
1.4.1. The p21 family of cdk inhibitors 
There are two families of cyclin dependent kinase inhibitors (CKI), known as the 
INK4 inhibitors and the Cip/Kip inhibitors. The INK4 family specifically inhibits 
Cdk4 and Cdk6 activity during the G1 phase of the cell cycle, while the Cip/Kip 
family (p21
Waf1/CIP1
, p27
Kip1
, p57
Kip2
) can inhibit cdk activity during all phases of the 
cell cycle (Pietenpol and Stewart 2002). p21 was initially identified through its ability 
to interact with cdk2, however it has since been shown that members of this family 
are able inhibit a broad range of cyclin/Cdk complexes that include cdk1, 2, 4, 6 and 
cyclins A, B, D or E, but appear to show a preference for those containing Cdk2 
(figure 1.5) (:akayama 1998, Dotto 2000). In addition p21 is also able to interact 
with proliferating cell nuclear antigen (PCNA), an elongation factor for DNA 
polymerase δ, as well as a component of the DNA repair machinery (Fussenegger and 
Bailey 1998). The binding of p21 is able to inhibit the ability of PCNA to function in 
DNA replication but not DNA repair.  
 
The activity of this family of inhibitors is controlled at several levels; however the 
relatively constant levels of p27 mRNA as well as its rate of translation during the cell 
cycle would seem to suggest that the p27 protein is the main target for regulation. 
Several studies (Morisaki et al 1997 and Pagano et al 1995) have demonstrated the 
fact that the phosphorylation of Thr-187 in p27 by cyclin E/cdk2 during late G1 phase 
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sensitizes the protein to proteolysis. The suppression of cyclin D/cdk4, 6 or cyclin 
E/cdk2 ability to phosphorylate proteins responsible for the establishment of S phase 
prevents the cell from exiting the G1 phase of the cell cycle. Progression through S 
phase may also be blocked through the over expression of p21, most likely as a result 
of suppression of cyclin A,E/cdk mediated phosphorylation of the proteins required 
for replication of the cell’s DNA. p21 and in some cases p27 can also arrest cells in 
the G2 phase of the cell cycle presumably through the inhibition of cyclin A/cdk2 (Liu 
et al 2003). 
 
p21 expression is induced by the growth factors that control the Ras- Raf- MEK- 
MAPK pathway suggesting that p21 may play a positive role in the progression of the 
cell cycle. It has been suggested (Liu et al 1996) that at low concentrations p21 
facilitates cellular proliferation by promoting the assembly of p21/cyclin/cdk/PCNA 
complexes, whereas at high concentrations such as those invoked by cellular stress; it 
becomes inhibitory as the excess p21 molecules smother the complex. This is in 
agreement with (Zhang et al 1994) who found that p21/cyclin/cdk/PCNA complexes 
can be found in both catalytically active and inactive complexes in untransformed 
cells; however inactive complexes were shown to contain significantly more p21 
subunits. 
 
Although p21 has been shown to exert both pro and anti-apoptotic effects such effects 
are not fully understood (Liu et al 2003).  It has been suggested that through the 
binding of p21 to either procaspase 3 or 8, apoptosis signal-regulating kinase 1 
(ASK1) or any of the cyclin complexes it is able to inhibit apoptosis. In contrast the 
binding of p21 to caspase 3 may well induce apoptosis (Gartel and Tyner 2002).  
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Interleukins -6 and -4 have also been implicated in the prevention of apoptosis 
through the control of p21 (Gartel and Tyner 2002), resulting in cell cycle arrest 
instead.   
 
In order to function correctly and prevent degradation p21 requires stabilisation.  
Some of the stabilization partners include PCNA as mentioned earlier, but also 
chaperones like WISp39 and Hsp90. Without stabilisation the over-expression of p21 
has a limited effect on both cell cycle arrest and the induction of apoptosis (Liu and 
Lozano 2005). C/EBPα is also reported to be able to stabilise p21 during its 
interaction with the cdk2 complex in both quiescent hepatocytes and in differentiated 
adipocytes (Timchenko et al 1997) as well as in cultured cells (Harris et al 2001).  
p21 can also inhibit transcription factors like E2F, thereby blocking the transcription 
of growth-related genes (Coqueret 2003, Dotto 2000). In contrast the unregulated 
activity of E2F transcription factors have been shown to induce the over expression of 
p21, resulting in S phase cell cycle arrest (Radhakrishnan et al 2004).  Based on the 
current literature it would appear that the role the p21 protein  takes is very much 
dependent on its location (Coqueret 2003).   
 
1.5. The control of the cell cycle for enhanced productivity 
Control over the cell cycle and thus cell proliferation has long been employed by the 
biotechnology industry as a method to increase productivity. Unlike the variation in 
productivity observed between clones, described earlier in this chapter, controlled 
proliferation methods appear to increase cellular productivity in response to stimuli. 
The hypothesis behind this concept is based on the idea that slow growing or 
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proliferation arrested cells are able to devote their metabolic resources and protein 
synthesis machinery to the production of the desired recombinant protein as opposed 
to cell division (Fussenegger and Betenbaugh 2002).  The prevention of cell 
proliferation in cultures of optimal density has also been shown to reduce nutrient 
limitation, the accumulation of toxic by-products and cell lysis, as well as potentially 
reducing product contamination from cellular debris (Fussenegger et al 1998). This 
has the added effect of improving overall culture viability and duration. To date the 
debate over which particular phase of the cell cycle is most productive continues 
although several studies have implicated the G1 and G2 phases as being periods of 
high productivity (Carvalhal et al 2003).  
 
Several factors can affect productivity, including changes in cell morphology (Lloyd 
et al 2000, Mazur et al 1999, Ryu et al 2001), clonal variation due to the selection 
process or gene copy number (Ryu et al 2000, Kim et al 2000a, Ryu et al 2001, 
Meents et al 2002), the cell-line used and the protein being produced (Yoon et al 
2003, Carvalhal et al 2003) as well  as the type of promoter selected (Fussenegger et 
al 1997, Carvalhal et al 2003, Lloyd et al 2000, Meents et al 2002, Gu et al 1996, 
Banik et al 1996) (figure 1.6). In recent years it has been shown that the prevention of 
cellular proliferation alone is not directly responsible for the observed increases in 
productivity. It is possible for proliferation arrest to occur naturally during culture 
conditions following nutrient and serum depletion. (Yuk et al 2002, Kim et al 2000b, 
Sanfeliu et al 2000, Seifert and Phillips 1999, Carvalhal et al 2003). During these 
periods productivity is often adversely affected as media conditions play a vital role in 
determining productivity levels. (Lloyd et al 1999, Sanfeliu et al 2000).   
 
  
 
Figure 1.6. A simplified diagram of the key processes that occur within a 
production cell-line. 
 
 
Simplified diagram of the key processes that occur in a production 
via external stimuli or changes in growth conditions. These signals are processed by the cells 
signalling network resulting in either cell proliferation or a
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cell-line following stimulation 
poptosis as well as product secretion.
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In order to improve the productivity of industrially important cell-lines several 
strategies have been developed, which generally fall into one of three categories, 
environmental, chemical or genetic. Environmental factors that are able to affect cell 
proliferation are well documented and include the depletion of essential culture 
medium nutrients such as glucose, glutamine and serum (Yuk et al 2002, Lloyd et al 
1999, Sanfeliu and Stephanopoulos 1999, Sanfeliu et al 2000), the accumulation of 
toxic by-products such lactate and ammonia (Yang and Butler 2000), changes in 
temperature (Jenkins and Hovey 1993), and cell-cell contact inhibition (Modiano et al 
1999).  Although such changes directly affect the rate of proliferation the effect of 
such conditions on productivity is far from favourable. The analysis of which 
elements become depleted during periods of high productivity has however helped 
improve productivity by enabling the development of feed strategies. This enables the 
depleted nutrients that are essential for improved productivity to be replaced, thereby 
lengthening the period of production. 
 
More direct environmental methods include changing the growth medium osmolarity. 
During the culture period the osmolarity of the growth medium naturally increases 
due to the secretion of by products by the proliferating cells. There has to date been 
several studies into the effect of increasing or decreasing the osmolarity of the culture 
media on productivity. One of the most successful of these approaches has been to 
increase the osmolarity (hyperosmolarity) through the addition of low cost salts such 
as sodium chloride. (Kim et al 2000a, Oh et al 1993, Oh et al 1995, Ryu et al 2000, 
Ryu et al 2001, Takagi et al 2001). The exact mechanisms through which these 
changes are able to increase productivity remains unclear, but has been shown to 
result in a depression of the rate of cellular proliferation (Oyaas et al 1994, Lee and 
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Park 1995). One possible explanation suggested for this is an increase in recombinant 
protein mRNA levels (Lee and Lee 2000, Lee and Lee 2001, Ryu et al 2001), but at 
higher levels of osmolarity (e.g.542mOsm/kg) the enhancement of translation and 
post-translational processes may also play an important role (Ryu et al 2001). In 
contrast other studies  (Sun et al 2004) have shown that increases in mRNA levels 
may not be responsible for increased productivity and that  increased translation rates 
together with a decrease in the transit time through the endoplasmic reticulum and 
golgi body may well be the responsible for the observed changes in productivity.  
 
More recently (Mc:eeley et al 2005) examined stained antibody expressing 
hybridoma cells over a period of 50 hours, in order to examine the effects of osmotic 
shock on productivity.  The results seem to show an initial decrease in intracellular 
antibody concentration during the exponential phase followed by an increase in 
comparison to the control culture. This occurred regardless of cell cycle phase and 
when normalised to the increase in cell size observed in the osmotically shocked cells, 
was found to be significant.  No apparent relationship could be found between the 
intracellular antibody concentration and the rate of secretion. In another study of 
osmotically shocked hybridoma cells (Sun et al 2004) the analysis was extended to 
include translational and  posttranslational processing elements. It was found that 
osmotically shocked cells contained both more total RNA and mRNA throughout the 
culture period than the control culture; however when this increase was normalised 
with cell number it was determined to be relatively small. It was therefore determined 
that the levels of mRNA do not significantly contribute to the observed increase in 
productivity. Examination of the osmotically shocked cells on a per cell basis 
revealed an increase in translation within 8 hours of induction that continued for 84 
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hours following the initial increase in osmolarity. This was found to result in a 
significant increase in both the intracellular protein concentration and productivity. 
Interestingly this study also found that ER chaperones such as BiP, GRP and PDI did 
not change significantly during periods of osmotic shock indicating that they do not 
play a crucial role in improving productivity. It would appear that exposure of the 
cells to osmotic shock allows them to become more efficient in their utilisation of 
these chaperones during the process of antibody assembly. 
 
Based on the current literature it would therefore appear that there are at least four 
possible mechanisms for the observed increase in productivity that results from 
periods of osmotic shock. These include transcriptional activation due to changes to 
the chromatin structure (Lee and Lee 2000, Ryu and Lee 1999); induction of 
chaperone proteins that are directly involved in protein processing and secretion (Lee 
1992); enhanced transport of nutrients into the cell (Oh et al 1993, Oh et al 1995) and 
increased ATP production rates (Lin et al 1999). There is also the possibility that cells 
may accumulate within the G1 phase of the cell cycle. G1 has been previously been 
observed to be an optimal environment for increased production levels to occur 
(Fussenegger et al 1998, Fussenegger and Bailey 1999) however in this case this final 
hypothesis may be the least reliable as evidence exists for cells accumulating in the S 
phase of the cell cycle during hyperosmotic conditions (Yi et al 2004, Sun  et al 2004).   
 
The effect of medium osmolarity on culture viability and thus productivity has also 
been extensively studied as a drop in viability would seriously limit the use of 
hyperosmolarity media in biphasic cultures. The results of these studies vary; for 
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example (Carvalhal et al 2003) demonstrated a decrease in viability that was dose 
dependent, where as other studies have found no significant decrease (Sun et al 2004). 
In a similar study on BHK cells, it was found that increasing the osmolarity up to 470 
mOsm/kg did not increase the rate of apoptosis (Yi et al 2004), though (de Zengotita 
et al 2002) reported an increase in apoptosis due to elevated osmolarity.  This would 
seem to suggest that effect of medium osmolarity and therefore the potential to 
increase productivity is very much dependent on the cell-line used (Ryu et al 2000) 
and the gene copy number (Ryu et al 2001).   
 
In another study on several CHO clones with differing recombinant gene copy 
numbers (Ryu et al 2001), it was found that although all clones tested were affected 
by hyperosmotic conditions, resulting in a reduction in the rate of proliferation and 
increased productivity, the degree to which proliferation was arrested and productivity 
increased varied from clone to clone. The results demonstrate that the clone with the 
highest copy number was most susceptible to the effects of medium osmolarity. In 
order for osmolarity to be considered as a real strategy for use in the industrial scale 
production of recombinant proteins, it is essential that its effect on product quality and 
fidelity is fully understood. To date there have been very few studies in this area 
however a report published in 1999 (Cherlet and Marc 1999) demonstrated that a 
gradual increase in osmolarity during continuous culture resulted in an increase in the 
amount of defective antibodies produced. It has also been suggested that the potential 
exists to utilise hyperosmolarity to reduce the aggregation of proteins such as 
monoclonal antibodies, to better facilitate their separation and purification (Franco et 
al 1999).  In an alternate study (Lin et al 1999) it was found that the adaptation time 
of hybridoma cells during hyperosmotic conditions was 6 hours and that by increasing 
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the osmolarity gradually during the period of investigation it was possible to achieve a 
higher growth rate and thus productivity. In a similar study of Bcl-2 transfected 
hybridomas it was found that while it was impossible to adapt the control culture to 
400mOsm, the Bcl-2 transfected cells were able to withstand the osmotic stress, 
resulting in long term adaptation to a high salt environment.  In addition when grown 
in a high osmolarity medium, it was found that the productivity of the Bcl-2 
transfected cells was 100% higher than that of non adapted Bcl-2 transfected cells 
grown in normal osmolarity medium. 
 
Another environmental strategy which has been the subject of much investigation is 
the effect of changes in culture temperature away from the perceived optimal 37
0
C.  
Initial studies of the effects of mild increases in temperature; for the most part have 
been unsuccessful. Although such changes do result in growth arrest, in a number of 
instances this may also result in an increase in glucose metabolism as well as a 
reduction in both viability and productivity (Fussenegger and Bailey 1999). In 
contrast the effect of lowering cell culture temperature has proven to be a quite 
successful strategy for reducing cell proliferation rates and improving productivity 
(Furukawa and Ohsuye 1999, Schatz et al 2003, Bollati-Fogolin et al 2005). Evidence 
exists however which would seem to suggest that these observations may be cell-line, 
or product` specific as in some studies no effect on either proliferation or productivity 
was observed (Yoon et al 2003 and 2006, Barnabé and Butler 1994, Ryll et al 2000). 
 
Several studies on CHO cell-lines have demonstrated a positive effect on productivity 
during periods of growth at colder than usual temperatures. One example of this is a 
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study of 12 CHO clones subjected to low (32
0
C) culture conditions, all the clones 
tested showed both a reduction in proliferation and an increase in productivity; 
however following amplification with MTX several clones showed no further 
enhancement to their productivities (Yoon et al 2003). Other studies have also 
demonstrated variation in the temperature at which proliferation rate is affected for 
example analysis of CHO cells grown at temperatures ranging from 30
0
C to 37
0
C 
found that only temperatures below 35
0
C resulted in a reduction in the rate of 
proliferation (Furukawa and Ohsuye 1999). In contrast another study on CHO cells 
found no reduction in proliferation rates at temperatures above 32
0
C (Ducommun et al 
2002) and when hybridoma cells are exposed to similar conditions it has been found 
that rate of productivity either decreases or remains unchanged (Al-Fageeh et al 
2006).   
 
Possible explanations for the ability of mild hypothermia to arrest cell proliferation 
include the over expression of cold-shock proteins (CSPs) such as cold-inducible 
RNA-binding protein (CIRP) (:ishiyama et al 1997, Sonna et al 2002), and RBM3  
(Danno et al 2000). In addition several studies have also suggested that the observed 
reduction in cell proliferation occurs as a result of p53-dependent cell cycle arrest, in 
which cells accumulate within the highly productive G1 phase of the cell cycle 
(Fussenegger and Bailey 1999). It is interesting to note that over-expression of CIRP 
at 37
0
C results in the accumulation of cells in G1 phase suggesting that arrest at 32
0
C 
is an active process. Although G1 phase has been correlated with enhanced 
productivity, additional studies have shown other phases of the cell cycle are 
preferable for recombinant protein production. In fact, (Fox et al 2005) have 
suggested that the S-phase of the cell cycle is preferable for recombinant protein 
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production in CHO cells. In their study it was demonstrated that when CHO cells 
were grown at 32
0
C, increases in specific productivity directly correlated to the 
percentage of cells in the S phase of the cell cycle, suggesting that arrest in the G1 
phase is not the only factor involved in enhanced productivity during reduced 
temperature cultivation of CHO cells. 
 
Alternate studies have shown that when the temperature at which CHO cells are 
cultured is dropped from 37 to 30
0
C, up to 87% of cells undergo proliferation arrest at 
the G1 phase of the cell cycle resulting in a significant delay in the onset of apoptosis 
(Moore et al 1997). Interestingly it has also been reported (Zhang et al 2001) that the 
expression of the anti-apoptotic protein Bcl-2 is enhanced in hippocampal neurons in 
response to growth at 33
0
C. During periods of cultivation at 30
0
C it has also been 
shown (Moore et al 1997) that the rate of both oxygen uptake and ATP consumption 
in CHO cells are reduced by up to 50%. It is therefore quite possible that the observed 
delay in the onset of apoptosis and its associated increase in productivity during 
periods of mild hypothermia are partially due to a reduction in cellular metabolism. 
Despite the emergence of several hypotheses to the mechanisms through which 
hypothermia is able to induce proliferation arrest, the mechanisms by which 
productivity is enhanced remain less clear.  
 
There are a number of factors that contribute to increased recombinant protein 
productivity at reduced temperatures other than the ability to improve culture 
longevity. Recent studies have reported increases in both total RNA (Borth et al 1992) 
and recombinant mRNA levels (Furukawa and Ohsuye 1999, Yoon et al 2003) during 
growth at reduced temperatures. In a study of CHO cells producing recombinant 
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human IFN-y (interferon-y), it was found that during periods of growth at lower 
temperatures productivity increased due to higher recombinant IFN-y mRNA levels 
(Fox et al 2005).  It was also determined that product gene transcription rates increase 
and that product mRNA stability when normalised with actin mRNA stability, used as 
a housekeeping gene, were also changed to a similar extent. To date research into the 
effects of hypothermic growth conditions would seem to suggest that at reduced 
temperatures either transcription of the recombinant gene of interest is enhanced, or 
that mRNA stability of these transcripts is increased. This observation could provide, 
at least partially, an explanation as to why increased recombinant protein production 
is observed at reduced temperature cultivation.  
 
An alternative to the environmental methods described above is the addition of 
chemicals or additives to the culture medium that are able to halt cell proliferation. 
During the early 1990s DNA synthesis inhibitors (thymidine, hydroxyurea, TGF-β 
and adriamycin) (Suzuki and Ollis 1990) selective protein synthesis inhibitors 
(potassium acetate and cycloheximide) and the RNA synthesis inhibitor actinomycin 
D (Suzuki and Oliss 1990) along with several other chemical additives (aphidicolin, 
rapamycin, doxorubicin, staurosporine, mimosine and nocodazole) (Carvalhal et al 
2003, Grosjean et al 2002) underwent trials for their effects on cell proliferation and 
cell viability. In most cases the addition of these chemicals has been found to result in 
cell cycle arrest within a specific phase of the cell cycle dependent on the chemical 
used, but it has also been shown that culture viability can also be adversely affected 
dependent upon the type and concentration of chemical used (Fussenegger and Bailey 
1999). As a result of both their affect on culture viability as well as issues with the 
49 
 
downstream processing and purification process these chemicals are generally 
considered unsuitable for industrial application. 
 
One chemical which is commonly used in the biopharmaceutical industry is sodium 
butyrate (Fussenegger and Bailey 1999). It has the ability to not only arrest cell 
proliferation in a variety of mammalian cell-lines, but also elicits an increase in the 
production of a wide variety of industrially important proteins including tissue-type 
plasminogen activator (t-PA) (Arts and Kooistra 1995, Kooistra et al 1987), follicle 
stimulating hormone (FSH) (Gebert and Gray 1995) and monoclonal antibodies 
(Chevalot et al 1995, Mimura et al 2001, Oh et al 1993). Sodium butyrate has 
previously been shown to be capable of inducing a number of changes within the 
nucleus of the cell, including hyperacetylation and DNA methylation (Fussenegger 
and Bailey 1999) increasing transcription and resulting in p53-independent induction 
of p21 (Kijima et al 1993, :akano et al 1997). Sodium butyrate itself is known to be 
cytotoxic at higher concentrations which may well result in a decrease in culture 
viability. In a recent study of recombinant CHO cells expressing human 
thrombopoietin (hTPO), grown as serum-free suspension cultures; it was found that 
productivity could be enhanced through induced proliferation arrest as a result of 
sodium butyrate addition. During exposure to sodium butyrate it was noted that cells 
underwent apoptosis in a dose-dependent manner. Through the expression of the anti-
apoptotic gene Bcl-2 it was possible to prevent apoptosis and extend culture longevity 
whilst enabling productivity to be enhanced 10/fold in comparison to non-Bcl-2-
expressing cultures (Sung and Lee 2005). 
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More recently several groups have examined the potential for the use of extracellular 
nucleotides, nucleosides and bases as proliferation arresting agents.  Although natural 
adenosine derivatives like NADH, NAD, ATP, ADP, AMP and adenosine have 
previously been shown to inhibit the proliferation of normal and tumour cells in vitro 
(Wagner 1997), in a study of CHO cells by Carvalhal and co-workers (Carvalhal et al 
2003) they were able to demonstrate the ability of these compounds to enhance 
productivity. In this study it was found that adenosine 5’-monophosphate (AMP) was 
able to produce the greatest increase specific productivity as a result of proliferation 
arrest in the S phase of the cell cycle.  Although not clear one possible mechanism for 
the effect of nucleotides on proliferation and productivity is that during their addition 
the nucleotides are taken into the cell and phosphorylated by adenosine kinase to 
AMP which primarily inhibits the 5 Phosphoriboxy-1-diphosphate-synthetase. As a 
result, the nucleotide pool, with the exception of AMP, ADP and ATP, decreases 
potentially leading to a reduction in cell growth (Wagner 1997). An important 
consideration when using such natural compounds is that their effect depends on the 
medium that is used since some mediums include certain amount of the nucleotides, 
nucleosides and bases (Carvalhal et al 2003). The main advantage however of these 
compounds is that they are naturally synthesized by the cell and are therefore 
expected to be less toxic than other foreign compounds (Carvalhal et al 2003).   
 
The final approach taken in recent years is the use of recombinant DNA technology in 
order to produce cell-lines able to express cytostatic genes. The  development of 
expression systems able to coordinated and regulate multiple genes (Gòdia and Cairo 
2002, Fussenegger and Bailey 1999) has made it possible to in a sense switch on or 
off the expression of cytostatic genes. One of the best studied of the cytostatic genes 
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is p21. The biphasic induction of p21 is most commonly established through the use 
of either tetracycline repressible expression control (TetOFF) (Fussenegger et al 
1997, Sekiguchi and hunter 1998) or the lac operon operator and repressor gene 
switch (LacSwitch) (Ibarra et al 2003, Watanabe et al 2002). There is the potential 
for the use of other multicistronic expression systems (Fussenegger 2001); however 
they are generally not as well documented through the current literature.  
 
Several studies have demonstrated the ability of p21 over-expression to arrest cell 
proliferation in numerous industrially important cell-lines including BHK, CHO and 
NS0 (Sekiguchi and Hunter 1998, Bi et al 2004, Watanabe et al 2002).  During the 
over-expression of p21 cell proliferation becomes arrested at the G1 phase of the cell 
cycle and an increase in cell size is often observed (Bi et al 2004). In order to achieve 
complete cell cycle arrest the level of p21 expression must be high. This is due to the 
fact that a single cyclin kinase requires more than one p21 molecule to inhibit its 
activity (Sekiguchi and Hunter 1998). As a result only the sustained expression of p21 
is able to result in long term proliferation arrest (Watanabe et al 2002). When p21 
expression is halted it has been shown that cells are quickly able to begin recycling 
through the cell cycle (Bi et al 2004).   
 
To date almost all of the published work on p21 have shown that during its over-
expression the specific productivity of the cell is increased (Watanabe et al 2002, 
Fussenegger et al 1997, Fussenegger et al 1998), with the exception of one study in 
which no change in protein production was observed (Mazur et al 1998). The exact 
mechanisms through which productivity is increased remains unclear however it has 
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been suggested that an uncoupling of growth and proliferation occurs, resulting in the 
independent and continued growth of the proliferation-arrested cells. Similarly there 
is relatively little published material on the metabolic changes and protein quality 
during p21 induction, however in one study (Bi et al 2004) it was noted that metabolic 
activity, as determined through an MTT assay, increased 1.6/fold during p21-induced 
proliferation arrest and was in addition accompanied by an increase in mitochondrial 
mass. Interestingly the study also found an increase in S6 ribosomal protein 
expression in p21 expressing cultures. Since S6 protein plays a key role in ribosomal 
biogenesis this may partially explain the observed the increase in protein synthesis.  
 
The effect on culture viability during periods of p21-induced cell cycle arrest seems to 
vary and may well be cell-line dependent. Several studies have shown that during 
p21-induced proliferation arrest the viability of the arrested cells does not decrease 
significantly (Bi et al 2004) whilst others have found a slight decrease (Watanabe et 
al 2002).  Despite this there is evidence to suggest that p21 may actually protect 
certain cell-lines from apoptosis (Polyak et al 1996, Fussenegger et al 1998), 
although this appears to be limited to certain insults such as mitogen deprivation and 
prostaglandin A2 (Wang and Walsh 1996, Gorospe and Holbrook 1996) 
 
Like p21, biphasic induction of p27 may be achieved through the use of either the 
tetracycline repressible expression control (TetOFF) (Fussenegger et al 1997, 
Kaufmann et al 2001, Mazur et al 1999) or a ecdysone-inducible gene regulation 
system (Meents et al 2002). Expression of p27 has also been shown to result in cell 
cycle arrest in the G1 phase of the cell cycle phase and as seen with p21 results in 
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both an increase in cell size (Meents et al 2002, Mazur et al 1999) and specific 
productivity (Mazur et al 1998, Fussenegger et al 1997).  In one study in which the 
ecdysone-inducible system was utilised , the productivity of p27-expressing cultures 
was observed to increase steadily until it was approximately 5/fold higher (Meents et 
al 2002). Analysis of product quality has shown no change during periods of p27 
expression, with both isoform patterns and sialylation ratios remaining similar to 
those seen in proliferating cells (Kaufmann et al 2001). 
 
Although viability has been shown to remain high in p27-expressing cultures 
(Fussenegger et al 1997, Kaufmann et al 2001, Meents et al 2002, Mazur et al 1998) 
the spontaneous formation of mutants that are able to escape from proliferation arrest 
has been shown to readily occur (Mazur et al 1999).  In an alternate study 
(Fussenegger et al 1998) was able to demonstrate that by over-expressing p27 
together with bcl-xL, the productivity of SEAP could be further increased by a factor 
of 3 from that observed during p27 over-expression alone.  It was suggested that 
tetraploidy and the consequent amplification of genetic information following bcl-xL 
over-expression could be responsible however it is clear that genetic methods of 
controlling proliferation have not been as well understood as other methods.   
 
IRF-1 is a transcription factor that has previously been shown capable of inducing the 
transcription of several interferon-induced genes including the cell cycle-dependent 
kinase inhibitor p21, the translation-initiation factor 2 kinase PKR, the p200 family of 
transcription repressors, and 2.5-oligoadenylate synthetase, whose products activate 
the mRNA-degrading enzyme RNase L (Kirchhoff et al 1993, Harada et al 1998). 
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This would seem to suggest that IRF-1-induced growth arrest results from the activity 
of multiple gene products. Previous studies have shown that the over-expression of 
recombinant IRF-1 results in the inhibition of cell proliferation, the extent of which is 
dependent on the intracellular concentration of active IRF-1. In order to achieve this 
in mammalian cell-lines fusion protein composed of IRF-1 and the hormone binding 
domain of the human estrogen receptor has been used. This system allows the gradual 
control of cell proliferation by adjusting the intracellular concentration of active IRF-
1 via the addition of estradiol to the culture medium (Kirchhoff et al 1996). 
 
IRF-1-induced proliferation arrest has been shown to increase productivity in cell-
lines expressing various monoclonal antibodies (Geserick et al 2000) as well as 
resulting in an increase in cell size and a dramatic change in cell morphology 
(Carvalhal et al 2002).  Unlike p21 and p27 the over expression of IRF-1 has been 
shown to lengthen all phases of the cell cycle, but decreased cell viability, possibly as 
a result of apoptosis, but more likely, due to necrosis (Carvalhal et al 2001, Carvalhal 
et al 2002). The specific productivity of IRF-1 expressing BHK cells has been 
reported as being either unchanged or lower than the control cultures despite an 
increase in the total protein content per cell towards the end of the culture.  This is 
likely to be due to an increase in intracellular protein synthesis, including higher 
proteolytic enzyme activity (Kirchhoff et al 1996, Kirchhoff et al 1993, Carvalhal et 
al 2001, Müller et al 1999).   
 
It has been reported that some cell-lines may be able to ‘adapt’ to the presence of 
estradiol, thereby releasing the cells from proliferation arrest (Carvalhal et al 2001). 
In an attempt to overcome this problem it has been shown that by cycling the addition 
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of estradiol rather than continuously adding it to the growth medium it is possible to 
maintain proliferation arrest without the risk of cells becoming resistant to its effects 
(Carvalhal et al 2001). This method may serve a dual purpose as long term exposure 
to estradiol and the subsequent arrest has been reported to result in a reduction in 
culture viability (Carvalhal et al 2000). Despite this during the long term perfusion 
culture of IRF-1 inducible BHK cells it has been shown that it is possible to increase 
the production of antibody by 6/fold upon growth arrest, although the protein 
expression did decrease gradually over the 7 week culture period. In addition it was 
also found that these cells could not be induced further in subsequent growth-
repression cycles (Geserick et al 2000).   
 
Upon IRF-1 induction there is a significant change in the metabolism of the cell. It 
has been shown that although the DNA content remains unchanged, the cell 
undergoes a significant increase in proteolytic enzyme activity, metabolic activity, as 
determined through a MTT assay, protein synthesis and mitochondrial activity 
(Carvalhal et al 2002).  These changes have been shown to result in an increased 
catabolic flux of glucose and glutamine with lower yields of ammonia and lactate 
(Carvalhal et al 2002). In terms of protein quality, IRF-1 induction results in proteins 
with equivalent glycosylation patterns to that of the control as well as a slight increase 
in sialylation (Mueller et al 2000). In summary` controlled proliferation either through 
the addition of chemical additives, environmental changes or genetic engineering, can 
be achieved in animal cell culture.  Using the techniques described above, 
proliferation can be effectively controlled, and in numerous cases result in higher 
specific productivity of heterologous protein than the non-arrested controls  
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1.6. An overview of the development of research in the field of 
programmed cell death 
The subject of cell death has been challenging scientists for almost 200 years (see 
figure 1.7 for summary). As early as 1842 the physiological existence of cell death 
had been identified and by the late nineteenth century several publications had began 
to emerge describing cell death during the development and metamorphosis of insects 
(Clark and Clark 1996). By the 1950s it had also been established that cell death was 
also able to occur in individual cells during vertebrate embryo development 
(Glucksman 1951). This eventually led to the discovery that cell death played a vital 
role in the sculpting of tissues during embryonic development. 
 
It was not until the mid-twentieth century that the term programmed cell death (PCD) 
was really introduced as a term used to describe the observed process of cell death 
during development (Lockshin and Zakeri 2001, Clarke and Clark 1996). Up until 
this point the terminology used had been confusing to most scientists and was used to 
describe different things by different research groups. Lockshins definition described 
a series of events that was predetermined and occurred as a specific series of events.  
In 1966 it was determined that PCD was not universal to all cell types and therefore 
not always necessary, instead it was shown that PCD could be activated by external 
stimuli such as through exposure from secreted hormones from a different cell type 
(Saunders 1966). These findings ultimately lead to the discovery that cells are able to 
utilize the process of PCD to facilitate their own demise in response to unfavourable 
growth conditions. 
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Figure 1.7. A schematic diagram of key historic events in the field of cell death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A basic timeline of the key discoveries in the field of cell death which have lead to the 
development of our understanding of the process of apoptosis. 
 
 
As the subject of cell death grew and diversified within the biological fields a 
multitude of terms were put forward to describe PCD including necrosis, cell 
shrinkage and necrobiosis. In 1972 Kerr, Wyllie and Currie introduced the term 
“apoptosis” based on an ancient Greek word for the "falling off" of leaves from trees 
or petals from flowers, to describe a mechanism of controlled cell death, which 
appeared to have a complementary but opposite role to mitosis in the regulation of 
cellular proliferation (Kerr et al 1972). It was observed that during the process of 
apoptosis the cells followed a specific pattern of morphological changes that included 
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the shrinkage of the cell with little or no damage to organelles, coalescence and 
margination of chromatin, and the fragmentation of the cell and its nucleus. This led 
to the belief that apoptosis was the primary mechanism by which all cells die and are 
replaced within most normal tissues as well as being responsible for the destruction of 
cells, as necessary during embryonic development.  
 
By the second half of the 1970s the increasing development of molecular genetics 
techniques made it possible to analyze the mechanisms through which cell death is 
controlled. The discovery of the complete cell lineage of Caenorhabditis elegans 
(Kimble and Hirsh 1979, Sulston et al 1983) made it possible to analyze cell 
destruction and formation in the developing Caenorhabditis elegans embryo, enabling 
John Sulston and Robert Horvitz to demonstrate that approximately 13% of somatic 
cells in the developing embryo die predictably at set time intervals (Sulston and 
Horvitz 1977). This provided the first model to allow the study of the genetic basis of 
cell death and by 1982 members of the Massachusetts Institute of Technology 
laboratory had successfully established the existence of genes that controlled 
essentially all the somatic cell deaths, including ced-3 (Horvitz et al 1982, Hedgecock 
et al 1983, Horvitz et al 1983, Trent et al 1983, Ellis and Horvitz 1986, Horvitz 2003). 
 
During the 1990s interest into the subject of apoptosis surged, leading to several 
studies by research groups from various backgrounds. The identification of p53s 
function as a pro-apoptosis regulator by a research group headed by Elisheva Yonish-
Rouach (Yonish-Rouach et al 1991, Lowe et al 1993) inspired several other groups to 
take up the search for inducers of apoptosis and eventually lead to the discovery of a 
similar function for c-Myc (Buttyan et al 1988, Evan et al 1992). At the same time 
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another group lead by David Vaux and his colleagues identified the B-cell lymphoma 
gene Bcl-2 as an anti-apoptosis gene (Vaux et al 1988) thus, bringing the subject of 
apoptosis into the field of immunology and leading to the aggressive pursuit of the 
identification of Bcl-2 and its family members by other research groups including that 
of Stanley Korsemeyer. (Korsemeyer 1999). The final key discovery was the 
identification of Fas/Apo-1 as a death-transducing cell-surface receptor (Trauth et al 
1989). These discoveries began the avalanche that eventually lead to the unification of 
immunology, cell biology, embryology and neurobiology in the pursuit for and 
understanding into the mechanisms and regulation of the process of cell death. 
 
 
1.7. Morphological features of apoptosis 
 
Apoptotic cells all undergo several significant morphological changes that include the 
overall shrinkage of the cell, deformation and loss of its ability to make contact with 
neighbouring cells, chromatin condensation and margination of the nuclear membrane 
(Majno and Joris 1995, Kressel and Groscurth 1994, Rao et al 1996, Liu et al 1998). 
Blebbing or budding also occurs within the plasma membrane, ultimately leading to 
the fragmentation of the cell into compact membrane-enclosed structures, called 
'apoptotic bodies' which contain cytosol, condensed chromatin, and cellular 
organelles. 
 
In order to promote their phagocytosis apoptotic cells often also undergo several 
plasma membrane changes that are able to trigger a response from macrophages, 
including the translocation of phosphatidylserine from the inner leaflet of the cell to 
the outer surface. Within living tissues the macrophages engulf the apoptotic bodies 
thus removing them without an inflammatory response. These morphological changes 
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occur as a direct result of molecular and biochemical events occurring from within the 
cell. These events include the activation of proteolytic enzymes which facilitate the 
cleavage of DNA into oligonucleosomal fragments. Proteolytic enzymes are also 
responsible for well the cleavage of a multitude of specific protein substrates which 
usually determine the integrity and shape of the cytoplasm or organelles (Hengartner 
2001, Rosenblatt et al 2001, Grimsley and Ravichandran 2003). 
  
The alternative to apoptosis is a process known as necrosis in which in response to a 
major insult there is a loss of membrane integrity, swelling and rupturing of the 
cellular membranes (Leist and Jaattela 2001). Unlike during apoptosis, the cellular 
contents of necrotic cells are released in an uncontrolled manner, resulting in 
significant damage to neighbouring cells and the activation of a strong inflammatory 
response (Shimizu et al 1996, :icotera et al 1998). 
 
1.8. The mechanisms of apoptosis 
While it is relatively easy to distinguish morphologically apoptosis from necrosis 
there are some examples where the characterisation as either apoptotic of necrotic is 
not so clear cut (Columbano 1995) therefore an understanding into the biochemical 
pathways involved in both apoptosis and necrosis is key to understanding fully the 
processes through which cell death occurs.  
 
Apoptosis is a highly complex and strictly regulated sequence of events that through 
the process of evolution has resulted in the formation of a strategy in which the 
components of the apoptotic machinery are compartmentalised within different 
cellular regions, to be brought together only in response to specific stimuli. Within 
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mammalian cells it is generally considered that there exist 3 major compartments in 
which the apoptotic machinery is housed. The first of these compartments include the 
cell membrane and cytosol. Following the initiation of apoptosis,
 
the contact between 
neighbouring cells is lost. Experimentation on embryonic epithelia and cultured 
Madin-Darby canine kidney cells grown as
 
monolayers has shown that dying cells are 
able to generate signals that activate actin-
 
and myosin-dependent mechanisms in the 
surrounding cells (Rosenblatt et al 2001). This in turn is able to facilitate the removal 
of dying cells from the epithelia and monolayer.
 
The loss of microvilli results in the 
formation of plasma membrane protrusions and the cell shrinks.
 
The plasma 
membrane protrusions then separate, forming apoptotic
 
bodies densely packed with 
cellular organelles and nuclear fragments
 
that may then be engulfed through 
phagocytosis (Hengartner 2001).
  
 
Following the initiation of the apoptotic cascades several structural proteins are 
processed including actin, (Mashima et al 1997) which results in the formation of 
microfilaments and thereby regulates the
 
cells shape. Other
 
proteins that are cleaved 
by caspases during apoptosis include spectrin,
 
fodrin, ß-catenin, gelsolin, growth 
arrest-specific
 
2 (Gas2) and p21-activated kinase 2 (PAK2). These proteins have been 
shown to be involved in
 
the maintenance, organization, and attachment of the 
cytoskeleton as well playing a role in cell-to-cell
 
junctions (Dejana 2004). The over-
expression
 
of cleaved gelsolin and Gas 2 has been shown to result in changes in cell 
shape that resemble those that occur during
 
apoptosis (Kook et al 2003). Similarly 
Death-associated protein kinase (DAP kinase) and DAP
 
kinase-related kinase (DRP 
kinase) have recently shown to play a role in membrane blebbing (Inbal et al 2002). 
Both these kinases function independently
 
of caspase activity, but it has been shown 
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that activated DRP kinase
 
is able to
 
activate caspase-dependent events. In experiments 
involving Dominant-negative mutants
 
of DAP and DRP kinase, reduced blebbing and, 
interestingly,
 
reduced autophagy have both been shown to occur (Inbal et al 2002).
  
 
The second compartment in which the apoptotic machinery is housed is the 
mitochondria. Changes including cellular stress and the cells bio-energetic
 
state can 
lead to the initiation of apoptosis and are therefore continuously monitored by the 
mitochondria. Mitochondria are then able to
 
integrate these multiple pro-apoptotic 
signals into common apoptotic
 
degradation cascades, primarily through the 
permeabilization
 
of the mitochondrial membrane (Ferri and Kroemer 2001). The
 
initiation of mitochondrial membrane permeabilization has been shown to be 
regulated through the activity of pro-apoptotic members of the Bcl-2 family (Kroemer 
et al 2007, Chipuk and Green 2008), in contrast
 
anti-apoptotic members of the Bcl-2 
family have been shown to be able to inhibit this process as illustrated in figure 1.8 
(Armstrong 2006, Kroemer et al 2007).  
 
Permeation of the mitochondrial membrane has been shown to result in a large 
number of proteins being released into the cytosol, including cytochrome c, Apoptosis 
inducing factor (AIF) and Second mitochondria-derived activator of caspase/direct 
inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO) (Shi 2002, 
Ravagnan et al 2002).
 
Cytochrome c binds to apoptotic protease activating factor-1 
(Apaf-1), resulting in the formation of an Apaf-1 oligomer (the apoptosome) which in 
turn is able to bind and activate caspase-9 (Adrain et al 2006). Smac/DIABLO
 
also 
facilitates the activation of caspases through its binding to a family
 
of proteins known 
as inhibitor of apoptosis proteins (IAP) (Shiozaki and Shi 2004).  
 Figure 1.8. Representation of 
and pro
 
Representation of possible interactions between anti
members of the Bcl-2 family at the outer mitochondrial membrane. Apoptotic signals relocate 
Bax from the cytoplasm to the mitochondrion (1). Anti
such as Bcl-2 itself and Bcl-
forming heterodimers (2). However, other pro
interact with Bcl-2 and Bcl- 
relationship between pro-apoptotic and anti
to apoptosis. If there are more pro
membrane potential and a number of apoptosis
apoptosis-inducing factor (AIF) are released into the cytoplasm (4).
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In contrast to the caspase-activating proteins AIF is able to translocate in to
 
the 
nucleus where it is able to induce chromatin condensation and DNA fragmentation 
(Sanges and Marigo 2006). Despite the significant changes that occur within the 
mitochondria following the initiation of apoptosis their appearance when viewed with 
either a light or electron microscope remains relatively unchanged until the
 
later 
apoptosis, when they swell like other
 
cell organelles. 
 
Morphologically the hallmark features of apoptosis occur in the nucleus
 
and include 
chromatin condensation and nuclear fragmentation. Microscopically chromatin 
condensation can be observed, beginning initially along the nuclear
 
membrane, 
forming a crescent or ring like structure. In the later
 
stages of apoptosis the nucleus 
condenses further until it finally breaks down (Majno and Joris 1995). As well as 
chromatin condensation, it is also possible to detect DNA strand breaks through the 
use of terminal Deoxynucleotidyl Transferase and Nick Translation Assays (Gorczya 
et al 1993). These morphological changes may be initiated through the cleavage
 
of 
various proteins by the caspases. Nuclear fragmentation is dependent on the 
disintegration of the nuclear lamina and the collapse of the nuclear envelope. The first 
of these events involves the proteolysis of lamins A, B and C by caspases (Rao et al 
1996). Experimentation involving the expression of mutant forms of lamins, resistant 
to caspase-mediated proteolysis have shown to be able to prevent the loss of laminar 
integrity, therefore delaying the onset of DNA fragmentation (Rao et al 1996). 
Although several other nuclear membrane and laminar proteins have been identified 
as caspase substrates, none of these proteolytic events has so far been shown to result 
in nuclear fragmentation (Lüthi and Martin 2007).  
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Another major hallmark of apoptosis that occurs within the nucleus is the 
internucleosomal
 
fragmentation of double-stranded DNA by a number of caspase 
substrates that are involved in DNA
 
repair and replication (Wyllie et al 1980, Kerr et 
al 1972). To date it still remains relatively unclear why the nucleus fragments and 
disperses throughout the cell body during apoptosis however this process may well 
contribute towards the efficient removal of potentially immunogenic chromatin, as 
well as making the process of cell death irreversible. 
 
A cells actin cytoskeleton also plays an important role in nuclear fragmentation. The 
nuclear lamina is surrounded by a net of actin, which is also associated with the 
nuclear envelope. Inhibition of either Rho-associated, coiled-coil containing protein 
kinase 1 (ROCK1), myosin light chain kinase or the disruption of actin filaments have 
all been shown to prevent nuclear fragmentation (Croft et al 2005). Caspase-mediated 
proteolysis results in the loss of the C terminus of ROCK1 which in turn activates this 
kinase resulting in the re-organization of the actin–myosin system (Coleman et al 
2001, Sebbagh et al 2001). Due to the fact that the actin cytoskeleton and the nuclear 
envelope are connected the nucleus becomes torn apart (Croft et al 2005). The 
cleavage of lamin alone is not enough to cause nuclear fragmentation but is able to 
weaken the nuclear lamina, possibly resulting in the nuclear envelope tearing (Croft et 
al 2005). During nuclear fragmentation the microtubule-based cytoskeleton has been 
shown to play a role in the dispersal of nuclear fragments into the resulting plasma 
membrane blebs (Moss et al 2006). The endoplasmic reticulum (ER) has also been 
shown to be involved in apoptosis regulation and has been found to be the location of 
caspase 12, another apoptotic protease which may be activated in response to stress in 
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the ER such as the presence of high levels of intracellular Ca
2+
, brefeldrin A or 
tunicamycin (Shiraishi et al 2006). 
 
1.8.1. Caspases 
Within any given cell there are several forms of apoptotic executors, but by far the 
most important and well understood are the family of cysteine proteases known as 
caspases which function via the use of the sulphur atom in cysteine to
 
cleave 
polypeptide chains. Caspases are not indiscriminate proteases;
 
they have the ability to 
recognise specific sequences in their target
 
proteins, typically cleaving solely next to 
aspartate amino
 
acids (thus the name caspase "c" for cysteine protease and
 
"asp" for 
the strong aspartate preference). All living cells contain caspases however the number 
and function may vary from species to species. Through the recent development of 
sequence analysis it has been found that there are probably only seven caspases within 
the Drosophilla genetic code (Dorstyn et al 2005, Kumar and Doumanis 2000) 
compared 14 within mammalian cell-lines, located mainly within the cytosol (Eckhart 
et al 2005, Shi 2002). 
 
The caspases are generally considered to be divided into 2 separate groups based upon 
their sequence alignment (Thornberry and Lazebnik 1998, Shi 2002). The first group 
consists of those that are related to Ced-3 and the second to those that are related to 
caspase 1 (Interleukin-1 converting enzyme ICE). Members of the Ced-3 subclass, 
including caspases 2, 3, 6, 7, 8, 9 and 10 have all been shown to play a critical role in 
the initiation and propagation of apoptosis whereas members within the ICE 
subfamily such as caspases 1, 4, and 5 are probably involved in proteolytic activation 
(Earnshaw et al 1999). Members of the Ced-3 subclass can be additionally divided 
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into 2 further sub classes; initiator caspases such as 2, 8, 9 and 10 and executor 
caspases such as 3, 6 and 7. Initiator caspases function by activating executor 
caspases leading to the activation or deactivation of the cellular proteins responsible 
for either the apoptotic pathway or the dismantling of the cell (Mehmet 2000).  
 
All caspases are proteolytic enzymes that when inactive lie dormant within the cell in 
the form of zymogens. These procaspase molecules have 3 basic domains, the 
prodomain, the large subunit and the small subunit. Caspases involved with the 
initiation of apoptosis posses a long prodomain and are regulated by proteins other 
than caspases whereas caspases involved with the execution of apoptosis possess a 
short prodomain and receive regulation directly from other caspases. As the activation 
of an initiator caspase in cells inevitably triggers a cascade of downstream caspase 
activation, it is tightly regulated and often requires the assembly of a multi-component 
complex under apoptotic conditions (Adams and Cory 2002).  
 
Upon receiving a pro-apoptotic stimulus, the procaspases are sequentially processed 
into a precursor consisting of a non-catalytic domain and two catalytic subunits a 
large subunit 17-20 kDa containing the active site Cys, and a smaller 10 kDa subunit 
(Muzio et al 1998, Yamin et al 1996)
 
to produce a dimer of these two subunits. This 
catalytic tetramer contains two active sites, each of which is characterized by the 
presence of a deep pocket which binds to the Asp found at the cleavage site together 
with a second more irregular pocket that binds the preceding three amino acids. The 
structure of the second pocket results in the formation of a unique binding site, 
specific for each caspase.  
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Pro-apoptotic caspases containing long prodomains also contain protein motifs, such 
as caspase recruitment domains (CARD), like those found in caspase 9 and 2 or death 
effecter domains (DED) found in caspase 8 and 10). These protein domains contain 
several charged patches on their surfaces that are able to interact with adaptor proteins 
that contain a similar structure and a complementary charge. This leads to the 
formation of a multimeric complex that is required in order to bring two caspase 
precursors together to activate each other and produce an active tetramer (Figure 1.9). 
 
Figure 1.9. A simplified diagrammatic representation of caspase activation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The procaspase is cleaved at specific caspase cleavage sequences (Asp X). 2 large and 2 small 
subunits combine to form the active tetrameric enzyme 
 
 
 
Initiator caspases can be activated via 2 pathways, either the Death Receptor or 
extrinsic Pathway which utilizes the receptors found in the plasma membrane or by 
the mitochondrial or intrinsic pathway which utilizes apoptosis protease activating 
factor 1 (Apaf-1) and therefore requires the presence of cytochrome c from the 
mitochondria (:agata 1999). Following apoptotic stimuli, several proteins are 
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released into the cytoplasm from the intermembrane space of the mitochondria (Wang 
2001).  
 
In the extrinsic pathway there are at least five different cell death receptors, all of 
which are members of the transmembrane tumour necrosis factor (TNF) receptor 
super family. The two most well understood members of this family are Fas and the 
type I TNF receptor (:agata 1999). Within all death receptors there is a polypeptide 
domain termed the death domain (DD) located within the cytoplasmic domain that is 
structurally very similar to that of the caspase recruitment domains (CARD) and death 
effecter domains (DED). When these death receptors bind with TNF or other 
homologous ligands they are able to bind additionally to other proteins such as Fas 
associated death domain (FADD) via the interactions with their own death domain. 
FADD also contains a death effecter domain making it possible to bind and activate 
caspase 8 and caspase 10 via their own death effecter domains to produce a complex 
known as the death inducing signalling complex (DISC) (Peter and Krammer 2003).  
 
In parallel the activation of caspase 2 uses the adaptor protein receptor death domain 
which contains both a caspase recruitment domain (CARD) that is able to bind to the 
corresponding CARD domain on caspase 2 and a death domain which appears to bind 
to a yet unidentified receptor (Duan and Dixit 1997 and Ahmad et al 1997) thus 
unlike in C. elegans which has a single round of caspase activation in mammalian 
cells there are 2 stages of activation required in order to complete the pro-apoptotic 
cleavages; simplified as an initial activation of initiator caspases triggered by a variety 
of stimuli followed by a second stage of executioner caspases activated as a final 
pathway. 
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In the mitochondrial or intrinsic pathway several apoptogenic factors such as 
cytochrome c, apoptosis inducing factor (AIF) and procaspases 2, 3 and 9 which are 
located within the intermembrane space of the mitochondria are released into the 
cytosol via the opening of a transmembrane potential pore following apoptotic stimuli 
(Rodriguez and Lazebnik 1999, Zou et al 1999, Saleh et al 1999). Cytochrome c 
released from the mitochondria binds to the cytosolic protein Apaf-1. This interaction 
results in a conformational change in Apaf-1 which, when stabilised by the binding of 
ATP, allows molecules of Apaf-1 to associate with each other (Li et al 1997). This 
results in the formation of a wheel-like structure that contains 7 molecules each of 
Apaf-1, cytochrome c and ATP. This wheel-like structure, known as the apoptosome, 
permits the recruitment of 7 molecules of procaspase 9 to the complex (Rodriguez and 
Lazebnik 1999). The exact mechanism of caspase activation is still uncertain although 
two possibilities have been proposed. In one case the Apaf-1, cytochrome c and 
procaspase 9 complexes can act as a platform for the activation of cytosolic 
procaspase 9, as it is recruited to the apoptosome. In the other scenario two 
apoptosome have been proposed to interact with each other and to activate the caspase 
9 located on the other apoptosome (Riedl and Salvesen 2007). Activation of caspase 9 
or other initiator caspases leads to the activation of other downstream executor 
caspases thus unleashing the death cascade and the release of the caspases 2, 3 and 9 
from the mitochondria. Their subsequent activation in the cytosol is then able to 
contribute to the amplification of the caspase cascade. 
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1.9. Regulation of apoptosis 
It is as yet unknown what factors promote the release of cytochrome c from the 
mitochondria however since Bax, and other Bcl-2 proteins, show structural 
similarities with pore-forming proteins it has been suggested that Bax can form a 
transmembrane pore across the outer mitochondrial membrane (Jurgensmeier et al 
1998, Tsujimoto 2000). This may lead to the loss of membrane potential and efflux of 
cytochrome c and AIF (apoptosis inducing factor). Bcl-2 and Bcl-XL may therefore 
be responsible for preventing this pore formation (Dlugosz et al 2006). Evidence to 
substantiate this shows that heterodimerisation of Bax or Bad with Bcl-2 or Bcl-XL 
appears inhibit their protective effects (Dlugosz et al 2006, Antignani and Youle 
2006). It is also thought that proteins such as Bax and Bad can promote the formation 
of the large diameter PT pore, with subsequent loss of cytochrome c and initiation of 
apoptosis (Tsujimoto 2000).  
 
At least 29 Bcl-2 family proteins have been discovered in mammalian cells as well as 
others in Drosophila, C elegans and multiple virus species (Gross et al 1999, Igaki et 
al 2000). It is generally accepted that members of the Bcl-2 family may be divided 
into 3 distinct groups all of which share at least one conserved Bcl-2 homology (BH) 
domain (Figure 1.10). It is the BH domains which are responsible for the functionality 
of each of the Bcl-2 related proteins by dictating their ability to bind to neighbouring 
Bcl-2 proteins or other necessary proteins (Willis et al 2007, Youle 2007). Bcl-2 itself 
comprises of all four domains, and close relatives also possess at least the first three 
(BH1-BH3) domains. 
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Figure 1.10. The three subfamilies of Bcl-2 related proteins. 
 
 
 
 
  
 
 
 
 
 
 
 
 
The four receptor domains (BH1–4) are highly conserved among all family members. Most 
members have a carboxyl-terminal hydrophobic domain that aids association with intracellular 
membranes, the exceptions being A1 and many of the BH3-only proteins (Bad, Bid, 'oxa, Bmf 
and Puma).  
 
 
1.9.1 The Bcl-2 family. 
Bcl-xL (Muchmore et al 1996), Bcl-2 (Petros et al 1996) and Bcl-w all have a similar 
molecular structures that they share with the viral Bcl-2 homologue (Huang et al 
2002). All contain five amphipathic α-helices surrounded by two central hydrophobic 
α-helices. As noted previously they also all posses at least one of the four possible 
Bcl-2 homology (BH) domains. Members of the Pro-survival family all have the 
ability to inhibit apoptosis in response to many cytotoxic and physical insults. These 
proteins contain a unique hydrophobic carboxy-terminal domain that enables them to 
target the cytoplasmic surface of intracellular membranes such as the outer 
mitochondrial membrane, the endoplasmic reticulum (ER) and the nuclear envelope 
(Thomadaki and Scorilas 2006). Bcl-2 exists permanently within these membranes, 
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whereas Bcl-w and Bcl-xL only become associated with the membrane after a 
cytotoxic signal is received, indicating that there may be induced conformation 
changes that must occur before the protein is able to associate with the membrane 
(Cory and Adams 2002). 
 
In contrast it would appear that the anti-apoptotic Bcl-2 family members function by 
preventing the release of apoptogenic proteins from the mitochondria (Adams and 
Cory 2001). The exact mechanisms of this form of regulation remains unclear, but it 
thought that the formation of ion channels by Bcl-2 family proteins on the outer 
mitochondrial membrane may play a key role (Youle and Strasser 2008). Evidence to 
support this pore forming theory comes from three-dimensional structure of the Bcl-
xL protein that resembles the pore forming bacterial toxins diphtheria and colicin 
(Muchmore et al 1996, Minn et al 1997, Qian et al 2008, Anderluh and Lakey 2008). 
Additionally it has been shown that Bcl-xL, Bcl-2 and Bax have the ability to form 
ion channels in synthetic membranes within an in-vitro environment. (Minn et al 
1997, Schendel et al 1997, Antonsson et al 1997).  It would also appear that the ability 
to integrate within an intracellular membrane is crucial for the regulation of 
mitochondrial permeability as studies examining mutated Bax which lacked the C-
terminal transmembrane domain display no pro-apoptotic activity (Zha and reed 
1997, Shimizu et al 1999, Simonen et al 1997). All cells require the presence of at 
least one Bcl-2 homologue in order to survive, and the abundance of these pro-
survival proteins is responsible for the regulation of tissue homeostasis. In contrast the 
inactivation of the Bcl-2 homologous genes results in apoptosis in specific cell types, 
presumably because the concentrations of other Bcl-2 family members are too low to 
compensate.  
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1.10. Aims and Objectives of this thesis 
The research in this thesis is divided between the four results chapters that follow, 
each of which has its own hypothesis, aims and objectives. In the first of these, 
(chapter 3) it was hypothesised that it may be possible combine the inducible 
expression of p21
CIP1
 with the continuous expression of Bcl-2 in an industrially 
relevant CHO cell-line previously engineered to express the monoclonal antibody 
IgG. The objective for this work was to establish if the combined expression of 
p21
CIP1
 and Bcl-2 would have a significant impact of the levels of productivity that 
could be obtained during the culture period. It was also theorised that the expression 
of anti-apoptotic Bcl-2 would also result in a reduction in the rate of cell death due to 
apoptosis and therefore the overall viability of the resulting cell-line was expected to 
remain significantly higher than cell-lines in which Bcl-2 was not expressed.  
 
This chapter was successful in terms of the creation of a several clones capable of 
expressing p21
CIP1
, Bcl-2 and the chimeric antibody IgG4. Analysis of the clones 
growth profiles, productivity, ability to undergo p21
CIP1
 induced cell cycle arrest and 
withstand cellular stress when challenged with staurosporine and serum deprivation, 
enabled the successful selection of the clone that exhibited the most desirable 
characteristics. The expression of both p21
CIP1
 and Bcl-2 were additionally confirmed 
via western blot analysis, resulting in the successful development of a p21
CIP1
/Bcl-2 
co-expressing cell-line which could then be used in the remaining chapters 
 
In the second of the results chapters (chapter 4) I examined the hypothesis that a 
relationship exists between the expression of p21
CIP1 
and the increase in productivity 
of CHO cells observed in chapter 3. In addition I hypothesised that that cellular 
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growth and proliferation may be uncoupled in p21
CIP1
-expressing cultures. The aim of 
this chapter was therefore to identify potential changes occurring in the cells 
metabolism during periods of p21
CIP1
-induced proliferation arrest, the objective being 
to determine if such metabolic changes are able to have a direct impact on cellular 
productivity. 
 
In this chapter an IgG4 expressing CHO cell-line in which p21
CIP1
 expression could 
be inducibly expressed was successfully created. Using this cell-line it was possible to 
determine the exact phase of the cell cycle in which cells congregate following the 
initiation of p21
CIP1
-induced cell cycle arrest, as well as the effect of p21
CIP1
-
expression on cell volume during the culture period. Due to limitations in the 
equipment available at the time of analysis, it was not possible to do an in-depth 
examination of the changes which occur in the metabolic pathways of p21
CIP1
 
expressing cell lines. Despite this I was able to examine the usage of key nutrients 
including glucose, glutamine, ammonia and lactate during periods of cell cycle arrest, 
which when combined with information obtained on cell volume, total protein and 
mitochondrial activity would seem to support my previous hypothesis that cell growth 
and proliferation may be uncoupled during periods of cell cycle arrest. In addition 
there would appear to be indications that changes occur within the pathways involved 
in energy metabolism as a result of the over-expression of p21
CIP1
. 
 
The third results chapter (chapter 5) focuses on the hypothesis that the ability to halt 
cell cycle progression in the G1 phase of the cell cycle, through the over-expression 
of p21
CIP1
 would facilitate cell survival within suspension and protein-free growth 
environments by reducing the requirement for growth factors. In addition I theorised 
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that the prevention of cell cycle progression may also allow the resulting genome 
damage, created through the direct withdrawal of serum, to be repaired prior to cell 
cycle release. The objective of this chapter was therefore to examine the effect of 
periods of p21
CIP1
-induced cell cycle arrest on the ability of an anchorage-dependent 
CHO cell-line to survive and adapt to both suspension and protein-free growth 
environments whilst maintaining productivity.  
 
In the final results chapter (chapter 6), the hypothesis of chapter 5 were further 
expanded, to include the anti-apoptotic effects of the over-expression of Bcl-2. The 
objective of this chapter was to determine if combining the expression of Bcl-2 with 
the over-expression of p21
CIP1
 would further reduce the time required for successful 
adaptation to both suspension and protein-free culture conditions.  
 
The results of these final two chapters potentially have significant implications for the 
biopharmaceutical industry, as I was successfully able to demonstrate the ability to 
substantially reduce the time required for successful adaptation to both suspension 
and protein free growth environments, through the expression of the cell cycle 
inhibitor p21
CIP1
.  In addition I was able to demonstrate a further reduction in 
adaptation time is possible when combining periods of p21
CIP1
 induced cell cycle 
arrest with the anti-apoptotic properties of Bcl-2 expression. These findings may 
ultimately lead to the swift development of commercial cell-lines, better able to meet 
the increasing demands for higher productivity and longevity whilst withstanding the 
stresses imposed by growth within a chemically defined bio-processing environment. 
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2. Materials and Methods 
 
2.1 Cell culture and maintenance  
These methods were employed for the creation and maintenance of the cell-lines used in 
chapters 3, 4, 5 and 6 of this thesis prior to experimentation. 
 
2.1.1. Transfection and maintenance 
The parental cell-line CHO-22H11 was kindly supplied by Lonza Biologics (Slough, UK). 
CHO-22H11 has previously been transfected with the human-mouse chimeric B72.3 IgG4 
antibody gene, using the glutamine synthetase (GS) expression system (Bebbington et al 
1992, Bi et al 2004). Cells were maintained in a high glucose (17mM) medium DMEM NUT 
MIX F-12 without glutamine (GIBCO, Paisely, UK) supplemented with 10% heat inactivated 
foetal calf serum (PAA laboratories GmH), 50µM methionine-sulphoxomine (MSX; Sigma, 
Poole, UK) and 2% Glutamine synthetase (GS) supplement (Sigma, Poole, UK). Cells were 
cultured in vented tissue culture flasks (T-flask) at 37°C in the presence of 5% CO2. 
 
In order to obtain inducible expression of p21
CIP1
 the Lacswitch system was used. First lac 
repressor expressing cells were constructed using CMVlacI plasmid DNA (Stratagene), 
kindly supplied by Dr K Saqib (Institute for Cancer Studies, Birmingham University, UK). 
DNA was introduced into CHO-22H11 cells by liposome-mediated transfection using 
Lipofectin reagent (Life Technology, UK) according to manufacturer’s instructions. 
Transfected cells were selected in DMEM NUT MIX F-12 without glutamine medium 
(GIBCO, Paisely, UK) containing 400µg/ml Hygromycin B (Sigma, Poole, UK). After 2 
weeks selection, the whole population of stable transfectants was then transfected with 
78 
 
pOPRSV1/p21
CIP1
 plasmid DNA using Lipofectin reagent (Life Technology, UK) to produce 
a selection of p21
CIP1
-expressing clones from which the 3B2 clone was previously selected 
(Bebbington et al 1992, Bi et al 2004). Plasmid pOPRSV1/p21
CIP1
, which contains the mouse 
p21
CIP1
 cDNA (Erhardt and Pittman 1998), was kindly provided by Dr. R. Pittman 
(University of Pennsylvania, Philadelphia, PA). Stable clones were selected in 400µg/ml 
Geneticin 418 (GIBCO), and isolated by limiting dilution. 
 
To create a Bcl-2-and-p21
CIP1
-co-expressing cell-line the expression vector pEFBcl-2 
(carrying the human Bcl-2 gene) and control vector pEFneo (kindly provided by Susan Cory, 
University of Melbourne, Australia) on a plasmid containing a hygromycin B gene was first 
introduced into the parental 22H11 line via liposome-mediated transfection, using Lipofectin 
reagent (Life Technology, UK) according to the manufacturer’s instructions. Transfected 
cells were selected by the addition of 400µg/ml Hygromycin B (Sigma, Pool, UK) to the 
growth medium for a period of 2 weeks; after which, the whole population of stable 
transfectants were then transfected with the pOPRSV1/p21
CIP1
 plasmid deoxyribonucleic acid 
(DNA) containing the mouse p21
CIP1
 complementary DNA (Erhardt and Pittman 1998) 
kindly provided by Dr. R. Pittman (University of Pennsylvania, Philadelphia, PA) using 
Lipofectin reagent (Life Technologies). Stable clones were selected in the presence of 
400µg/ml Geneticin 418 (GIBCO Paisley, UK) and isolated by limiting dilution. 
 
Induction of p21
CIP1
-expression was achieved via the addition of 5mM isopropyl-β-D-
thiogalactoside (IPTG; GIBCO) to the culture medium. Cells were maintained for several 
passages before experimentation in Dulbecco’s modified Eagle’s medium (DMEM) F12 
minus glutamine supplemented with 10% heat-inactivated foetal calf protein (PAA, Yeovil, 
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UK), 50µM methionine sulphoxomine (MSX), and 2% GS supplement (Sigma, Poole, UK). 
Cells were cultured in vented tissue culture flasks with 5% CO2 at 37°C. All cultures were 
passaged every 72 hours by washing the cells with warm 1× phosphate-buffered saline (PBS) 
followed by the addition of non-enzymatic cell dissociation solution (Sigma, Poole, UK). 
Cells were then washed with warm culture medium before being centrifuged at 90g for 5 
minutes and re-suspended in fresh culture medium. 
 
2.1.2. Cell cloning 
Cells from mid exponential cultures were diluted to 100, 50, and 10 cells/ml concentrations. 
100µl of each of the dilutions were dispensed into each well of a 96 well culture plate 
containing DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf 
serum and 50µM MSX. Clones expressing the desired vectors were selected by the presence 
of 400µg/ml Hygromycin B (Sigma, Poole, UK) and 400µg/ml Geneticin 418 (GIBCO 
Paisley, UK) in the culture medium. The plates were incubated at 37˚C in the presence of 5% 
CO2 for 72 hours before they were inspected using inversion microscopy for the presence of 
single colonies. Wells exhibiting single cell colonies were then marked and had a 50% 
culture medium change performed every 72 hours until they became confluent. The cultures 
were then expanded into 24 well plates and the process repeated until sufficient cells were 
produced for cell banking and experimentation. 
 
2.1.3. Medium preparation and additives 
All the cell-lines used in this thesis were grown in either DMEM F12 without glutamine 
culture medium supplemented with 10% heat inactivated foetal calf serum (PAA laboratories 
ltd, Yeovil, UK) or ProCHO4 protein-free growth medium (Cambrex, UK), in both cases 
supplemented with 50µM MSX. Continuous growth of the GS-CHO p21
CIP1
/Bcl-2 cell-lines 
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in selection media containing both Hygromycin B and Geneticin 418 is known to inhibit 
growth and cause changes in cellular metabolism. Therefore the cells were cultured without 
the presence of these antibiotics for 5 passages to enable successful growth. After 5 passages 
the antibiotics were added to the cell culture medium for 2 passages at a concentration of 
400µg/ml of Hygromycin B (Sigma, Poole, UK) and 400ug/ml of Geneticin 418 (Sigma, 
Poole, UK).   
 
2.1.4. Heat inactivation of foetal calf serum 
Serum is commonly used as a supplement to basal growth medium in cell culture. The most 
common type of serum used for cell growth is foetal bovine serum (FBS), also known as 
foetal calf serum (FCS). Foetal bovine serum is obtained from foetuses harvested in abattoirs 
from healthy dams fit for human consumption. Occasionally, there may be use of other 
bovine sera, such as newborn calf serum or donor bovine serum. In cell culture, serum 
provides a wide variety of macromolecular proteins, low molecular weight nutrients, carrier 
proteins for water – insoluble components, and other compounds necessary for in vitro 
growth of cells, such as hormones and attachment factors. Serum also adds buffering capacity 
to the medium and binds or neutralizes toxic components. Heat inactivation of serum is 
performed by raising the temperature of the serum to 56
o
C and maintaining that temperature 
for 30 minutes. Heat inactivation is the method of choice to destroy complement, and to 
ensure that the cells will not be lysed by antibody binding. 
 
2.1.5. Cell culture vessels and sub-culturing. 
During routine culture conditions all cells were cultured in either sterile static vented tissue 
culture flasks (T flask) or sterile Erlenmeyer flasks rotated at 125 rpm. During cloning sterile 
well plates of various capacities were used. The cells were seeded at 1-6x10
5 
cells/ml into a 
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culture vessel containing 1/3 of the vessels working volume of medium to allow for a 
sufficient surface / volume ratio for oxygen transfer. All cultures were maintained at 37˚C 
and 5% CO2 and passaged during mid-exponential growth at approximately 72 – 96 hours 
dependent on culture volume. 
 
2.1.6. Cryopreservation 
Cells from dividing cultures were harvested during mid exponential phase and centrifuged at 
90g for 5 minutes before being re-suspended in a solution of DMEM F12 containing 10% 
(v/v) heat inactivated foetal calf serum and 10% (v/v) Dimethyl sulfoxide (DMSO) (Sigma, 
Poole, UK) to give a final cell concentration of 10
7
 cells/ml
-1
. 1ml aliquots were then 
transferred to 2ml max volume cryovials (Nunc) and labelled with the cell-line name, date, 
and users name. They were then placed into a flask containing iso-propan-2-ol (Sigma, Poole, 
UK) which had previously been allowed to warm to room temperature. The flask was then 
placed into a - 70°C freezer overnight or for at least 4 hours. The frozen vials were then 
removed and placed into a long-term storage Dewar containing liquid nitrogen. 
 
2.1.7. Cell revival 
Cryovials were removed from the liquid nitrogen storage Dewar and warmed to 37°C in a 
water bath. Once fully thawed the cells were transferred into a suitable vessel and 10ml of 
pre-warmed culture medium was added drop by drop to expel the DMSO from within the 
cells without causing cell lysis. The cells were then centrifuged at 90g for 5 minutes and re-
suspended in fresh pre-warmed culture medium before incubation at 37°C. Culture viability 
was assessed and cells cultured for at least 3 passages before use for experimentation 
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2.2. Experimental methods  
The methods described in this section are those which were utilised to fulfil the experimental 
objectives of chapters 3, 4, 5 and 6. 
 
2.2.1. Cell counting via Trypan blue exclusion method. 
Viable and total cell numbers were accessed by counting cells using a Neubauer 
haemocytometer under a phase contrast microscope. 100µl of cells taken from the cell culture 
were diluted 1:1 with Trypan blue (Sigma, Poole, UK 0.4% (w/v) in water) in a 96 well plate. 
The cells were counted with the aid of a microscope (Olympus BH-2, Olympus, Japan) at 10x 
or 20x magnification.  At least 4 grids were counted on each side of the haemocytometer. 
This was then repeated  
 
Cell density = (number of cells counted) / (number of grids counted) x 2 x10000  
 
The cell density is given in 10
5 
cells/ml.  For the viability determination, the total number of 
cells (stained or unstained) is counted in a similar fashion as mentioned above. The 
calculations for viability based on one side of the haemocytometer were as follows: 
 
Cell viability = (number of unstained cells) / (total number of cells) x100 
 
2.2.2. Determination of apoptosis via acridine orange/ propidium iodide (AOPI) method 
Acridine orange is a fluorescent dye which binds to genetic material and can differentiate 
between deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Propidium iodide is an 
intercalating agent and a fluorescent molecule that can be used to stain DNA. It can be used 
to differentiate necrotic, apoptotic and normal cells. 
83 
 
 
 A solution was prepared by mixing 100µl of 1mg/ml
-1
 propidium iodide  (PI, Sigma, Poole, 
UK) and 100µl of 1mg/ml
-1
 acridine orange (AO, Sigma, Poole, UK) to 10mls of 1x PBS. 
The stain solution was added to the cell sample and 100 cells counted in triplicate to 
determine the percentage of early/late apoptotic, necrotic and viable cells. 
 
2.2.3. Glucose concentration 
Glucose measurements were carried out in triplicate from experimental replicates using 
samples of cell free supernatants taken at various time points.  Samples of the culture 
supernatant were stored at -20
0
C and allowed to warm to room temperature before readings 
were taken.  Glucose levels were determined using a blood glucose meter (Ascensia Blood 
Glucose meter, Bayer Healthcare LLC, IN, USA) with a wide operating range of 0.6-
33.3mmol/l.  Each test stripe was placed into the meter and drop of well-mixed sample was 
allowed to react on the strip.  The meter produces an electrochemical reaction utilising a 
glucose dehydrogenase-flavin adenine dinucleotide (FAD) immobilized strip with 
ferricyanate as a mediator for electron transfer.  The meter was calibrated using a glucose 
control solution to determine the linearity of the measurements.  
 
2.2.4. Lactate concentration 
Lactate concentrations were determined from the supernatant of three replicate cultures by 
enzymatic analysis (r-biopharm, Darmstadt, Germany) according to the manufacturer’s 
instructions. Samples were measured at 340nm using a microplate reader.  All samples were 
done in triplicate.  Readings were taken every half an hour until no changes in absorbance 
could be seen.  Samples were compared to the calibration standard that is provided with the 
kit. 
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2.2.5. Ammonia concentration 
Ammonia concentrations were determined by an ammonia enzymatic kit (r-biopharm, 
Darmstadt, Germany) using 3 replicate cultures.  Samples were diluted 10 times due to the 
low working range of the assay but maintained an absorbance above 0.1 absorbance units.  
Measurements were carried out in triplicate at 340nm using a 96-well microplate reader. 
Readings were taken every half an hour until the absorbance was constant.  Subtraction from 
the initial absorbance could subsequently be done to provide an accurate reading. The 
supplied assay control solution was used as an internal standard in order to check the assay 
performance and to determine whether the sample solution was free from interfering 
substances: 
 
2.2.6. Glutamate concentration  
Glutamate concentrations were determined from the supernatant of three replicate cultures by 
enzymatic analysis (r-biopharm, Darmstadt, Germany) according to the manufacturer’s 
instructions. Samples were measured at 492nm using a microplate reader.  All samples were 
done in triplicate.  Readings were taken every half an hour until no changes in absorbance 
could be seen.  Samples were then compared to the calibration standard that is provided with 
the kit. 
 
2.2.7. Total protein concentration 
Total intracellular protein was determined using the BCA protein assay kit. BCA or 
bicinchoninic acid is a colorimetric assay utilised for the detection of total protein.  After 
counting cells, 5mls of cell culture containing at least 2x10
6
 cells was centrifuged at 500g for 
5 minutes. The supernatant was then removed and 2mls of sterile PBS was added to disperse 
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the cell pellet before the cells were centrifuged again at 500g for 5 minutes. This process was 
repeated with 2mls of distilled water but this time the cells were centrifuged at 500g for 10 
minutes.  Care was taken not to disturb the cell pellet when removing the supernatant. 100µl 
of lysis buffer (Cellytic M, Sigma, Poole, UK) was then added and gently vortexed for 1 
minute before freezing at -20
0
C until analysis.  At the time of analysis, the samples were 
allowed to warm to room temperature before being vortexed gently to mix. Debris was 
removed by centrifuging at 15000g for 15 minutes. The remaining supernatant was then 
diluted 60-80x with distilled water before use.  The BCA assay was run according to the 
manufacturer’s instructions using a microplate reader and a standard curve with a working 
range from 5-250µg/ml.  Samples were analysed from three cultures in triplicate. 
 
2.2.8. Secreted Monoclonal antibody concentration 
An enzyme linked immunoabsorbent assay (ELISA) was used to determine the concentration 
of MAb excreted into the culture medium. This method was adapted from that used by Dr 
Margaret Goodall at the Department of Immunology at the Medical school of Birmingham 
University. Nunc maxisorp plates were prepared by the addition of 10µl of coating antibody 
(Anti-human IgG fc antibody (does not recognise γ2) (Sigma, Poole, UK) in 10ml coating 
buffer (Na2CO3) (BDH AnalaR 10240 4H) 1.59 g/l, NaHCO3 (Sigma, Poole, UK) 2.93 g/l in 
distilled water. Adjust to pH 9.6 if necessary) (1/1000 dilution) dispensed at 100µl per well.  
 
Each plate was then covered with a plate sealer and incubated at 4˚C overnight. The next day 
the plates were washed four times with wash buffer (Tween 20 (polyoxyethylenesorbitan 
monolaurate) (Sigma, Poole, UK), 0.05% v/v in 1x PBS). The plates were then tapped gently 
onto a tissue to remove excess wash buffer before 100 µl of blocking buffer (Skimmed milk 
powder (MARVEL) 10 g/l in 1x PBS) was dispensed into each well. The plate was once 
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again sealed and incubated at room temperature for 1 hour to block any remaining binding 
sites. Whilst the plates are incubating serial dilutions of the standards (Supplied by Lonza 
Biologics, clarified supernatant from NSO 6A1 culture, in which the levels of monoclonal 
antibody have previously been determined) and culture supernatant samples were prepared. 
The standard requires a broad range dilution to allow for the production of a straight line on 
the standard curve likewise the dilution used for the samples must be such as to allow the 
absorbance to lie within the limitations of the standard curve (figure 2.1). Following the 
hour’s incubation the plates were once again washed four times with wash buffer and tapped 
to remove excess fluids before 100µl of each dilution of the standard were added in duplicate 
to each of the plates. Next 100µl of the diluted supernatants was added to the remaining 
wells, ensuring 2 wells remain empty in order to produce the blank control reading. The 
plates were the resealed and incubated for one hour at room temperature. Following 
incubation the plates were then washed four times with wash buffer before being tapped dry. 
100µl of the secondary antibody (Anti-human kappa light chain antibody conjugated to 
horseradish peroxidase (Sigma, Poole, UK). (1:10 000 dilution) diluted in blocking buffer 
was then added to each of the wells before re-sealing the plates and incubating for a further 
hour at room temperature. 
 
The plates were then washed four times in wash buffer and 100µl of the substrate solution 
(0.1M Citric acid 5ml, 0.2M di-Sodium phosphate 5ml, O-phenylenediamine dihydrochloride 
(OPD)  (Sigma, Poole, UK) 4 mg (1 tablet), Hydrogen peroxide (4µl) dispensed into each 
well. The plate was once again sealed and incubated at room temperature in a dark room until 
the appearance of a colour change on the standards. 100µl of stop solution (Sulphuric acid 
(H2SO4) 12.5 % v/v) was then added to each well and the absorbency at 492 nm using a 620 
nm reference was determined using a SLT spectra ELISA plate reader. 
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Figure 2.1. Elisa standard curve 
 
 
Figure 2.1. ELISA standard curve produced through the serial dilution of the clarified 2SO 6A1 
supernatant standard (Supplied by Lonza Biologics), in which the levels of monoclonal antibody have 
previously been determined. The amount of monoclonal antibody present in the experimental samples 
was determined by comparison of their absorbance to that of the standard. 
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2.2.9. Western blot analysis  
The Western Immunoblotting protocol was adapted from Sambrook et al (1989). 1x10
6
 cells 
were harvested then centrifuged at 450g for 5 minutes. The supernatant was removed and the 
remaining pellet re-suspended in warm PBS to wash cells. The cells were then centrifuged at 
450g for 5 minutes, the supernatant removed and the pellet re-suspend in to 500µl of Cellytic 
M lysis buffer. The samples were then stored at -70
0
C until SDS-PAGE gels could be run. 
Before running gels, the samples were thawed and diluted with 2x Lamelli sample buffer 
(Sigma, Poole, UK) before being denatured at 95
0
C on a PCR thermal cycler (Eppendorf UK 
Limited, Cambridge, UK) to reduce liquid loss.  
 
SDS-PAGE gels were run using Pierce (Pierce Biotechnology, IL, USA) Precise pre-cast gels 
(8% gels).  For all samples the same cell volume was added into each well. The gels were 
then run at 75V for about 90 minutes in BupH Tris-HEPES-SDS running buffer (Pierce 
Biotechnology, IL, USA) using a BioRad Mini-protean II gel tank (Bio-Rad Laboratories, 
CA, USA). The proteins were then transferred to Hybond ECL nitrocellulose membranes (GE 
Healthcare, Buckinghamshire, UK) in BupH Tris-Glycine transfer buffer (Pierce 
Biotechnology, IL, USA) for 1 1/2hr at 100V (10V per 1cm
2
).  
 
After the transfer, the membranes were washed before blocking took place. Blocking was 
done by incubation in 10% Marvel milk powder dissolved in PBST for 1 1/2 hours on a 
rocking plate (30-35 rpm). After blocking, membranes were washed with PBST 3 times 
before adding 5% milk solution with the primary mAb (see table 2.1) at the dilution: of 1:500 
to 1:1000. This was allowed to react on a rocker (25 rpm) for 1 1/2 hours at room 
temperature.   
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After primary antibody coupling, the membrane was washed with PBST 3 times for 5 
minutes each. This was to make sure that the entire primary antibody was removed.  The 
secondary antibody (see table 2.1) was added (1:2000 to 1:10000 in 5% Marvel milk powder 
dissolved in PBST) and incubated for 1hr at room temperature on the shaker (25 rpm). 
Detection was achieved via an ECL kit (ECL Plus, GE Healthcare, Buckinghamshire, UK) 
and visualized on an X-ray film (Hyperfilm, GE Healthcare, Buckinghamshire, UK).  Fixing 
and developing solutions were obtained from Kodak (Kodak Limited, Hempstead, UK).   
 
 
Table 2.1.  Primary and secondary antibodies used for western blot analysis. 
 
Antibody name Description Supplier 
Catalogue 
number 
Anti p21 Mouse anti-human p21 
Santa Cruz 
Biotechnology 
SC-817 
Anti-Bcl-2 Mouse anti-human Bcl-2 
Santa Cruz 
Biotechnology 
SC-130307 
Anti-Rabbit IgG (Whole molecule)- 
peroxidase conjugate 
Goat Anti-rabbit IgG 
(Whole molecule) 
Sigma  A6154 
 
The detection of p21
CIP1
 and Bcl-2 was achieved through western blot analysis using the primary and 
secondary antibodies listed in this table. Supplier and catalogue numbers are provided for clarity. 
 
 
2.2.10. Mitochondrial activity via MTT 
Cells were seeded at 2.5x10
6 
with/without 5mM IPTG into fresh growth medium then 
incubated for 72 hours at 37˚C in the presence of 5% CO2. A 5mg/ml solution of MTT with 
PBS was made and sterile filtered before use. Cells were then counted and 2x10
6
 cells 
harvested and re-suspend in 1ml of medium plus 100µl MTT. The cells were then incubated 
for 2 hours to allow the MTT to diffuse throughout before the cells were centrifuged at 200 g 
and the pellet re-suspend in 1ml iso-propanol. The samples were then placed on a shaker at 
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90g for 20 minutes prior to being serial diluted to 1x 2x 4x 8x 16x and 32x concentrations 
with iso-propanol. 100µl of the sample solutions were placed into a 96 well plate and read at 
540 nm with a SLT Spectra Elisa plate reader. 
 
2.2.11. Guava cell cycle analysis 
The cell concentration was determined via the Trypan blue exclusion method and the cell 
volume adjusted to between 5x10
5 
to 1x10
6 
cells/ml. 200µL of each cell sample was then 
placed into individual tubes (Eppendorf UK Limited, Cambridge, UK) before being 
centrifuged at 450g for 5 minutes with the brake on low. The supernatant was then removed 
and the same volume of 1X PBS was added to each tube as was in the original culture (or to 
get approximately 1x10
6
 cells/ml). The samples were then mixed well by vortexing or 
pipetting repeatedly to ensure a homogenous suspension before once again being centrifuged 
at 450g for 5 minutes with the brake on low. The supernatant was once again removed 
leaving approximately 500µl of 1X PBS. The cells in the residual 1X PBS were then re-
suspended and transferred drop-wise while vortexing on medium speed (setting at 5) into a 
50ml conical tube containing enough 70% ethanol to make the final concentration 
approximately 10
6
 cells/ml. The samples were then refrigerated for at least 12 hours prior to 
staining. Fixed cells are stable for several weeks at 4 °C and for two to three months at –
20°C. 
 
Following fixation the cell cycle staining reagent (Guava) and 1x PBS were warmed to room 
temperature. The tubes containing the samples were then centrifuged at 450g for 5 minutes 
with the brake on low at room temperature and the supernatant was removed carefully as not 
to touch the pellet. Using a Multi-channel pipette 200µl of 1X PBS was added to each tube 
and mixed well by pipetting up and down several times. The tubes were then allowed to stand 
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at room temperature for 1 minute before being centrifuged at 450g for 5 minutes with the 
brake on low at room temperature. Once again the supernatant was removed and discarded 
being careful not to touch the pellet. 200µl of Cell Cycle Staining Reagent was then added to 
each tube and mixed well by pipetting up and down several times. The samples were then 
incubated at room temperature shielding away from light for 30 minutes before running them 
on the Guava PCA system. 
 
To further analyze the data for more subtle changes between the phases of the cell cycle 
Multicycle software (De Novo, Los Angeles, CA) that applies sophisticated curve fitting 
algorithms to the Guava cell cycle data that more accurately calculates the percentages of the 
cell populations and their relevant statistics were used 
 
2.2.12. Cell volume via Malvern mastersizer 
The cell size and volume was determined using the Mastersizer S instrument with a small 
volume sample unit (Malvern Instruments, Worcestershire, UK). The Mastersizer uses laser 
diffraction technology to determine size distribution in a sample.  Size range was determined 
to be between 5um to 30um to remove debris and cellular aggregates.  Between 1-2x10
6
 cells 
were used for the analysis and readings were taken over a period of 5 minutes in triplicate. 
 
2.2.13. Determination of cell volume via volumetric analysis  
It has previously been reported (Stettler et al 2006) that the analysis of packed cell volume 
may be used as a means of assessing biomass in mammalian cell culture and was therefore 
used here as a means of gauging the changes in cell volume in this study.  A total of 2x10
5 
cells from both arrested and non arrested cultures were used for each sample to determine the 
packed cell volume. The cells were counted in triplicate and a correct volume of cell culture 
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was transferred into the packed cell volume tubes (PCV, TPP AG, Switzerland).  The tubes 
were then placed in a microcentrifuge (Eppendorf UK Limited, Cambridge, UK) and 
centrifuged at 2000g for 5 minutes. The tubes were visually inspected to observe the 
difference in the cell volume and photographic records were made. 
 
2.2.14. Growth profile of clones 
All clones were cultured as static in T flasks containing DMEM F12 plus 10% heat 
inactivated FCS and 50µM MSX. Flasks were set up for each day of the experiment seeded at 
a density of 2 x 10
5 
(cells/ml) at time point 0. Each day cells from one of the flasks were 
washed with 1 x PBS before being removed from their T-flask using 1x cell dissociation 
solution. The viable and total cell numbers were determined each day via the Trypan blue 
exclusion method. 
 
2.2.15. The effect of serum deprivation. 
Clones previously  grown as static cultures in DMEM F12 containing 10% heat inactivated 
FCS and 50µM MSX were washed with 1 x PBS before being removed from their T-flasks 
using 1x cell dissociation solution. A 1x PBS wash was repeated before cells were 
centrifuged at 90g. Cells were then seeded into fresh T-flasks containing DMEM F12 and 
50µM MSX at a density of 1x10
5
 cells/ml. Cultures were incubated at 37ºC for 72 hours 
before being harvested and analysed for cell death using the AOPI staining method, which 
utilises acrylamide orange and propidium iodine to distinguish between viable, apoptotic and 
necrotic cells. 
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2.2.16. The effect of exposure to staurosporine 
Each of the cloned cell-lines had previously been grown as monolayer cultures in tissue 
culture flasks containing DMEM F12 culture medium supplemented with 10% heat 
inactivated FCS and 50µM MSX. Cells were washed with 1 x PBS before being removed 
from their tissue culture flasks using 1x non-enzymatic cell dissociation solution (Sigma, 
Poole, UK). A 1x PBS wash was repeated before the cells were centrifuged at 90g for 5 
minutes. Cells were then seeded into fresh T25 tissue culture flasks containing DMEM F12 
culture medium supplemented with 10% heat inactivated FCS and 50µM MSX at a cell 
density of 1x10
5
 cells/ml. 0.5µM staurosporine (stock) was added to each of the flasks before 
the cultures were incubated at 37ºC for 24 hours. Cultures were then harvested and analysed 
for cell death using the AOPI staining method and cell viability via the Trypan blue exclusion 
method. 
 
2.2.17. The determination of p21
CIP1
-expression 
Each of the cloned cell-lines had previously been grown as monolayer cultures tissue culture 
flasks containing DMEM F12 culture medium supplemented with 10% heat inactivated FCS 
and 50µM MSX. Cells were washed with 1x PBS before being removed from their tissue 
culture flasks using 1x non enzymatic cell dissociation solution (Sigma, Poole, UK). A 1x 
PBS wash was repeated before cells were centrifuged at 90g for 5 minutes. Cells were then 
seeded into fresh tissue culture flasks containing DMEM F12 supplemented with 10% heat 
inactivated FCS and 50µM MSX at a density of 2x 10
5
 cells/ml. For each clone 2 flasks were 
set up as described above. 5mM of isopropyl b-D-thiogalactopyranoside (IPTG) (Sigma, 
Poole, UK) was added to the culture medium of one of the flasks at the start of 
experimentation; the other flask was kept as a control (0mM IPTG). Cultures were incubated 
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at 37ºC for 96 hours before the cells were harvested and the viable cell count determined via 
the Trypan blue exclusion method. 
 
2.2.18. Analysis of the rate of adaptation of a CHO cell-line to growth in a suspension 
culture environment through the expression of p21
CIP1
 or p21
CIP1
/Bcl-2 
Cultures previously grown in static conditions were detached from the surface of the tissue 
culture flask using 1x non-enzymatic cell dissociation solution (Sigma, Poole, UK) and re-
suspended in fresh culture medium consisting of DMEM F12 growth medium supplemented 
with 10% heat inactivated foetal calf serum and 50µM MSX. The viable cell number and 
percentage viability was determined via the Trypan blue exclusion method, before the cells 
were centrifuged at 90g for 5 minutes and re-suspended in fresh growth medium (prepared as 
described above) All cultures were seeded at a cell density of 4×10
5
 cells per ml into a final 
volume of 100ml using 250ml vented Erlenmeyer flasks (Corning Ltd, UK). The culture was 
agitated at a rate of 125 rpm at 37◦C in the presence of 5% CO2. Adaptation was considered 
successful following the return to an equal or better growth and production rate to that 
observed with the original culture.  
 
For experiments involving the expression of either p21
CIP1
 or p21
CIP1
/Bcl-2 cell-lines, four 
flasks were set up as described above. 5mM of Isopropyl β-D-1-thiogalactopyranoside (IPTG 
Sigma-Aldrich) was added to the culture medium of three of the flasks at the start of 
experimentation in order to induce p21
CIP1
 vector expression; the other flask was kept as a 
control (0mM IPTG). Expression of p21
CIP1
 was maintained in the first flask for a period of 3 
days, the second for 6 days and the third for 9 days. Every 72hrs, the cultures were 
centrifuged at 90g and re-suspended in fresh culture medium (as previously described). 
Flasks in which p21
CIP1
-expression was to be maintained had 5mM IPTG added back into the 
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fresh culture medium. Non-Induced cultures were passaged back to 4×10
5
 cells/ml. 
Following 3, 6, and 9, days of cell cycle arrest, p21
CIP1
-expression was halted by the removal 
of IPTG from the culture medium. Each culture was examined daily in triplicate via the 
Trypan blue exclusion method to determine viable and total cell numbers. Mean and standard 
error were calculated from this data and the significance determined via t-test analysis.  
 
2.2.19. Analysis of the rate of Adaptation of a CHO cell-line to growth in a protein-free 
culture medium through the expression of p21
CIP1
 or p21
CIP1
/Bcl-2 
Suspension cultures previously grown in DMEM F12 culture medium supplemented with 
10% heat inactivated foetal calf serum and 50µM MSX were harvested during mid-
exponential phase and the viable cell number and percentage viability were determined via 
the Trypan blue exclusion method.  The cells were then washed in warm 1% PBS before 
being centrifuged at 90g for 5 minutes. The cells were then re-suspended in fresh protein-free 
medium (ProCHO4; Cambrex BioScience) supplemented with 50µM MSX. All cultures were 
seeded at a cell density of 4×10
5
 cells per ml into a final volume of 100ml using 250ml 
vented Erlenmeyer flasks (Corning Ltd, UK). The culture was agitated at a rate of 125 rpm at 
37◦C in the presence of 5% CO2. Adaptation was considered successful following the return 
to an equal or better growth and production rate to that observed with the original culture. 
 
 For experiments involving the expression of either p21
CIP1
 or p21
CIP1
/Bcl-2 cell-lines, four 
flasks were set up as described above. 5mM of Isopropyl β-D-1-thiogalactopyranoside (IPTG 
Sigma-Aldrich) was added to the culture medium of three of the flasks at the start of 
experimentation in order to induce p21
CIP1
-expression; the other flask was kept as a control 
(0mM IPTG). Expression of p21
CIP1
 was maintained in the first flask for a period of 3 days, 
the second for 6 days and the third for 9 days. Every 72hrs, the cultures were centrifuged at 
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90g and re-suspended in fresh protein free culture medium (as previously described). Flasks 
in which p21
CIP1
-expression was to be maintained had 5mM IPTG added back into the fresh 
culture medium. Non-arrested cultures were passaged back to 4×10
5
 cells/ml. Following 3, 6, 
and 9, days of cell cycle arrest, p21
CIP1
-expression was halted by the removal of IPTG from 
the culture medium. Each culture was examined daily in triplicate via the Trypan blue 
exclusion method to determine viable and total cell numbers. Mean and standard error were 
calculated from this data and the significance determined via t-test analysis. 
 
2.2.20. Determination of cell aggregation during adaptation to suspension culture 
During the process of adaptation to protein-free media, 1ml samples of culture medium were 
taken in triplicate from each of the four cultures, set up as described previously, at 72 hour 
intervals. The samples were stained using the Trypan blue exclusion method and the number 
and size of cell aggregates determined. The aggregations were classified as single-cell, 2-, 3-, 
4-, 5- and more-than-5-cell aggregates. 
 
2.2.21. Determination of aggregation following cryopreservation and growth in static 
cultures 
In order to establish if the p21
CIP1
-adapted cell-lines were better able to return to their state of 
adaptation following growth as static cultures or after periods of cryopreservation, protein-
free suspension cultures that had previously been adapted to these conditions with or without 
the use of periods of p21
CIP1
-induced cell cycle arrest were seeded into 75ml tissue culture 
flasks containing protein free-culture medium (ProCHO4 Cambrex) supplemented with 
50µM MSX at a concentration of 2×10
5
 cells/ml. All cells were allowed to attach to the 
flasks’ surfaces and to divide for 72 hours, after which they were removed from the flasks by 
washing the cells with warm 1× PBS followed by the addition of 1x non-enzymatic cell 
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dissociation solution (Sigma, Poole, UK). Cells were then washed with warm protein-free 
medium before being centrifuged at 90g for 5 minutes and re-suspended at a cell density of 
4×10
5
 cells/ml back into a protein free suspension environment consisting of 100ml of fresh 
protein-free growth medium supplemented with 50µM MSX in vented 250ml Erlenmeyer 
flasks. The culture was agitated at a rate of 125 rpm at 37
◦
C in the presence of 5% CO2. 
Samples were taken in triplicate at 72 hour intervals for viability and determination of 
aggregate formation, as described above, before being passaged back to 4×10
5
 cells/ml.  
 
To find out if the characteristics of adapted cells would remain unchanged after 
cryopreservation, cells previously adapted to growth as protein free suspension cultures were 
frozen down as described on page 78. Following 6 weeks of storage, vials were removed 
from the liquid nitrogen storage and thawed according to the normal procedure described 
previously. The cells were then centrifuged at 90g for 5 minutes and re-suspended into a 
suspension culture consisting of 100ml of fresh, pre-warmed, protein-free growth medium 
supplemented with 50µM MSX in vented 250ml Erlenmeyer flasks. The cultures were 
agitated at a rate of 125 rpm at 37 ◦C in the presence of 5% CO2. Samples were taken at 72 h 
intervals for viability and determination of aggregate formation before being passaged back 
to 4×10
5
 cells/ml. The aggregations were classified as single-cell, 2-, 3-, 4-, 5- and more-
than-5-cell aggregates. 
 
2.2.22. The effect of p21
CIP1
-expression on anchorage-dependent growth 
Monolayer cultures were set up in duplicate in vented T75 flasks seeded at a density of 4×10
5
 
cells/ml. At the start of experimentation, one flask had 5mM IPTG (Sigma-Aldrich) added in 
order to initiate cell cycle arrest, and the remaining culture was left un-arrested. Following 24 
hours growth as static cultures, cells were washed with a warm 1× PBS solution before the 
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addition of 10ml of 1:1 dilution of non enzymatic cell dissociation: 1× PBS solution. At 1-
minute intervals, samples were taken in triplicate for determination of viable and total cell 
numbers via Trypan blue exclusion. 
 
2.3 Cell culture calculations 
The calculations described in this section are those utilised in chapters 3, 4, 5 and 6 to 
determine the validity of the results obtained 
 
2.3.1. The specific growth rate. 
This provides a measurement of the rate of growth per unit of biomass based on the 
assumption that all cells within the culture are within the exponential growth phase. In order 
to determine the growth rate between two points the following calculation was used. 
µ = (Ln Xv1 – LnXv0) / (t1- t0) 
Where:            Ln = Natural logarithm (log) 
Xv1 = Viable cell concentration at time 1 (10
5
ml
-1
 or 10
6
ml
-1
) 
Xv1 > Xv0 
Xv0 = Viable cell concentration at time point 0 (10
5
ml
-1
 or 10
6
ml
-1
) 
t1 Elapsed time 1 
t1 > t0 
t0 = Elapsed time 0 
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2.3.2. The doubling time 
Doubling time is another method for providing the growth rate at which a culture is growing 
and can therefore be related to the specific growth rate as follows 
 
td = Ln2/µ 
 
Where:            Ln = Loge 2 
µ = Specific growth rate as calculated previously 
 
2.3.4. Cumulative cell time 
The area under the growth profile is estimated as the sum of the individual areas associated 
with each pair of data points (see figure 2.2 below).  The area of each rectangle is calculated 
as the average viable cell concentration between the two data points multiplied by the time 
difference between the two data points. 
 
The area associated with an individual pair of data points as shown above is calculated using 
the following equation.  Note that for consistency viable cell concentrations should be 
expressed in 10
6
/ml giving CCT units of 10
9
 cell h/l. 
 
 
Cell time = Xv0 + Xv1 . (t1 – t0) 
2 
 Where: Xv0 Viable cell concentration at first sample (10
6
/ml) 
   Xv1 Viable cell concentration at second sample (10
6
/ml) 
   t0 Elapsed time at first sample (hours) 
   t1 Elapsed time at second sample (hours) 
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Figure 2.2. Cumulative cell time as calculated during batch culture. 
 
 
The calculation of cumulative cell time is an estimate of the area under the growth profile.  Increasing the 
number of data points increases the accuracy of this estimation. 
 
Example (highlighted area of figure 2.2) 
 
 Xv0  44.0 x 10
5
/ml = 4.4 x 10
6
/ml 
 to  120 hours 
 Xv1  50.0 x 10
5
/ml = 5.0 x 10
6
/ml 
 t1  144 hours 
 Cell time  112.8 x 10
9
 cell h/l 
 
Cumulative cell time (CCT) is then calculated as the sum of the individual areas across the 
entire growth profile 
 
CCT = CT1 + CT2 + CT3 + …… + CTn 
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2.3.5. Product concentration 
The product concentration is obtained by dividing the amount of recombinant protein 
produced by the volume. Measurement of productivity was obtained with the standard 
analytical methods ELISA. 
 
2.3.6. Specific Antibody production 
The production of antibody is modeled as a function of the viable cell density. In batch 
culture, assuming there is no degradation of antibody, the equation describing the rate of 
change in antibody concentration is:  
 
 
The specific rate of production qp (pg/cell/day) is assumed to be constant during the time 
interval measured.  
Solving for the specific production rate: 
 
 
Where 
Abt = Antibody concentration at time 2 
Ab0 = Antibody concentration at time 0 
Xvt = Cell concentration at time 2 
Xv0 = Cell concentration at time 0 
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Alternatively specific productivity can be calculated by equating assayed product 
concentration with culture cumulative cell time.  Typically two distinct specific production 
rates can be calculated. 
• qp harvest 
• qp overall 
qp harvest is calculated by equating the product concentration at harvest with the cumulative 
cell time at harvest 
 
qp harvest = Pharv / CCT 
 
 Where: Pharv  Product concentration at harvest (mg/L) 
   CCT  Culture cumulative cell time (10
9
 cell h/L) 
 
qp overall is calculated as the linear regression slope of the plot of product concentration 
against cumulative cell time. As for qp harvest, qp overall provides no information as to the 
productivity characteristics during culture. Because the calculation is based on multiple data 
points it is less prone to measurement errors. 
 
2.3.7. Specific utilisation (or accumulation) rate 
As per specific production rate; although more useful information is obtained by looking at 
smaller subsets of the entire data.  Calculation of daily rates is the basis of some nutrient feed 
control strategies akin to the prediction of viable cell concentration detailed above. 
 
 
 
 
 2.4. Statistical analysis 
The calculations described in this section are those utilised in chapters 3, 4, 5 and 6 to 
determine the significance of the results obtained
 
2.4.1. Standard error 
The Standard Error, or Standard Error of the Mean, is an estimate of t
the sampling distribution of means, based on t
                                                
                             SD= 
Where   
            SD = Standard deviation
X = Sample 
_ 
            X = Sample mean 
 
            n = Sample number 
 
From the standard deviation the standard error of the mean is calculated as follows
 
                                                                           
Where  
SD = Standard deviation
n = Sample number  
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he standard deviation of 
he data from one or more random samples.
 
   SD 
SE =    _______ 
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2.4.2. Students t-test  
A t-test is any statistical hypothesis test in which the test statistic has a Student's t distribution 
if the null hypothesis is true. There are different versions of the t test depending on whether 
the two samples are independent of each other or paired, so that each member of one sample 
has a unique relationship with a particular member of the other sample. 
 
 
 
Where s is the grand standard deviation (or pooled sample standard deviation), 1 = group one, 
2 = group two. The denominator is the standard error of the difference between two means. 
For significance testing, the degrees of freedom for this test is 2n − 2 where n = # of 
participants in each group. 
 
2.4.3. P-value 
Once a t value is determined, a p-value can be found using a table of values from Students t-
distribution. The p-value of a statistical significance test represents the probability of 
obtaining values of the test statistic that are equal or greater in magnitude than the observed 
test statistic. 
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3. Multigenic expression of p21CIP1/Bcl-2 and IgG in a 
CHO cell-line for improved productivity and increased 
cellular robustness 
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3.1. Abstract 
The ability to extend a period of high productivity at high cell density is extremely 
desirable for the industrial production of biopharmaceuticals. Previous studies of low 
density cultures have shown that arresting cell proliferation in the G1 phase of the cell 
cycle results in an increased productivity. This increase in productivity is often 
accompanied by a much less desirable increase in the rate of apoptosis as a result of 
preventing cell cycle progression and thus cell division. In this study we have overcome 
this problem via the multigenic manipulation of both the cell cycle and apoptosis to 
significantly enhance the specific production rates of an industrially relevant CHO cell-
line, whilst also enhancing cellular robustness through a reduction in apoptosis, thereby 
increasing the overall time scale for which productivity can be maintained. We examined 
the growth and productivity profiles of several CHO clones, which have been engineered 
to constitutively expresses a chimeric IgG4 antibody, co-transfected to inducibly 
expresses the p21
CIP1
 cyclin-dependent kinase inhibitor and the wild type Bcl-2 anti-
apoptotic protein. The resulting clones were analysed for their expression of p21
CIP1
 and 
Bcl-2 as well as the impact upon cell proliferation, cell viability during batch culture, 
serum deprivation and exposure to staurosporine. All clones exhibited some levels of 
reduction in cell proliferation following induction of p21
CIP1
 and all demonstrated some 
degree of increased cellular robustness when faced with chemical toxicity or serum 
deprivation in comparison to the control cell-lines. Through the combined expression of 
p21
CIP1
 and Bcl-2 this study has demonstrated that it is not only possible to substantially 
improve productivity but that it is also possible to break the link between cell cycle arrest 
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and the initiation of apoptosis leading to an increase in the overall length of viable cell 
culture at much higher production rates.  
 
3.2. Introduction 
In recent years significant progress has been made in the development of strategies for 
the optimisation of growth conditions, in order to maximize the production potential of 
mammalian cell cultures. As our understanding of the mechanisms that regulate cell 
proliferation, cell death, and the protein synthesis and secretion have increased, new 
strategies have been developed which have enabled production processes to be 
intensified. Despite this progress, the scale-up and optimization of cell cultures to meet 
the ever increasing demands of the biopharmaceutical industry has proved to be 
extremely challenging. This is particularly true for mammalian cell-line cultures, which 
in comparison to most other host systems have a tendency to result in low productivity 
levels and instability in the cell-lines used. Despite this CHO has remained the preferred 
choice for the large scale production of recombinant protein, due to the fact that they are 
fast growing, relatively easy to transfect and have the ability to perform complex post-
translational modification required for biological activity  
 
In order to optimize the mammalian cell-line production processes active cell growth, 
without the accumulation of toxic metabolites or limiting conditions that will confer loss 
of cell viability and productivity are essential. In an ideal situation the cells would be 
allowed to expand until they have reached their peak productivity phase, at which point 
they are maintained by the sustained induction of cell cycle arrest and thus cessation of 
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cell division. This shift away from cell replication would allow for the diversion of 
energy away from cell division, towards the synthesis of protein products whilst avoiding 
the problems associated with high cell density cultures (Al Rubeai et al 1992a, Kaufmann 
et al 2001, Simpson et al 1999, Watanabe et al 2001 and 2002, Bi et al 2004). 
 
Several strategies designed to control cell proliferation have been developed including 
the transfection of industrially relevant cell-lines with cytostatic genes. One of the earliest 
attempts involved the expression of the interferon-repressive factor 1 (IRF-1) which was 
found to inhibit cell growth as well as producing tumour suppression activities within the 
transfected cell-line (Kirchhoff et al 1993 and 1996, Geserick et al 2000, Carvalhal et al 
2001, Schroeder et al 2002). Alternate efforts by our laboratory and others have focused 
on cytostatic genes such as cdk inhibitors, in particular p21, p27 and the tumour 
suppressor gene p53, all of which have been shown to result in a G1 phase cell cycle 
arrest following their over expression (Fussenegger et al 1997 and 1998, Mazur et al 
1998, Fussenegger and Bailey 1998, Kaufmann et al 2001, Fussenegger 2001 review, 
Watanabe et al 2001 and 2002, Bi et al 2004, Lloyd et al 1997). 
 
As discussed in the introduction of this thesis, p21
CIP1
 is one of the key cyclin-dependent 
kinases inhibitors which are responsible for the regulation of cell cycle progression and is 
known to inhibit kinase activity in a wide range of cyclin-cyclin-dependent kinase 
complexes involved in the G1/S phase transition of the cell cycle (Gartel et al 1996 
review, Harper et al 1993 and 1995, Xiong et al 1993). Of interest here is the fact that 
earlier studies by our group have demonstrated that during periods of G1 phase cell cycle 
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arrest in both CHO and NS0 cell-lines, productivity is substantially enhanced (Watanabe 
et al 2001 and 2002, Bi et al 2004, Ibarra et al 2003). It has been suggested that this 
improvement in productivity occurs as a direct result of deferring the energy usually 
required for cell division away from the cell cycle machinery. This energy may then be 
re-focused towards the process of product formation.  
 
Although the prevention of cell cycle progression potentially offers a solution to low 
production levels, studies by our laboratory and others have shown that despite the 
maintenance of low cell densities apoptosis remains a problem during periods of cell 
cycle arrest and may in fact occur as a direct result of preventing cell cycle progression 
(Singh et al 1994, Tey et al 2000, Watanabe et al 2002). Apoptosis also presents a 
problem in proliferating cultures and in recent years several studies have demonstrated 
that during large scale cultivation in the bioreactor environment mammalian cells are 
prone to undergo apoptotic cell death as a result of either amino acid, glucose, oxygen 
and serum deprivation, the build up of toxic metabolites or as a result of shear forces 
within the bioreactor environment itself (Al-Rubeai et al 1990 and 1992a, Franek and 
Dolnikova 1991, Mercille and Massie 1994, Singh et al 1994).  
 
In order to overcome this problem several groups have investigated the possibility of 
improving cellular robustness through the transfection of cell-lines with genes possessing 
anti-apoptotic properties. The most commonly used target for this type of research has 
been the well classified Bcl-2 gene. So far the transfection of several cell-lines including 
Burkett’s Lymphoma (Singh et al 1994) insect cells (Alnemri et al 1992, Mitchell-Logean 
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and Murhammer 1997) and hybridoma cell-lines (Itoh et al 1995, Simpson et al 1998, 
Fassnacht et al 1998b and 1999) with anti-apoptotic genes, have all shown a significant 
improvement in the overall cellular robustness achievable. As a consequence Bcl-2-
expressing cultures exhibit an extended lifespan which has been shown to result in 40–
400% greater productivity of monoclonal antibody (Itoh et al 1995, Simpson et al 1997, 
Suzuki et al 1997, Terada et al 1997)  
 
I hypothesise that it may be possible to create a CHO cell-line in which the expression of 
p21
CIP1 
may be combined with the anti-apoptotic properties of Bcl-2 and that in doing so 
we will be able to create a cell-line capable of producing increased levels of monoclonal 
antibody for extended periods of time. More over we would expect such a cell-line to 
respond more favourably to the stresses imposed by the culture environment. To achieve 
this we have adopted a genetic strategy in which the effect of apoptosis due to cell cycle 
arrest can be eliminated through the over-expression of the anti-apoptotic Bcl-2 gene. 
Such a strategy based on the simultaneous control of cell proliferation and apoptosis 
would obviously offer significant advantages for the improvement of culture 
productivity.  
 
3.3. Results.  
To create a Bcl-2-and-p21
CIP1
-coexpressing cell-line the expression vector pEFBcl-2 and 
control vector pEFneo was first introduced into the parental 22H11 line via liposome-
mediated transfection as described in the Materials and Methods. The 22H11 cell-line has 
previously been engineered to express the human-mouse chimeric B72.3 IgG4 antibody 
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gene, using the glutamine synthetase system and in order to obtain inducible expression 
of p21
CIP1
 the Lacswitch system was used. Bcl-2 transfected cells were selected by the 
addition of 400µg/ml Hygromycin B to the growth medium for a period of 2 weeks; after 
which, the whole population of stable transfectants were then transfected with the 
pOPRSV1/p21CIP1 plasmid DNA containing the mouse p21CIP1 complementary DNA 
using Lipofectin reagent. Stable clones were selected in the presence of 400µg/ml 
Geneticin 418 and isolated by limiting dilution. The resulting transfectants were then 
cloned via limiting dilution to produce the clones used for the rest of this study. 
 
3.3.1. The growth profile of p21
CIP1
/Bcl-2-expressing clones 
Before batch analysis of the resulting clones was carried out the stability of the clones, in 
terms of growth rate and antibody production was carefully monitored in triplicate for a 
period of 30 days prior to the initiation of experiments. The clones were cultured in tissue 
culture flasks, seeded at a density of 2 x 10
5 
(cells/ml) and passaged at 72 to 96 hour 
intervals dependent on cell density. Throughout this period the maximum obtainable 
viable cell count for each of the clones remained unchanged indicating a constant growth 
rate. Figure 3.1 shows the typical growth curve obtained for each of the clones and shows 
a relatively narrow spectrum of maximum obtainable viable cell densities ranging from 
17.5 x 105 cells/ml for 1H7 to 15.4 x 105 cells/ml for clone 1G6 a difference of 2.1 x 105 
cells/ml. 
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Figure 3.1. Static batch cultures of p21
CIP1
/
 
Bcl-2 transfected clones. In order to determine the growth 
profiles of each of the clones they were cultured in DMEM F12 culture medium supplemented with 
10% heat inactivated foetal calf serum. p21
CIP1
-expression was not induced during the culture period 
however Bcl-2 was expressed throughout. Cultures were set up in T75 tissue culture flasks and 
incubated at 37ᵒC. Error bars show the standard error of three replicates. The cumulative cell time 
(CCT) was calculated in order to give an estimate of the integral of the viable cell concentration 
against a time curve. The effect of Bcl-2-expression was compared to the non-p21
CIP1
/Bcl-2-
expressing negative control cell-line (22H11) to determine if Bcl-2-expression could have an effect on 
the culture viability and duration. 
 
The typical growth curve for the 10 resulting clones was accessed over 336 hours (Figure 
3.1) the exponential growth phase was found to last between 192 to 216 hours, dependent 
on the clone, at which point the viability begins to decline. In order to access the number 
of viable cells produced during the period of batch culture, the cumulative cell time 
(CCT) was used as this allows for a direct comparison of total cell growth for each of the 
clones. Clone 1H7 had the highest CCT where as clone 1G6 was found to have the 
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lowest. All of the clones exhibited a similar overall viability with the onset of cell death 
occurring between 192 to 216 hours. Figure 3.2 shows the specific growth rates for each 
of the clones and although there appears to be some variation between the highest 
(0.01061 hr-1) and the lowest (0.01016 hr-1) the actual difference found to be less than 5% 
and therefore is not considered significant. 
 
Figure 3.2. Specific growth rate. Results were obtained during the exponential growth phase of non-
induced p21
CIP1
/Bcl-2-transfected clones grown as static cultures in T75 tissue culture flasks 
containing DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf serum. 
p21
CIP1
 was not expressed during the culture period however Bcl-2 was continuously expressed. The 
specific growth rates of the transfected clones were compared to a negative control cell-line (22H11) 
which does not over-express either p21
CIP1
 or Bcl-2. Error bars show the standard error of three 
replicates. 
 
3.3.2. The effect of p21
CIP1
-expression on p21
CIP1
/Bcl-2-expressing clones. 
To access the effects of p21CIP1-expression on the resulting clones, their growth 
behaviour was examined during p21CIP1-induced and non-induced culture conditions over 
a period of 96 hours (Figure 3.3) All clones were seeded in duplicate into 75ml tissue 
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culture flasks at an initial density of 2 x 10
5
 cells/ml with or without the addition of 5mM 
IPTG. Following 96 hours growth all cultures were analysed. This process was then 
repeated in triplicate to get the standard error of the mean. Positive, p21
CIP1
-expressing 
(3B2) and negative, non-p21CIP1-expressing cell-lines (22H11) were used as controls 
throughout. 
 
 
Figure 3.3. The effect of p21
CIP1
-expression on the viable cell count of p21
CIP1
/Bcl-2-transfected cell-
lines following 96 hours of static culture in DMEM F12 culture medium supplemented with 10% heat 
inactivated foetal calf serum. Black bars represent the viable cell count in cultures in which the 
addition of 5mM IPTG at the start of experimentation has resulted in p21
CIP1
-induced cell cycle 
arrest. Grey bars represent cultures which have not been exposed to IPTG and therefore are not 
over-expressing p21
CIP1
. Cultures were set up in triplicate in order to determine the standard error of 
the mean. Student’s t-test indicated significant differences between the p21
CIP1
/Bcl-2-expressing 
clones and the negative control which does not express p21
CIP1
 or Bcl-2 (p < 0.0001).  A positive 
control cell-line expressing p21
CIP1
 (previously described in the Materials and Methods) was also used 
in order to compare the effect of combined p21
CIP1
/Bcl-2-expression to p21
CIP1
-expression alone.  
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Although there was some variation in the levels of cell cycle arrest amongst the clones, 
all demonstrated high levels of p21
CIP1
-expression when compared to the non-p21
CIP1
-
expressing control cell-line. Clone 2C4 exhibited excellent cell cycle arrest following the 
addition of IPTG and also showed the highest viable cell count when p21CIP1-expression 
was not induced. Clones 1H7 and 3F11 also demonstrated a good viable cell count when 
not arrested, however the expression of p21
CIP1
 in these clones failed to result in complete 
cessation of the cell cycle. All clones exhibited a lower overall cell count than the 
p21
CIP1
-expressing control cell-line, indicating that the additional expression of Bcl-2 
may have a negative impact on the growth rate of the p21
CIP1
/Bcl-2-expressing clones. 
Expression of p21
CIP1
 was additionally confirmed via the Western blot technique as 
described in the Materials and Methods. Samples were taken following 96 hours of 
growth from cultures in which p21CIP1-expression had either been induced through the 
addition of IPTG at the beginning of experimentation or had remained un-induced 
throughout (Figure 3.4).  
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                        1G4              2G6            1H7             1G6           2C2  
        IPTG    +         -        +        -        +         -        +         -         +         -  
      
p21 21kDa 
 
                      3F11            3B10            1B2             1F1              2C4 
       IPTG   +         -        +        -        +         -        +         -         +         - 
          
p21              21kDa 
 
  
                     22H11           3B2                        
       IPTG   +         -        +        -         
 
p21                 21kDa 
 
 
 
 
Figure 3.4. Western blot analysis of p21
CIP1
-expression in p21
CIP1
/Bcl-2-expressing clones. Samples 
were analysed following 96 hours growth as static batch cultures grown in T75 tissue culture flasks 
containing DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf serum. 
Each clone was cultured either with or without the addition of 5mM IPTG in order to induce p21
CIP1
-
expression at the start of experimentation. 22H11 was used as a negative control as this has not been 
transfected with p21
CIP1
. 3B2 was used as a positive control as it has previously been transfected with 
p21
CIP1 
(as described in the Materials and Methods). Each well was loaded with 30µl of sample which 
was previously normalised to the same cell density. 
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3.3.3. The effect of Bcl-2-expression on p21
CIP1
/Bcl-2-expressing clones 
To determine that the expression of the anti-apoptotic Bcl-2 gene would result in 
enhanced cell survival, the clones were exposed to the toxic effects of the protein kinase 
inhibitor staurosporine. Cultures were set up in triplicate as described previously in the 
Materials and Methods. At the start of experimentation staurosporine was added to each 
of the culture flasks at a concentration of 0.5µM. After 24 hours exposure, cells were 
harvested from their tissue culture flasks and the viability determined via the Trypan blue 
exclusion method. Levels of apoptosis and necrosis were also determined for each of the 
clones using fluorescence microscopy and the AOPI staining method. In order to 
determine that the transfection of p21
CIP1
 had no positive influence on culture viability 
and apoptosis, a second control cell-line, which had previously transfected with p21CIP1 
was used along with a non-p21CIP1/Bcl-2-expressing control.  
 
The results shown in (Figure 3.5A) demonstrate that in all of the clones tested, the 
expression of Bcl-2 is able to produce a significant reduction in the percentage of cells 
undergoing both early and late apoptosis, however there was also a slight increase in the 
percentage of cells dying by necrosis when compared to the non-Bcl-2-expressing 
controls, suggesting that Bcl-2 is able to offer protection against apoptosis but not 
necrosis.  
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C 
     
Figure 3.5. The effect of staurosporine on p21
CIP1
/Bcl-2-expressing clones. A) shows the effect of Bcl-
2-expression on apoptosis following exposure to staurosporine as determined by AOPI. B) and C) 
show the effect on the viable cell count and culture viability as determined via the Trypan blue 
exclusion method. Clones  previously grown as static cultures in DMEM F12 culture medium 
containing 10% heat inactivated foetal calf serum and 50µM MSX were washed with 1x PBS before 
being removed from their tissue culture flasks using 1x cell dissociation solution. A 1x PBS wash was 
repeated before cells were centrifuged at 90g for 5 minutes. Cells were then re-suspended into fresh 
T25 tissue culture flasks containing DMEM F12 culture medium supplemented with 10% heat 
inactivated foetal calf serum and 50µM MSX at a cell density of 1x10
5
 cells/ml. 0.5µM staurosporine 
was added to each flask before the cultures were incubated at 37ºC for 24 hours. Cultures were then 
harvested as described in the Materials and Methods and analysed for cell death using the AOPI 
staining method. Cell viability was also determined via the Trypan blue exclusion method. Error 
bars show the standard error of three replicates. Student’s t-test indicated significant differences 
between the Bcl-2-expressing clones and the negative control (22H11) which does not express p21
CIP1 
or Bcl-2 (p < 0.0001). To determine that the transfection of p21
CIP1
 had no effect on culture viability 
or apoptosis a control cell-line (3B2) which had previously transfected with p21
CIP1
 (see chapter 2 
Materials and Methods) was also used. 
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Following exposure to staurosporine clone 1G6 maintained the highest viable cell count 
as determined through AOPI staining (Figure 3.5A) and also demonstrated a substantial 
reduction in the percentage of early and late apoptotic cells when compared to the non-
Bcl-2-expressing control cell-lines. In contrast clone 3B10 showed a relatively poor 
viable cell count and an increased percentage of both apoptotic and necrotic fractions, 
this however was still an improvement on the non-expressing controls. When the clones 
were analysed via Trypan blue exclusion, the results (5B and C) showed that during 
exposure to staurosporine the Bcl-2 clones still exhibited a higher viable and total cell 
count than the control cultures and most maintained a viability within the 60 to 70% 
range with the exception of 3B10 which only showed a 33% viability. This however was 
still higher than the control cultures which had viabilities ranging from 25 to 30% 
 
To test the effect of Bcl-2-expression on nutrient limitation as a result of serum 
deprivation experiments were set up as described previously in the Materials and 
Methods. Cultures were placed DMEM F12 culture medium lacking foetal calf serum, 
following 72 hours growth cells were removed from their tissue culture flasks and 
examined via AOPI and Trypan blue exclusion method (Figure 3.6A-C).  The results in 
Figure 3.6A show a clear reduction in the percentage of cells undergoing apoptosis for all 
of the Bcl-2-expressing clones when compared to the non-Bcl-2-expressing control cell-
lines. Clone 3F11 demonstrated both the highest percentage of viable cells and the lowest 
percentage of necrotic cells; in contrast clone 1B2 exhibited both the lowest percentage 
of viable cells and the highest proportion of necrotic cells. As seen previously with 
exposure to staurosporine clones expressing Bcl-2 showed enhanced protection against 
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apoptosis but not necrosis and in comparison to the control cell-lines the level of necrosis 
was greatly increased. This would once again suggest a switch in the mode of cell death 
occurs during Bcl-2-expression. 
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Figure 3.6. The effect of serum deprivation on p21
CIP1
/Bcl-2-expressing clones. A) shows the effect of 
Bcl-2 on apoptosis following the withdrawal of serum from the culture medium as determined by 
AOPI. B) and C) show the effect on the viable cell count and culture viability as determined via the 
Trypan blue exclusion method. Clones  previously grown as static cultures in DMEM F12 culture 
medium containing 10% heat inactivated foetal calf serum and 50µM MSX were washed with 1 x 
PBS before being removed from their tissue culture flasks using 1x cell dissociation solution. A 1x 
PBS wash was repeated before cells were centrifuged at 90g for 5 minutes. Cells were then re-
suspended into fresh T25 tissue culture flasks containing DMEM F12 culture medium supplemented 
with 50µM MSX at a cell density of 1x10
5
 cells/ml. The cultures were incubated at 37ºC for 72 hours. 
Cells were harvested as described in the Materials and Methods and analysed for cell death using the 
AOPI staining method. Cell viability was also determined via the Trypan blue exclusion method. 
Error bars show the standard error of three replicates. Student’s t-test indicated significant 
differences between the Bcl-2-expressing clones and the negative control (22H11 as described in the 
chapter 2 Materials and Methods) which does not express p21
CIP1 
or Bcl-2 (p < 0.0001). To determine 
that the transfection of p21
CIP1
 had no effect on culture viability or apoptosis a control cell-line which 
had previously transfected with p21
CIP1
 (see chapter 2 Materials and Methods) was also used. 
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The results (Figure 3.6B and C) show the viable and total cell counts and percentage 
viability following 72 hours of serum deprivation, all clones showed a significantly 
higher viable cell count compared to the non-p21CIP1/Bcl-2-expressing control lines, and 
most achieved an overall higher cell density. The results also show a marked decrease in 
cell proliferation during the 72 hour test period indicating the need for serum for cell 
proliferation.  
 
All of the clones tested showed a significant improvement in the overall viability as 
determined via t-test analysis, demonstrating the effect of Bcl-2-expression; this was 
further confirmed via western blot analysis (Figure 3.7). Each of the clones was tested 
following 96 hours growth as static cultures. All clones appear to express the 26-kDa 
Bcl-2 protein; this however was not observed in the 22H11 control cell-lines. 
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Figure 3.7. Western blot analysis of Bcl-2-expression in p21
CIP1
/Bcl-2 transfected clones. Samples 
were analysed following 96 hours growth as static batch cultures grown in T75 tissue culture flasks 
containing DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf serum. 
Each well was loaded with 30µl of sample which was previously normalised to the same cell density. 
The 22H11 cell-line (previously described in chapter 2 Materials and methods) was used as a negative 
control 
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3.3.4. Clone Productivity. 
The productivity of each clone was analysed following the initiation of p21
CIP1 
expression 
at the start of experimentation through the addition of IPTG to the culture medium. The 
results (Figures 3.8 and 3.9) show a broad range of variation in productivity amongst the 
clones both during normal growth and following the induction of p21CIP1-expression. Due 
to the nature of the transfection used expression of Bcl-2 was not inducible therefore it 
was expressed continuously in all of the clones tested. The analysis of clones in which 
p21
CIP1
-expression was not induced revealed several clones exhibit a slight decrease in 
productivity when compared to the non-p21
CIP1
/Bcl-2-expressing control cell-line. This 
would seem to indicate that the expression of Bcl-2 alone affords no enhancement to the 
productivity of the CHO cell-line used in this study.  
 
During periods of p21
CIP1
-induced cell cycle arrest, all clones did however show a 
significant increase in their specific production rates; with some clones specific 
production rates being increased by up to 90% in comparison to the corresponding non-
induced p21
CIP1
/Bcl-2-expressing cultures, as determined via t test analysis. Several 
clones also exhibited up to a 65% higher production rate than that observed in the non 
p21
CIP1
/Bcl-2-expressing control culture.  
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Figure 3.8. The productivity of chimeric antibody in p21
CIP1
/Bcl-2 expressing cultures. The human-
mouse IgG4 chimeric MAb concentration was determined via enzyme linked immunoabsorbent 
assay (ELISA) as described in the Materials and methods. Results were obtained following 120 hours 
of growth as monolayer cultures in DMEM F12 culture medium supplemented with 10% heat 
inactivated foetal calf serum and 50µM MSX. For each cell-line duplicate cultures were set up. One 
culture had the expression of p21
CIP1
-induced through the addition of 5mM IPTG at the start of 
experimentation. The other culture was left non-induced throughout. Dark grey bars represent 
productivity of chimeric antibody in p21
CIP1
/Bcl-2-expressing cultures. Light grey bars represent the 
productivity of the same cell-lines during culture without the induction of p21
CIP1
-expression. Results 
were compared to a negative control (22H11) culture (described in chapter 2 Materials and Methods) 
which does not express p21
CIP1
 or Bcl-2. Error bars show the standard error of three replicates. 
Student’s t-test indicated significant differences between the productivity of Induced p21
CIP1
/Bcl-2-
expressing cultures and the control. (p < 0.0003. 
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Figure 3.9. The specific production rate of p21
CIP1
/Bcl-2-expressing clones grown as monolayer 
cultures in- DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf serum 
and 50µM MSX. Dark grey bars represent productivity of chimeric antibody in p21
CIP1
/Bcl-2-
expressing cultures. Light grey bars represent the productivity of the same cell-lines during culture 
without the induction of p21
CIP1
-expression. Results were compared to a negative control (22H11) 
culture (described in chapter 2 Materials and Methods) which does not express p21
CIP1
 or Bcl-2. 
Error bars show the standard error of three replicates. Student’s t-test indicated significant 
differences between the productivity of induced p21
CIP1
/Bcl-2-expressing cultures and the control. (p 
< 0.0003.) 
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3.4. Discussion 
In this study we have succeeded in demonstrating that through the combined expression 
of p21
CIP1 
and Bcl-2 it is possible to engineer a CHO cell-line that is able to better 
withstand the rigors of the bio-processing environment whilst also improving 
productivity. During the course of experimentation several clones expressing both Bcl-2 
and an inducible copy of p21
CIP1
 were produced and although some variation was 
observed between each of the clones, the expression of Bcl-2 resulted in a significant 
increase in cellular robustness when challenged via nutrient deprivation and cytotoxic 
stimuli in all of the clones tested. This in turn led to a vast reduction in the occurrence of 
apoptotic cell death and an increase in culture duration and viability  
 
This ability to simultaneously control apoptosis and cell proliferation has the potential to 
significantly improve the overall obtainable product titres of several industrially 
important mammalian cell-lines. Previously our group (Watanabe et al 2002) has 
reported that G1 phase cell cycle arrest, as a result of inducible p21
CIP1
-expression is able 
to produce a 4 fold enhancement in cell productivity in NS0 cell-lines. In addition it has 
also been shown that Bcl-2-expression is able to dramatically improve culture viability 
(Bierau et al 1998) and may also through its expression exert an influence upon the G1 to 
S phase transition (Marvel et al 1994, O`Reilly et al 1996, Simpson et al 1999). These 
findings are in agreement with the results demonstrated in this study which showed a 
significant increase in productivity during cell cycle arrest in the p21
CIP1
/Bcl-2-
expressing clones tested, however the enhancement was not as pronounced as those seen 
in NS0-lines (Watanabe et al 2002) possibly as a result of the combined expression of 
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p21
CIP1 
and Bcl-2 as non-induced clones expressing Bcl-2 alone were found to have a 
slightly lower specific production rate when compared to the non-Bcl-2-expressing 
control line. Also we cannot exclude the possibility that the parental cell-line is a high 
producing clonal cell-line that may have reached its optimal intrinsic productivity level. 
 
This finding is in agreement with other studies from our laboratory (Tey et al 2000) and 
others (Murray et al 1996), who have reported no significant increase in productivity as a 
result of Bcl-2-expression alone. It would appear that although the expression of Bcl-2 
offers protection against nutrient limitation the exhaustion of the precursors for gene 
expression has a limiting effect on productivity. Other studies into murine hybridomas 
(Fassnacht et al 1998b) however have found that a significant improvement in 
productivity in high cell density perfusion culture. Moreover fed batches of NS0 cell-
lines resulted in a significant increase in both the maximum cell number and antibody 
productivity when compared to the non-Bcl-2-expressing control (Tey et al 1999).  
 
The significant increase in productivity during cell cycle arrest in p21
CIP1
/Bcl-2-
expressing clones is most likely the result of altering the growth rate, potentially leading 
to a change in the energy transfer of the cellular biosynthetic machinery away from 
proliferation and towards product synthesis. However this has proven to be relatively 
difficult to achieve due to the induction of apoptosis under cell cycle arrest (Singh et al 
1994). In this study the combination of p21
CIP1
 and Bcl-2-expression appears to have 
overcome this problem resulting in a 42.85% and 18.64% increase in the specific 
production rate when compared to Bcl-2 and p21
CIP1-
expressing cell-lines, respectively. 
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Interestingly arresting the cells in the G1 phase of the cell cycle may also have an 
influence on the cells requirement for growth factors/complex nutrients that are present in 
the growth medium, therefore arresting cells at G1 may also potentially reduce the need 
for nutrients previously determined as essential for productivity (Tey et al 2000).  
 
What is clear from this study is the fact that through the genetic modification of the host 
cell-line it may be possible to significantly enhance the period of time cells are able to 
remain highly productive and viable. This may lead to the ability to specifically tailor the 
host cell-line to the desired culture conditions and production needs rather than matching 
the culture conditions with the growth requirements of the cell-line used. 
 
 
 
 
 
 
 
 
136 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. The effect of p21CIP1-expression on cell size, cell cycle, 
metabolism and productivity in CHO cell-lines 
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4.1. Abstract 
In this chapter we have examined the effect of G1 phase cell cycle arrest through the 
expression of the cyclin dependent kinase inhibitor p21
CIP1 
on the productivity of a 
chimeric IgG4 antibody expressing CHO cell-line, whilst also analysing the associated 
changes in cellular metabolism that occur during periods of high productivity. The results 
of this study clearly demonstrate that through the induction of cell cycle arrest it is 
possible to uncouple cell growth from cellular proliferation which in turn increases the 
overall specific production rate. Analysis of the rate of glucose and lactate metabolism 
show a 78.4% and 166.6% increase respectively in induced cultures in comparison to 
cultures in which p21
CIP1
 was not expressed. This was also accompanied by a 614.2% 
increase in the rate of glutamate metabolism and an 86% increase in ammonia production 
rates. This clearly demonstrates a significant increase in the activity of the cells metabolic 
pathways during periods of cell cycle arrest and may well explain the observed increase 
in productivity. When cell division was halted it was observed that the cells increased in 
volume by up to 125%. This was also accompanied by a 183% increase in the cells total 
protein content suggesting that the protein normally synthesised prior to cell division is 
stored within the arrested cell thus leading to the observed increase in cell size. This 
study therefore provides several insights into how productivity may be improved in 
industrially relevant CHO cell-line as well as offering vital information into the metabolic 
changes that occur during periods of cell cycle arrest, and its effect on productivity. 
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4.2. Introduction  
Intricate metabolic processes control the growth and productivity of all mammalian cell 
cultures as well as the cells physiology. The accumulation of waste products, the 
depletion of energy sources, amino acids, lipids, vitamins or trace elements as well as the 
exhaustion or inactivation of growth factors (Ljunggren and Haggstrom 1995) all limit 
the metabolic potential of cell cultures commonly used by industry. In an attempt to 
overcome these limitations and thereby improve productivity several methods have been 
employed, including media optimisation (Xie and Wang 1994,  Zhang and Robinson 
2005) and feed strategies (Wurm 2004, Sauer et al 2000, deZengotita et al 2000) both of 
which are designed to improve process scale-up and development. Using such strategies 
several groups have shown that it is possible to increase productivity, either as a result of 
higher cell density, improved viability (Xie and Wang 1997, Zhou and Thompson 1997) 
and/or by increasing the specific production rate (Takagi et al 2001, Wong et al 2005).  
 
The energy required by a cell during the process of protein production may well 
constitute a significant part of the total cellular energy. Therefore an understanding of the 
mechanisms through which a cell obtains and uses cellular energy is critical for the 
optimization of protein production. Several studies (Bi et al 2004, Carvalhal
  
et al 2001, 
Carvalhal et al 2003, Fussenegger et al 1998,  Ibara et al 2003, Watanabe et al 2001) 
have demonstrated the ability to increase the productivity of industrially important cell-
lines during periods of cell cycle arrest. In these studies significant changes in the cells 
metabolism have also been observed, which have resulted in the accumulation of cellular 
constituents and thus cell death (Sukhorukov et al 1994, Saunders et al 1999, Carvalhal 
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et al 2002). Based on these findings it is clear that the production of a cell-line which is 
able to devote a significant proportion of its metabolic and energy resources towards the 
production of a desired protein at high cell density would represent an ideal industrial 
process. Such a diversion of resources would lead to high product yields and less 
metabolic wastage. 
 
In the previous chapter I was able to successfully demonstrate that the productivity of 
CHO cells could be enhanced through the expression of p21
CIP1
, which results in the 
cessation of the cell cycle and thus cellular proliferation. Understanding the relationship 
between the cell cycle and productivity is vital in order to determine the mechanisms 
behind product synthesis and also to enable the optimisation of commercial culturing 
protocols that will maximize the final product titres. Several studies (Feder et al 1989, 
Kromenaker and Srienc 1991, Al-Rubeai and Emery 1990, Fussenegger et al 1997, Gu et 
al 1993) have produced conflicting evidence on the relationship between cell cycle and 
productivity, however it is generally accepted that productivity is higher in larger cells. 
 
 It is not possible to assume that the changes in metabolism that occur during periods of 
cell cycle arrest are universal for all methods used, or that such changes are directly 
linked with the observed increase in productivity therefore in this chapter  aim to confirm 
the existence of a relationship between p21
CIP1
-induced cell cycle arrest and the 
productivity of CHO cells. Furthermore I aim to examine the hypothesis that cellular 
growth and proliferation may be uncoupled in p21
CIP1
-expressing cultures, whilst also 
identifying potential changes which occur in the cells metabolism during periods of 
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proliferation arrest, the hope being that I may be able to determine if such metabolic 
changes have a direct impact on the cellular productivity. 
  
In order to do this I have utilised a Chinese hamster ovary (CHO) cell-line, which 
through the addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) to the culture 
medium is able to inducibly express the cdk p21
CIP1
. In this chapter I have examined the 
effect of cell cycle arrest on the metabolism of key nutrients in an attempt to determine if 
a relationship exists which is able to explain the observed increase in specific production 
rates during periods of cell cycle arrest. 
 
4.3. Results 
In order to produce a CHO cell-line capable of the inducible expression of p21CIP1 the 
Lacswitch system was used. Parental 22H11 cell-line, described previously were 
transfected with the CMVlacI plasmid DNA as described in the Materials and Methods. 
Transfected cells were then selected in a medium containing 400µg/ml Hygromycin B. 
After 2 weeks selection, the whole population of stable transfectants was then transfected 
with pOPRSV1/p21
CIP1
 plasmid DNA. The resulting transfectants were then cloned via 
limiting dilution to produce the cell-line used for the rest of this study. 
 
4.3.1. The effect of p21
CIP1
-expression on cell cycle progression 
Several studies have previously demonstrated the ability to arrest the progression of the 
cell cycle of several industrially important cell-lines, through the expression of p21
CIP1 
(Fussenegger et al 1998, Watanabe et al 2002, Bi et al 2004, Ibara et al, 2003). In order 
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to determine the effectiveness of the proliferative arrest caused by p21
CIP1
-over-
expression in the CHO cell-line used for this study, cells were cultured for 120 hours in 
the presence or absence of IPTG. The cultures were then analysed at 24 hour intervals via 
propidium iodide (PI) staining using Guava personal cell analysis (PCA) over a period of 
120 hours.  
 
The results shown in Figure 4.1A demonstrate a sharp increase in the number of cells in 
the G1 phase of the cell cycle following the initiation of p21
CIP1
-expression. 
Approximately 61% of cells were observed to congregate in this phase following 24 
hours of p21
CIP1
-over-expression, rising to 69% following 120 hours of expression. A 
gradual decline in the percentage of cells in S phase from 49% at 24 hours to 8% at 120 
hours was also observed. During the course of experimentation it was noted that there 
was a slight increase in the number of cells in the G2 phase of the cell cycle rising from 
18% to 23% over the 120 hour period of experimentation.  
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Figure 4.1 Cell cycle  of induced (A) and non-induced (B) p21
CIP1
-transfected cell-lines over a 120 
hour period determined via Guava cell cycle analysis To further analyze the data for more subtle 
changes between the phases of the cell cycle Multicycle software that applies sophisticated curve 
fitting algorithms to the Guava cell cycle data that more accurately calculates the percentages of the 
cell populations and their relevant statistics were used. Error bars show the standard error of three 
replicates. 
 
In contrast to the culture expressing p21
CIP1
, the results from the control culture, in which 
p21
CIP1
-expression was not induced (Figure 4.1B) show the percentage of cells in the G1 
phase of the cell cycle to be significantly lower, with only 34% of cells congregating at 
this phase following 24 hours of culture. During the remaining culture period the 
percentage of cells entering the G1 phase rose slightly, but still only reached 55% 
following 120 hours. A progressive decrease in the percentage of cells in S phase from 
49% to 21% also resulted as the cells entered stationary phase at around the 120 hour 
mark.  
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4.3.2. The effect of p21
 CIP1
-expression on cell size and volume 
In order to study the effect of p21
CIP1
-over-expression on cell volume, experiments were 
set up as described previously in the Materials and Methods. Samples were taken in 
triplicate on a daily basis from both p21CIP1-expressing and non-expressing cultures. Each 
sample was analysed via a Malven mastersizer to determine the mean volume of the cells 
at that particular point in time.  
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Figure 4.2 Analysis of cell volume in (A) a control non-p21
CIP1
-expressing cell-line and (B) a p21
CIP1
-
expressing cell-line in which vector expression has been induced (diamonds) or non-induced 
(squares) at the start of experimentation. The cell volume was determined at 24 hour intervals via a 
Malven mastersizer as described in Materials and Methods. Error bars show the standard error of 
three replicates. Student’s t-test indicated significant differences between volume of induced and non-
induced cultures. (p < 0.0003.) 
 
The results shown in Figure 4.2 show a significant increase in the overall cell volume 
following the initiation of cell cycle arrest at the start of experimentation. p21CIP1- 
expressing cells were found to be on average up to 125% larger when compared to 
cultures in which p21
CIP1
-expression was not induced and up to 135% larger than the  non 
p21
CIP1
-expressing control cell-line. To confirm this increase in cell volume, samples 
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containing an equal number of cells were taken from both induced and non-induced 
cultures as described in the Materials and Methods. These samples were then centrifuged 
in order to produce a compact pellet which could be visualised. The results shown in 
Figure 4.3 demonstrate that after 72 hours of cell cycle arrest there was an increase in cell 
volume of approximately 100%, which, despite the differences in methods was in relative 
agreement with the results obtained via the Malven mastersizer previously. 
 
 
 
 
Figure 4.3 Analysis of packed cell volume of cultures in which p21
CIP1
-expression was either induced 
or non-induced at the start of experimentation. Samples containing 2x10
5 
cells were taken from 
induced and non-induced cultures before being centrifuged at 2000g to produce a visible pellet. The 
procedure was repeated in triplicate to ensure the reproducibility of the observed result before 
photographic evidence was taken. 
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4.3.3. The effect of p21
 CIP1
 expression on cell metabolism 
In order to understand the physiological mechanisms that operate during periods of cell 
cycle arrest, firstly the metabolic activity of the cell was determined using a MTT assay 
as described in the Materials and Methods. This method enables the calculation of 
mitochondrial dehydrogenase enzyme activity in both induced and non-induced cultures 
as well as a non p21
CIP1
-expressing control cell-line based on 2x10
6 
cells per sample. The 
results (figure 4.4A) show the effects of 72 hours of p21
CIP1
-induced cell cycle arrest on 
the activity of mitochondrial dehydrogenase enzymes. During p21
CIP1
-expression a 
77.5% increase in activity was observed when compared to non-induced culture and a 
118% increase in comparison to the non-p21
CIP1
-expressing negative control (figure 
4.4B).  
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Figure 4.4 Analysis of mitochondrial activity determined via an MTT assay in cultures in which 
p21
CIP1
-expression  (A) induced (Diamonds) or non-induced (Squares) at the start of 
experimentation, as well as a (B) control non-p21
CIP1
-expressing cell-line. (C) summarises the 
difference between the mitochondrial activity of induced, non-induced and control cultures following 
72 hours of culture. Error bars show the standard error of three replicates. Student’s t-test indicated 
significant differences between the mitochondrial activity of induced and non-induced cultures. (p < 
0.0003.) 
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Analysis of the total protein (Figure 4.5) reveals a significant increase the amount of total 
protein produced during periods of p21
CIP1
-induced cell cycle arrest, as determined via a 
BCA total protein kit. The expression of p21
CIP1 
was found to result in approximately a 
183% increase in the amount of total protein produced when compared to non-induced 
cultures and a 214% increase compared to the non-p21CIP1-expressing control cell-line. 
These results would seem to indicate either an increase in overall protein synthesis or that 
the prevention of cell division results in all of the protein usually synthesized prior to cell 
division remaining within the cell.  
 
 
 
Figure 4.5 Analysis of the total protein content of cultures in which p21
CIP1
-expression was either 
induced or non-induced at the start of experimentation and a control culture in which p21
CIP1
 was 
not expressed. The total protein content of the cells was calculated following 72 hours of culture, via a 
BCA kit as described in Materials and Methods. Error bars show the standard error of three 
replicates. Student’s t-test indicated significant differences between the total protein content of 
induced and non-induced cultures. (p < 0.0003.) 
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Glucose is utilized as the main source of energy and metabolic intermediates of all 
cultivated mammalian cells (Altamirano et al 2001) and its passage through the 
glycolysis pathway results in the production of waste products such lactate.  Figure 4.6A 
shows the depletion of glucose and the accumulation of lactate in cultures in which 
p21CIP1-expression had been either induced or non-induced, analysed over a 216 hour 
period. Both cultures display a similar pattern of glucose utilization and lactate 
accumulation throughout the culture period. In cultures in which p21
CIP1
-expression was 
induced, the glucose concentration remained significantly higher than that observed in the 
non-induced culture and as a result the concentration of lactate produced remained lower. 
This finding however represents the differences in cell density between cultures in which 
p21CIP1-expression had been induced and those in which it had not. To more accurately 
determine the rate of glucose utilisation and lactate accumulation, these results were 
analysed on a per cell basis. The results (Figures 4.6B and C) clearly show the specific 
rate at which glucose is utilized and lactate accumulates to be significantly higher during 
periods of p21
CIP1
-expression. From this data it was also possible to calculate the yield of 
lactate from glucose for induced and non-induced cells following 120 hours of culture 
(YLac/Glc) as 0.454 mol
-1
 and 0.545 mol
-1
 respectivaly. These results clearly indicate 
that during periods of p21
CIP1
-induced cell cycle arrest, glucose may be utilised more 
readily than when a cell is undergoing rounds of proliferation. 
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Figure 4.6 Analysis of the concentrations of glucose and lactate (A) in cultures in which p21
CIP1
- 
expression had been induced (open squares and triangles) and non-induced (closed squares and 
triangles) as sampled over 216 hours. Bars demonstrate the changes in specific utilization rates of 
glucose (B) and (C) the specific production rates of lactate of in cultures in which p21
CIP1
-expression 
had been induced (light grey) and non-induced (dark grey) cultures. Error bars show the standard 
error of three replicates. Student’s t-test indicated significant differences between the glucose 
utilization rates and lactate production rates of induced and non-induced cultures. (p < 0.0003.) 
 
Interestingly it would apear from Figure 4.6B the rate at which glucose is utilised by 
p21CIP1-expressing cultures decreases following the first 48 hours of culture when 
compared to the culture in which p21CIP1-expression was not induced. This would sugest 
that glucose is more readily utilized in the early phases of culture.  
 
The results shown in figure 4.7 demonstrates the changes in glutamate concentration and 
specific utilization rates over time for both induced and non-induced p21
CIP1
-expressing 
cultures. Throughout the culture period the concentration of glutamate decreased in both 
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cultures, however the overall concentration remained higher in cultures in which p21
CIP1
 
was expressed, again reflecting the lower cell density. During the early phases of culture 
the specific utilization rate of both cultures was found to be relatively similar, but 
increased at a significantly higher rate in the p21CIP1-expressing cell-line during the latter 
half of the culture period. This was found to result in an approximate 2 fold increase in 
the specific utilization rate when compared to the non- induced culture. 
 
 
Levels of ammonia were also monitored during the culture period and the results (Figure 
4.8A) show the accumulation of ammonia in cultures in which p21
CIP1-
expression had 
been induced or non-induced. During the first 48 hours of culture the levels of ammonia 
similar for both cultures; however from mid exponential phase (72 hours) onwards the 
concentration of ammonia detected was considerably higher in the non-induced culture, 
reflecting the increase in cell  of the ammonia accumulation rateollowing 48 hours the 
specific rate of ammonia production decreased in both cultures, the rate of this decrease 
was much slower in cultures in which p21
CIP1
-expression had been inducedin an 86% 
specific ammonia production rate . 
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Figure 4.7 Analysis of the concentration of glutamate (A) in cultures in which p21
CIP1
-expression was 
induced (open squares) and non-induced (closed squares) as sampled over 216 hours. Bars 
demonstrate the changes in specific utilization rates (B) of induced (light grey) and non-induced 
(dark grey) cultures. Error bars show the standard error of three replicates. Student’s t-test 
indicated significant differences between the glutamate utilization rates of cultures in which p21
CIP1
- 
expression was induced and non-induced. (p < 0.0003.) 
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Figure 4.8 Analysis of the concentration of ammonia (A) in cultures in which p21
CIP1
-expression had 
been induced (open squares) and non-induced (closed squares) as sampled over 216 hours. Bars 
demonstrate the changes in specific production rates (B) of induced (light grey) and non-induced 
(dark grey) cultures. Error bars show the standard error of three replicates. Student’s t-test 
indicated significant differences between the ammonia production rates of induced and non-induced 
cultures. (p < 0.0003.) 
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4.3.4. The effect of p21
 CIP1
-expression on productivity 
The productivity of cultures in which p21
CIP1
-expression was induced or non-induced 
was analysed following the initiation of cell cycle arrest via ELISA as described in the 
Materials and Methods. The results (Figure 4.9) show the specific production rate 
following 72 hours in culture and demonstrate a 93.44% increase in productivity in 
p21
CIP1
-expressing cultures in comparison to the non-p21
CIP1
-expressing control. 
 
 
 
Figure 4.9 Bars show the specific production rate of p21
CIP1
-expressing cell-lines following 72 hours 
growth as serum-supplemented static cultures. Error bars show the standard error of three 
replicates. Student’s t-test indicated significant differences between the productivity of cultures in 
which p21
CIP1
-expression had been induced and those in which it was not-induced. (p < 0.0003.) 
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4.4. Discussion 
In this study it was confirmed that the induced expression of p21
CIP1 
results in the 
immediate cessation of cell cycle progression predominantly in the G1 phase. As 
observed previously (Bi et al 2004) during the later stages of culture a small percentage 
of cells did not accumulate in the G1 phase of the cell cycle and instead appear to be 
blocked in G2 phase. Despite this cell cycle arrest was shown to be complete and was 
also accompanied by a significant increase in the overall specific production rate. This is 
in agreement with our previous findings that during periods of p21
CIP1
-over-expression 
productivity may be substantially increased (Watanabe et al 2002 et al 2003).  
 
During periods of cell cycle arrest an inverse relationship has been shown to exist 
between the rate of cell proliferation and specific productivity (Altamirano et al 2001, 
Carvalhal et al 2003, Fox et al 2005, Kaufmann et al 1999, Lee and Lee 2000). Variation 
in the methods employed to induce proliferation arrest as well as the phase of cell cycle 
in which the cells congregate have a direct impact on the physical and chemical 
properties of the cells environment. Such changes have the potential to affect multiple 
cellular processes and as a result it is clear that the biological basis of how the prevention 
of cellular proliferation enhances productivity may not be universal to all methods used. 
This makes its determination extremely complex and as of yet the exact mechanisms 
remain elusive.  
 
 The maintenance of cell size is considered a homeostasis between macromolecular 
synthesis and degradation. In multicellular organisms, this is linked to the presence of 
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nutrient and growth factors and hence is also applicable to cell culture.  An increase in 
cell size may well reflect the metabolic potential of a cell, as this parallels its DNA 
content. It has previously been shown that there is a strong, positive relationship between 
genome size and cell size (Saucedo and Edgar 2002), similarly it has been reported 
(Dolznig et al 2004) that oncogene-driven cells have a higher rate of proliferation and 
also show an increase in cell volume.  
 
While the cell number did not increase in the arrested culture a 125% increase in cell 
volume resulted from the expression of p21
CIP1
 over a 72 hour period, with the average 
cell having a volume of 6300 µm
3
 as opposed to 2800 µm
3
 as observed in non-induced 
cultures. These findings are in agreement with several studies from both our laboratory 
and others in which proliferation arrested CHO (Bi et al 2004) and Rat Schwann cells 
(Conlon et al 2001 Conlon and Raff 2003) show similar size ranges (2000-10000µm
3
) 
and supports the hypothesis that cellular growth is able to occur independently of the cell 
type and the mode of proliferation arrest. The results presented here therefore indicate 
that a relationship exists between the specific production rate and cell volume as during 
experimentation both of these parameters increase simultaneously with time. This results 
in a peak at around 72 hours into the culture period, which has previously been shown to 
be the period of maximum productivity in arrested cells (Bi et al 2004).  
 
During the G1 phase of the cell cycle cells replicate their organelles and increase in 
biomass in preparation for cell division.  Once a predetermined threshold is reached, the 
cell cycle is able to progress into the S phase, at which point it is debatable whether cell 
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growth continues. During periods of cell cycle arrest it is likely that the accumulation of 
biomass is able to occur without hindrance. This would result in overall increase in the 
cells protein assembly machinery, that is the ER and Golgi, which in turn would facilitate 
the observed increase in specific productivity  
 
Although little is known about the relationship between cellular volume and productivity, 
in a recent study (Dinnis et al 2006) the analysis of four clones that varied in their 
specific productivities would seem to suggest that a denser cell, that is one having a high 
protein to cell volume ratio results in higher specific productivity rate. This contradicts 
previous finding (Lloyd et al 2000) that suggest that a larger cell volume results in an 
increased productivity and would therefore seem to suggest that cell volume and the total 
protein content are not necessarily correlated. In this study analysis of the cells total 
protein content reveals a significant increase in this parameter during periods of p21
CIP1
-
induced cell cycle arrest. Similar results have previously be obtained in other cell-lines 
including IRF-1 activated proliferation arrested BHK-21 cells (Carvalhal et al 2002), 
mouse Schwann cells (Conlon and Raff 2003) CHO cells (Bi et al 2004) and Rat 
Schwann cells (Conlon et al 2001, Conlon and Raff 2003).  This would seem to support 
the theory that the uncoupling of growth and proliferation observed in this study is not 
solely restricted to the over-expression of p21CIP1 and that alternative mechanisms for 
increasing specific productivity may well exist. The increase in total protein content 
would also appear to confirm the theory that during periods of cell cycle arrest an 
increase in the protein synthesis machinery is more readily able to occur and therefore 
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that proliferation, that is, the cycling and division of the cell, can be ‘uncoupled’ from 
cell growth.  
 
The exact mechanism through which this occurs remains elusive, however it may 
possible to partially explain this process through two of three models proposed by 
(Jorgensen et al 2004) that originally aimed to explain the relationship between cell 
growth and cell cycle co-ordination. In the first possible pathway cellular growth and cell 
cycle progression are viewed as separate events running simultaneously, only combining 
as a means of overcoming cell cycle inhibition following sufficient cellular growth. It is 
also possible that as an extension of this parallel pathway, a series of checkpoints exists, 
that coordinate the two events of cell cycle and cell growth. In contrast the second 
suggested pathway represents a linear series of events in which the initial cell cycle 
events themselves result in cellular growth and thus the subsequent events leading up to 
cell proliferation. Of these pathways, the one in which cell growth and the cell cycle 
occur in parallel would seem to preferentially fit the findings of this study, as opposed to 
a linear model and would therefore suggest that cell growth is controlled separately from 
cell proliferation and hence, only during periods of decreased proliferation could the 
accumulation of cellular biomass result. These models however only provide an insight 
into the possible biological pathways at play and do not fully represent the diversity or 
complexity of the multiple pathways and checkpoints that may well govern cellular 
growth and proliferation; they do however highlight the possibility for cellular growth to 
occur independently of cell proliferation.  
 
  
Figure 4.10. Diagramatic representation of the 3 pathways 
(Jorgensen et al 2004). In pathway A d
which in turn activates the chain of events leading to cell cycle initiation in a linear fashion. 
pathway B growth and cell cycle events
inhibition of cell cycle is lifted by the growth rate sensor and in pathway C initial cell cycle events 
result in cell growth and the subsequent events leading to cell proliferation in a linear fashi
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As discussed previously the finding of a correlation between increased total protein, cell 
volume and specific productivity in proliferation arrested CHO cells can be attributed to 
the uncoupling of growth and proliferation. This would additionally suggest that the 
energy required for cell division would now be available for cell growth and product 
formation, however in order to determine if such a diversion of cellular resources to 
recombinant protein production occurs during periods of p21
CIP1
-induced cell cycle 
arrest, key metabolic processes were also monitored.  
 
Analysis of the mitochondria reveals a significant increase in mitochondrial 
dehydrogenase enzyme activity during periods of proliferation arrest; this is in agreement 
with our  previous findings (Bi et al 2004) where it was observed that during periods of 
G1 phase cell cycle arrest an up regulation of mitochondrial activity was accompanied by 
an increase in mitochondrial mass. These results when combined with those presented 
here would seem to suggest the biogenesis of new mitochondria and not the activation of 
the existing organelles in arrested cultures. Analysis of the mitochondrial activity also 
provides an insight into the state of reduction/oxidation (redox), therefore the observed 
increase in mitochondrial activity in the arrested cultures would also seem to suggest the 
existence of a higher proliferative potential (Takahashi and Abe 2002).  
 
It would be expected that any increase in productivity would significantly increase the 
demands on the cell for increased energy metabolism; this was confirmed in this study 
through the analysis of the rates of glucose and glutamate consumption and lactate and 
ammonia production. Glucose is utilized by mammalian cells as the main source of 
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carbon and therefore passes through the glycolysis pathway extremely quickly resulting 
in the production of waste by-products such as lactate. In this study it was found that the 
specific utilization rate of glucose was significantly higher in cultures in which p21
CIP1-
expression had been induced when compared to non induced-cultures. Interestingly the 
difference in specific utilization rates was highest during the early stages of the batch 
culture, indicating the possibility of its utilization for the observed increase in cell volume 
and total protein which also occur during the early stages of culture.  
 
Since the CHO cells used in this study have previously been transfected with the GS 
expression system the cells are able to synthesize their own glutamine from glutamate 
when grown in glutamine free media. The conversion of glutamate to glutamine has been 
previously shown to be utilized within the cell for the metabolism of cellular energy as 
well as the production of recombinant proteins (Schneider et al 1996). Therefore 
glutamate becomes a significant factor in determining cell growth during the late 
exponential phase and its consumption was found to increase in response to diminishing 
glucose concentrations in the later stages of culture.  
 
Interestingly the results of this study would point to the possibility that a link may exist 
between the increase in glutamate utilization and productivity; in that the specific 
production rate increases as the utilization rate of glutamate also increases. This would 
seem to indicate that glutamate may be utilized by the cells in the process of antibody 
production and that during periods of cell cycle arrest this process is able to occur more 
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readily, possibly as a result of decreased cell density and thus a greater abundance of 
glutamate. 
 
What is clear from this study is the fact that arresting cells in the G1 phase of the cell 
cycle results in a significant increase in metabolic activity which almost certainly has an 
effect on production potential. It would also appear that cellular growth is able to be 
uncoupled from cell division, suggesting that in mammalian cells there is no underlying 
mechanism to regulate cell growth in the absence of cell division and hence rely on the 
mechanisms responsible for entry into mitosis and cytokinesis to ensure an appropriate 
cell size is reached before cell cycle progression. During the early stages of the cell cycle 
there is a great demand upon the cell to replenish energy supplies as well as the metabolic 
precursors that will later be required for cell division, ultimately resulting in an increase 
in cellular mass (Ko and Prives 1996, Linke et al 1996 and Bi et al 2004). In conclusion 
the physiological changes observed during periods of p21CIP1-over-expression can be 
summarized into two categories. The first involves the alteration of metabolic pathways, 
fuelled by the requirements for intermediates during higher protein synthesis and the 
second involves changes in energy metabolism that result from the higher demand for 
cellular energy. 
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5. The role of p21CIP1 in adaptation of CHO cells to 
suspension and protein-free culture. 
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5.1. Abstract 
 
 
The up-regulation of cyclin-dependent kinase inhibitor p21
CIP1
 has been shown to 
enhance productivity of monoclonal antibodies and has been linked to various regulatory 
processes. To identify the potential role of p21
CIP1
 in adaptation to suspension and 
protein-free cultures, I studied the survival and growth of anchorage- and serum-
dependent CHO cell-lines that differed only in the period of p21
CIP1
-induced arrest. 
p21CIP1 over-expression led to rapid adaptation of cells to suspension and protein-free 
cultures. The period taken to achieve adaptation was correlated with the time the cells 
were arrested after transfer from the monolayer and serum-fed culture. Interestingly, cell 
aggregation associated with protein-free suspension culture was reduced in p21
CIP1
-
expressing cultures in response to the loss of cellular adherence. The processes of 
adaptation to suspension and arrest did not decrease monoclonal antibody productivity. In 
contrast, following adaptation to protein-free growth media, an overall increase in 
specific productivity was observed. The ability of cells to survive in protein-free 
suspension cultures was due to the requirement of G1 cells to growth factors and to their 
relatively high resistance to the hydrodynamic forces. This improved process has the 
advantage of reducing the duration of critical path activity for developing CHO 
commercial cell-lines from 72 to 36 days. 
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5.2. Introduction 
 
 
Animal cell cultures have been widely used to produce therapeutic protein products due 
to the compatibility of post-translational product modification with the therapeutic target; 
however, the need for increased yields and the requirement to eliminate animal-derived 
elements are driving industry forward in the search for suitable methodologies that can 
sustain high yielding cell-lines and speed up the development and production process.  
 
Anchorage-dependent cells must be adapted to grow in suspension cultures due to the 
scale-up limitation associated with monolayer cultures. Cells which grow in suspension 
are readily scaled up to production level bioreactors, which are designed to reduce 
hydrodynamic forces and heterogeneity (Al-Rubeai et al 1995, Ludwig 1992, Keane 
2003). Anchorage-dependent cells can be made to be sufficiently robust in the bioreactor 
suspension environment by a time-consuming adaptation process that includes the 
addition of protective agents, such as Pluoronic F68 to the media (Kilburn and Webb 
1968, Al-Rubeai et al 1992b). While the effects in suspension culture of hydrodynamic 
forces and the sensitivity of mammalian cells to hydrodynamic stress have been fully 
examined, and while the mechanism is well understood (Hu and Wang 1986, Peterson et 
al 1988, Handa-Corrigan et al 1989, Oh et al 1989, Croughan et al 1989, Jordan et al 
1994, Kunas and Papoutsakis 1990a, 1990b, van der Pol et al 1992) the adaptation 
process has remained essentially unchanged.  
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Interestingly, it would appear that the susceptibility of any given cell to the forces exerted 
by the bioreactor environment are increased by, for example, decreased serum 
concentration (Kunas and Papoutsakis 1990a and b, McQueen and Bailey 1989) culture 
medium viscosity (Croughan et al 1989) and increased cell size (Al-Rubeai et al 1995). 
The role of cell size in determining cellular growth, productivity and response to the 
bioreactor environment may have not been fully appreciated, but cell size regulation is 
shared with the cell cycle, which, in effect, determines the metabolic potential of a cell 
and, indeed, its response to the environment. 
 
The ever-increasing need for improved biological safety is pushing industries forward in 
the development of new serum and protein-free media formulations. Cell-lines will have 
to be adapted to grow and produce the required product in a defined chemical 
environment. There have been several approaches for the adaptation of cell-lines to the 
required environments (Kovar and Franek 1984, Radford et al 1991, Keen and Steward 
1995 Sinacore et al 2000, Ozturk et al 2003) either by a gradual weaning of cultures via 
the reduction of serum over a set time period or by direct withdrawal of serum. In both 
cases, the process of adaptation can be extremely long and costly, depending on the cell-
line and medium selected. Therefore, a process that can speed up the rate of adaptation 
would provide a valuable tool for both industrial and research applications. 
 
As discussed previously the overall control of the cell cycle, and thus cellular 
proliferation, is based on the activity of cyclin-dependent kinases (cdks), which are 
activated by their association with cyclin regulatory subunits via phosphorylation and 
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may, in turn, be inhibited by the alternate binding of cdk inhibitors (ciks), such as 
p21
CIP1
. The effect of p21
CIP1
 activity in terms of its effect on productivity in cell culture 
is well documented (Fussenegger et al 1998, Watanabe et al 2002, Bi et al 2004, Ibara et 
al, 2003) however, it is the ability of p21CIP1 to induce arrest that is of particular interest 
in this study, which examines new roles for p21CIP1 in process development. 
 
Examination of the proteins and pathways involved in responding to the stresses caused 
by chemical or physical means has shown that an inbuilt adaptive response exists which 
is capable of adjusting the levels and/or activity of the genome protecting machinery, 
usually through the synchronization of cell cycle arrest, DNA repair and apoptosis 
(Hofseth 2004). By initiating p21CIP1 over-expression, cells accumulate in the G1 phase 
of the cell cycle. This arrest of cell cycle progression may allow additional time for repair 
of environmentally derived damage before the cell is replicated (Weinert and Hartwell 
1988).  
 
I therefore hypothesize that an extended period of cell cycle arrest allows cells to survive 
in a phase where extracellular growth factors are not needed, and/or the accumulation of 
extracellular autocrine growth factors to a level that can support proliferation. It may also 
allow the resulting genome damage, created through the direct withdrawal of serum, to be 
repaired prior to cell cycle release. Interestingly, recent studies also indicate that p21CIP1-
expression may also provide some protection against apoptosis during the process of 
adaptation to genotoxic stresses. A recent study (Roninson 2002) showed that wild-type 
p21
CIP1
 has the ability to inhibit apoptosis and stimulate transcription of secreted factors 
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with mitogenic and antiapoptotic activities. In this chapter, I have examined the effect of 
p21
CIP1
-induced cell cycle arrest on the ability of an anchorage-dependent CHO cell-line 
to survive and adapt to a suspension and protein-free growth environment whilst 
maintaining productivity. 
 
5.4. Results 
 
 
5.4.1. The effect of p21
CIP1
 over-expression on CHO cell-line adaptation to 
suspension culture 
In order to establish whether a period of cell cycle arrest would have an impact on the 
ability of industrially relevant CHO cell-lines to adapt to single-cell suspensions in 
serum-supplemented growth environments, four cultures of the transfected p21CIP1-
expressing cell-line were set up as described in the Materials and Methods section of this 
thesis. The results obtained (Fig. 5.1) clearly demonstrate the impact of 3-, 6- or 9-days 
of p21
CIP1
-induced cell cycle arrest in comparison to the non-induced control culture. 
Cultures that were maintained in a state of cell cycle arrest clearly demonstrated an 
increase in the rate of adaptation, as well as an overall increase in culture viability (results 
not shown). Following passage into fresh growth medium without IPTG, cells began to 
proliferate.  
 
The results also show a clear relationship between the length of cell cycle arrest and the 
length of time required for adaptation to single-cell suspension. It would appear that 
increasing the period of cell cycle arrest at the start of adaptation decreases the overall 
time required for adaptation to take place. Fig. 5.2 summarizes the overall time taken for 
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adaptation, using p21
CIP1
-induced cell cycle arrest for 3, 6 and 9 days, whereby it was 
possible to reduce adaptation time by 12, 23 and 31%, respectively, in comparison to the 
overall time taken for the unarrested control culture.  
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Figure 5.1. Passage cycles during adaptation from monolayer cultures to single-cell suspension 
through the expression of p21CIP1. Cultures previously grown in static conditions were detached from 
the surface of the tissue culture flask and re-suspended in fresh culture medium consisting of DMEM 
F12 growth medium supplemented with 10% heat inactivated foetal calf serum and 50µM MSX. The 
viable cell number and percentage viability was determined before the cells were centrifuged at 90g 
for 5 minutes and re-suspended in fresh growth medium. All cultures were seeded at a cell density of 
4×10
5
 cells per ml into a final volume of 100ml using 250ml vented Erlenmeyer flasks. The culture 
was agitated at a rate of 125 rpm at 37◦C in the presence of 5% CO2. Adaptation was considered 
successful following the return to an equal or better growth and production rate to that observed 
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with the original culture. For each set of experiments, four flasks were set up as described above. 
5mM of Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the culture medium of three of 
the flasks at the start of experimentation in order to induce p21
CIP1
-expression; the other flask was 
kept as a control (0mM IPTG). Expression of p21
CIP1
 was maintained in the first flask for a period of 
3 days, the second for 6 days and the third for 9 days. Every 72hrs, the cultures were centrifuged at 
90g and re-suspended in fresh culture medium. Flasks in which p21
CIP1
-expression was to be 
maintained had 5mM IPTG added back into the fresh culture medium. =on-induced cultures were 
passaged back to 4×10
5
 cells/ml. Following 3, 6, and 9, days of cell cycle arrest, p21
CIP1
-expression 
was halted by the removal of IPTG from the culture medium. Each culture was examined daily in 
triplicate via the Trypan blue exclusion method to determine viable and total cell numbers (see 
chapter 2 Materials and Methods). Mean and standard error were calculated from this data and the 
significance determined via t-test analysis. The first 2 passages represent growth in a static 
environment prior to the initiation of adaptation to serum-containing suspension. Error bars are not 
show for clarity but the average standard error of the mean was no more than 0.2. 
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Figure 5.2. Summary of the time taken for adaptation to single-cell (serum containing) suspension 
using p21
CIP1
-induced cell cycle arrest as determined from the data presented in figure 5.1. Bars 
represent the overall time taken for adaptation from static serum-supplemented culture to single-cell 
serum-supplemented suspension culture following either 3, 6, or 9 days of p21
CIP1
-induced cell cycle 
arrest. Error bars show the standard error of three replicates. Student’s t-test indicated significant 
differences between induced and non-induced cultures (p < 0.05). 
 
 
5.4.2. The effect of p21
 CIP1
 over-expression on CHO cell-line adaptation to protein-
free suspension culture 
Cultures that had previously been adapted to single-cell serum-supplemented suspension, 
as described in previously and shown in Figure 5.1 were used to demonstrate the impact 
of cell cycle arrest on the process of adaptation to protein-free culture. All cultures 
underwent a minimum of four passages in the current growth conditions before 
experimentation into the impact of adaptation to protein-free suspension was initiated. 
The results in Fig. 5.3 show a similar pattern of behavior to that seen in Fig. 5.1. 
Similarly, cultures that were initially arrested showed a significant reduction in the time 
173 
 
taken to achieve a successful adaptation to protein-free media, as determined via the t-test 
analysis. The results summarized in Fig. 5.4 show a similar, yet enhanced, profile to 
those shown in Fig. 5.2. It would therefore appear that the expression of p21
CIP1
 during 
adaptation to protein-free suspension conditions was able to significantly reduce the time 
taken for successful adaptation, with arrest periods of 3, 6, and 9 days resulting in 25, 37, 
and 50% decreases in the time taken for successful adaptation when compared to the non-
induced culture. 
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Figure 5.3. Passage cycles during adaptation from serum supplemented culture medium to protein-
free culture medium through the expression of p21
CIP1
. Suspension cultures previously grown in 
DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf serum and 50µM 
MSX were harvested during mid-exponential phase and the viable cell number and percentage 
viability were determined.  The cells were then washed in warm 1% PBS before being centrifuged at 
90g for 5 minutes. The cells were then re-suspended in fresh protein-free medium supplemented with 
50µM MSX. All cultures were seeded at a cell density of 4×10
5
 cells per ml into a final volume of 
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100ml using 250ml vented Erlenmeyer flasks. The culture was agitated at a rate of 125 rpm at 37◦C 
in the presence of 5% CO2. Adaptation was considered successful following the return to an equal or 
better growth and production rate to that observed with the original culture. For each set of 
experiments, four flasks were set up as described above. 5mM of Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to the culture medium of three of the flasks at the start of 
experimentation in order to induce p21
CIP1
-expression; the other flask was kept as a control (0mM 
IPTG). Expression of p21
CIP1
 was maintained in the first flask for a period of 3 days, the second for 6 
days and the third for 9 days. Every 72hrs, the cultures were centrifuged at 90g and re-suspended in 
fresh culture medium. Flasks in which p21
CIP1
-expression was to be maintained had 5mM IPTG 
added back into the fresh culture medium. =on-induced cultures were passaged back to 4×10
5
 
cells/ml. Following 3, 6, and 9, days of cell cycle arrest, p21
CIP1
-expression was halted by the removal 
of IPTG from the culture medium. Each culture was examined daily in triplicate via the Trypan blue 
exclusion method to determine viable and total cell numbers (see chapter 2 Materials and Methods). 
Mean and standard error were calculated from this data and the significance determined via t-test 
analysis. The first 2 passages represent growth in a static environment prior to the initiation of 
adaptation to serum-containing suspension. Error bars are not show for clarity but the average 
standard error of the mean was no more than 0.2.  
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Figure 5.4. Summary of the time taken for adaptation to protein-free growth environments using 
p21
CIP1
induced cell cycle arrest as determined from the data presented in figure 5.3. Bars represent 
the overall time taken for adaptation from single-cell serum-supplemented cultures to protein-free 
single-cell suspension culture following either 3, 6, or 9 days of p21
CIP1
-induced cell cycle arrest. 
Student’s t-test indicated significant differences between the induced and non-induced cultures (p < 
0.05). 
 
5.4.3. p21
 CIP1
-Dependent cell detachment and disaggregation 
During a preliminary study of adaptation from single-cell serum-supplemented 
suspension to protein-free suspension, it was observed that a significant amount of cell 
aggregation occurred, particularly in the non-induced cell-line. In order to determine the 
effect that p21
CIP1
-over expression had on the rate of aggregate formation during the 
process of adaptation, samples were taken from the adapting cultures at 72 h intervals and 
were analyzed to determine the percentage of single-, 2-, 3-, 4-, 5- and more-than-5-cell 
aggregates as described in the Materials and Methods. Fig. 5.5 shows the results obtained 
over the first 21 days of adaptation, which clearly demonstrate an increase in aggregate 
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formation in the non-induced culture (Fig. 5.5A) in comparison to the induced cultures 
(Fig. 5.5B–D), where, in the latter, there was a clear reduction in aggregate formation 
both during the period of cell cycle arrest and subsequently, after the removal of IPTG. 
The observed reduction in aggregation appears to be directly linked to the length of time 
cells were maintained in a state of cell cycle arrest, with the most significant result 
occurring following 9 days of p21
CIP1
-induced cell cycle arrest (Fig. 5.5D). 
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Figure 5.5. Analysis of cell aggregate formation. Cultures were analyzed at 72 hour intervals over 21 
days, during adaptation from 10% serum-containing suspension cultures to protein-free suspension 
(see Fig 5.3). Columns represent the percentage of cells per aggregate in cultures that were (A) left 
un-induced throughout, (B) induced for 3 days, (C) induced for 6 days, and (D) induced for 9 days 
(see chapter 2 Materials and Methods). Student’s t-test indicated significant differences between the 
induced cultures in (D) and the corresponding non-induced cultures in (A) (p < 0.05) 
 
In order to determine if the reduction in aggregation was a result of loss of anchorage 
dependence during cell cycle arrest, two static cultures were set up in T75 flasks, where 
one flask had 5mM IPTG added. The results, in Fig. 5.6, clearly show a reduction in the 
ability of arrested cultures to attach to the flasks’ surfaces, indicating a loss of anchorage 
dependence. Arrested cells detached at much faster rates than the control cell-line, with 
100% increase in cells detached within 5 min of treatment with the dissociation reagent. 
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Figure 5.6. The effect of cell cycle arrest on cell adhesion. Cells were grown in static for 24 h with or 
without the presence of IPTG. Cells were dissociated using 50% dilution of cell dissociation solution 
(non-enzymatic) and 1× PBS. Samples were taken at 60 second intervals and analyzed via Trypan 
blue in order to determine the cell concentration. The pale grey bars represented cultures in which 
p21
CIP1
-expression was induced and the dark grey, non-induced cultures (see chapter 2 Materials and 
Methods). Error bars represent the standard error of three replicates. Student’s t-test indicated 
significant differences between the induced and non-induced cultures at each time point (p < 0.05). 
 
5.4.4. The effect of adaptation using p21
CIP1
-expression on culture growth and 
productivity 
A successful process of adaptation should result in no loss in culture proliferation or 
productivity. Fig. 5.7 demonstrates this assertion by showing the viable and total cell 
counts over a 10- day batch culture during three different process conditions.  
 
180 
 
A 
T im e  ( D a y s )
0 2 4 6 8 1 0
C
e
ll 
c
o
u
n
t 
x
 1
0
5
 (
C
e
lls
/m
l)
0
2
4
6
8
1 0
1 2
1 4
1 6
1 8
2 0
M e a n  v i a b l e  c e l l  c o u n t
M e a n  t o t a l  c e l l  c o u n t
 
 
 
 
 
B 
T im e  ( D a y s )
0 2 4 6 8 1 0
C
e
ll 
c
o
u
n
t 
x
1
0
5
 (
C
e
lls
/m
l)
0
2
4
6
8
1 0
1 2
1 4
1 6
1 8
2 0
M e a n  v i a b l e  c e l l  c o u n t
M e a n  t o t a l  c e l l  c o u n t  
 
 
 
 
 
181 
 
C 
T im e  ( D a y s )
0 2 4 6 8 1 0
C
e
ll 
c
o
u
n
t 
x
 1
0
5
 (
C
e
lls
/m
l)
0
5
1 0
1 5
2 0
2 5
M e a n  v i a b l e  c e l l  c o u n t
M e a n  t o t a l  c e l l  c o u n t
 
 Figure 5.7. Batch cultures of p21
CIP1
-expressing cell-lines grown as (A) serum-supplemented static 
(B) serum-supplemented suspension or (C) protein-free suspension cultures. Cultures were set up 
either in (A) T75 flasks or (B and C) 250ml Erlenmeyer flasks. Samples were taken at 24 hour 
intervals and viable and total cell counts determined via Trypan blue exclusion (see chapter 2 
Materials and Methods). Error bars show the standard error of three replicates. 
 
The results clearly show an increase in attainable viable cell numbers following 
adaptations to both suspension and protein-free cultures. Moreover, it would appear that 
the process of adaptation to serum-supplemented suspension culture is able to increase 
the growth rate significantly in comparison to static culture (Figure 5.8); however, further 
adaptation to protein-free suspension culture appeared to reduce the growth rate back to 
that of the static culture. It appears that the protein-free formulation has specifically 
enhanced volumetric and cell-specific productivity while depressing growth rate (Figs. 
5.8–5.10). During growth as static, suspension, serum-supplemented, and protein-free 
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cultures, the activation of p21
CIP1
 via the addition of IPTG significantly increased the 
overall cell-specific production rate of antibodies (Fig. 5.10). 
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Figure 5.8. Specific growth rate following adaptation to growth in suspension and protein-free 
growth environments. Results were obtained during the exponential growth phase (see Fig. 5.7) of 
non-induced cultures grown either as serum supplemented static cultures or following adaptation to 
serum-supplemented suspension or protein-free suspension (see chapter 2 Materials and Methods). 
Error bars show the standard error of three replicates. 
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Figure 5.9. Productivity following adaptation to growth in suspension and protein-free media. 
Results were obtained after 120 h of growth in either, serum supplemented static, suspension or 
protein-free suspension cultures as determined via ELISA using a standard curve. Dark grey bars 
represent productivity of chimeric antibody in cultures in which p21
CIP1
-expression had been 
induced, and light grey bars represent non-induced cultures (see chapter 2 Materials and Methods). 
Error bars show the standard error of three replicates. Student’s t-test indicated significant 
differences between the productivity of induced and non-induced cultures at each condition (p < 
0.05). 
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Figure 5.10. Specific production rate following adaptation to growth in suspension and protein-free 
growth environments. Bars show the specific production rate of cultures in which p21
CIP1
-expression 
had been induced or non-induced. cells were grown either as serum-supplemented static cultures or 
following adaptation to serum-supplemented suspension or protein free suspension (see chapter 2 
Materials and Methods). Error bars show the standard error of three replicates. Student’s t-test 
indicated significant differences between the productivity of induced and non-induced cultures at 
each condition (p < 0.05). 
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5.4.5. Analysis of cell-line stability following adaptation to growth as protein-free 
suspension cultures 
In order to establish the stability of cultures adapted using p21
CIP1
expression, two 
cultures adapted with and without cell cycle arrest were cryopreserved for a period of 6 
weeks, following which they were revived using a standard procedure. Fig. 5.11 shows a 
decrease in the percentage of aggregates in cultures adapted using p21
CIP1
-induced cell 
cycle arrest, demonstrating an increased ability to return to a state of single-cell 
suspension culture through the p21
CIP1
-dependent adaptation in comparison to cultures 
adapted without the use of p21
CIP1
-induced cell cycle arrest. 
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Figure 5.11. Analysis of cell aggregate formation. Bars show the percentage of aggregation observed 
in cultures previously adapted (A) without or (B) with 9 days of p21
CIP1
-induced cycle arrest (see Figs 
5.1 and 5.3) following 6 weeks of storage in cryopreservation (see chapter 2 Materials and Methods). 
Error bars show the standard error of three replicates. 
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5.5. Discussion 
In this study, I have successfully demonstrated that p21
CIP1
-over-expression can 
significantly reduce the time necessary for the adaptation of an anchorage-dependent 
CHO cell-line to suspension and protein-free growth environments without 
compromising the growth or productivity of the cell-line. A previous study from our 
laboratory (Al-Rubeai et al 1995) has clearly demonstrated that cells in the G2/M phase 
of the cell cycle are more susceptible to mechanical damage than cells in the G1 phase. 
The authors have concluded that larger cells, such as those in S and G2, are preferentially 
destroyed and that the extent of G2 cell destruction is dependent on the intensity of the 
hydrodynamic forces exerted.  
 
Later, Abdul Majid and Al-Rubeai (1997) showed that mitotic cells were more 
susceptible to mechanical damage than cells in the interphase, thus suggesting that such a 
response was not merely due to the larger volume of G2/M cells. Therefore, it was 
proposed that by arresting the cell cycle in the G1 phase of the cell cycle it would be 
possible to limit the effect of hydrodynamic shear forces on anchorage-dependent cells 
within an agitated culture during the process of adaptation from a static to a suspension 
growth environment. Cell cycle arrest may also help cells to survive the lethal forces in 
an agitated or shaken environment that preferentially destroy dividing cells, thereby 
giving sufficient time for the cells to display increased robustness and apoptosis 
inhibitory function and induced expression of the cell surface molecule E-cadherin, 
which has been demonstrated (Mueller et al 2000) to closely correlate with the ability of 
the cells to grow independently of anchorage. 
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Interestingly, this study showed that p21
CIP1
-induced cell cycle arrest limited the 
formation of aggregates during the process of adaptation; this may well be the result of 
maintaining an increased viable cell number. It has been observed that floating colonies 
of epithelial cells produce a protein membrane closely resembling those of basement 
membranes that connect individual cells within and between colonies (Eckhart et al 
2003). More importantly, DNA released from dying or dead CHO cells in aggregate 
culture under suboptimal growth conditions was found to mediate cell–cell adhesion 
(Renner et al 1993). It appears that, by enhancing viability, p21
CIP1
 prevents the release of 
degraded DNA and cellular materials into the medium and may also play a role in the 
organization of the extracellular matrix by reducing the expression of extracellular 
adhesion factors. The forced expression of p21CIP1 resulted in a reduction in cell-to cell 
adhesion, thereby reducing multicellular aggregation, which can normally cause a 
reduction in viability due to the nutrient and mass transfer limitations within the spheroid 
structure of multicellular aggregates. 
 
The arrest of cells in the G1 phase of the cell cycle may also influence the adaptation 
process to protein-free culture by reducing the cell requirement for growth 
factors/complex nutrients that are present in the serum. Thus, G1 cells would survive the 
nutrient-deficient environment until they reach the restriction point, when growth factors 
are required for further progression toward the S phase. Several studies have 
demonstrated that cells only require growth factors at the mid-G1 phase to stimulate the 
formation or activation of cyclin D-cdk4/6 and cyclin E-cdk2, with consequent 
stimulation of DNA synthesis (for review, see Assoian 1997). Therefore, it is expected 
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that p21
CIP1
-induced cells, arrested in the G1 phase would not require growth factors or 
complex nutrient for their survival, as these molecules are only essential for the 
stimulation of cells to enter cell division. Arresting cells prior to adapting them to an 
environment lacking in serum-derived growth factors would therefore help them to 
subsequently grow in a protein-free medium. 
 
Finally, the results of this study provide a clear indication of the possible role of p21
CIP1
-
induced cell cycle arrest in adaptation of cell-lines to desirable bio-processing 
environments. We have shown that extended periods of cell cycle arrest can significantly 
decrease the time required for adaptation of industrially important cell-lines to suspension 
and protein-free growth environments. Although the precise mechanisms are not fully 
understood, what is clear is that engineering of cells for induced expression of p21CIP1 
will enable the rapid development of cell-lines specifically adapted to withstand the 
rigors and stresses of growth within chemically defined growth media in the bioreactor 
environment. 
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6. The role of Bcl-2 and its combined effect with p21CIP1 
in adaptation of CHO cells to suspension and protein-
free culture 
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6.1. Abstract 
 
The over-expression of the anti-apoptotic gene Bcl-2 has been previously shown to 
protect cells from undergoing apoptosis during exposure to environmental stress. There is 
strong evidence that, in addition to its well-known effects on apoptosis, Bcl-2 is involved 
in antioxidant protection and regulation of cell cycle progression (Lopez-Diazguerrero et 
al 2006). To determine if the over-expression of Bcl-2 could improve the process of 
adaptation to suspension and protein-free growth environments I have studied the growth 
and viability of anchorage-dependent CHO cell-lines that differ only in there expression 
of Bcl-2. In addition, I examined the effect of combining Bcl-2 and p21
CIP1
-expression 
during adaptation to suspension and protein–free environments. The results of this study 
provide evidence of a clear reduction in the overall time required for the process of 
adaptation to both suspension and protein-free environments in Bcl-2-expressing cultures 
and that through the combined expression of p21
CIP1
 and Bcl-2 it is possible to further 
reduce the time. The Bcl-2 results support the well demonstrated concept that this protein 
plays an important role in apoptotic signalling pathways and suggest that it may also 
provide more diverse functions beside its death-inhibiting role. 
 
  
 
 
 
 
192 
 
6.2. Introduction 
Suspension and protein-free cultures have long been the preferred choice for the 
industrial production of biopharmaceuticals for several reasons including, the scale-up 
limitations associated with monolayer cultures; cells which are able to grow in 
suspension environments are easily scaled up into bioreactors, which have been 
specifically designed to reduce hydrodynamic forces and heterogeneity within the growth 
environment (Al-Rubeai et al 1992b, Al-Rubeai et al 1995, Ludwig 1992, Keane 2003, 
Kilburn and Webb 1968). The ever-increasing need for improved biological safety is also 
driving industries forward in the development of new serum and protein-free media 
formulations, which in turn require the development of new approaches for the adaptation 
of the desired cell-lines to the required growth conditions (Kovar and Farnek 1984, 
Radford et al 1991, Keen and Steward 1995, Sinacore et al 2000, Ozturk et al 2003).  
Previous research has shown that mammalian cell-lines are often highly susceptible to 
apoptosis within the required bioreactor growth conditions (Singh et al 1994, Perani et al 
1999); therefore in order to increase productivity within the bioreactor environment 
several strategies have been employed, including the process of perfusion cultures. This 
facilitates the development of a high-density culture and thus high product titres can be 
achieved (Himmelfarb et al 1969, Tharakan and Chau 1986, Comer et al 1990, Ong et al 
1994, Jan et al 1993, Amos et al 1994, Emery et al 1995, Portner et al 1997, Fassnacht et 
al 1998(a). However, these systems tend to consist of large numbers of non-viable cells 
which can have a severe impact on the rate of cell division and thus on productivity (Al-
Rubeai and Emery 1990, Al-Rubeai et al 1992a). In addition the build-up of proteases 
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and glycosidases and other cellular components can lead to the degradation of the desired 
product while creating additional complications during downstream processing. 
As described in chapters 5 of this thesis, several studies (Al-Rubeai et al 1990, Mercille 
and Massie 1994, Singh et al 1994, Westlund and Haggstrom 1998, Ishaque and Al-
Rubeai 1999, 2002) have identified a number of factors which are able to affect the 
viability of cultures within the bioreactor environment including the deprivation of 
glucose, glutamine, essential amino acids, mineral salts and vitamins as well as the build-
up of toxic metabolites such as ammonia. All of these factors are able to initiate apoptotic 
cell death and thus decrease the duration of culture within the bioreactor environment 
which in turn limits the overall achievable productivity. One of the most successful 
strategies to prevent apoptosis has been the over-expression of members of the Bcl-2 
family in hybridoma, NS0 and CHO cell-lines.  
It has previously been shown (Perani et al 1999) that the over-expression of the Bcl-2 
protein can protect cells from death resulting from exposure to the stress associated with 
growth within the bioreactor environment. Under conditions of suboptimal pH, shear 
stress, hyperosmolarity as well as nutrient deprivation, Bcl-2-expression has been found 
to increase overall culture viability by at least 20% when compared to non-Bcl-2-
expressing cultures. In addition, the specific productivity of Bcl-2 transfected cells 
adapted to grow in high osmolarity medium has been previously reported to be 100% 
higher than that produced by cells grown in normal osmolarity medium (Perani et al 
1999), demonstrating the overall beneficial effect of Bcl-2-expression on the adaptation 
process and during exposure to a wide range of culture stresses.  
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In this chapter I examined the possible role for Bcl-2 in the process of adaptation to 
protein-free suspension cultures. In addition, because previous work (Astley et al 2007) 
has demonstrated the benefit of the cdk inhibitor p21
CIP1
 on adaptation to the same 
growth conditions, but also found that arresting cells generally results in reduced 
viability, I have examined the effect of combining the viability enhancer Bcl-2 and 
p21
CIP1
 on the process of adaptation. 
 
6.4. Results 
 
6.4.1. The effect of Bcl-2/p21
CIP1
 over-expression on the ability of a CHO cell-line to 
adapt to single-cell suspension culture 
In order to establish if the anti-apoptotic effect of Bcl-2 would improve the ability of 
industrially anchorage dependent CHO cell-lines to adapt to growth as single-cell 
suspensions, cultures were set up as described in the Materials and Methods section of 
this thesis. The results shown in Fig 6.1 clearly shows the positive effect of Bcl-2 on 
adaptation to serum-supplemented suspension compared to the non-Bcl-2-expressing 
control cell-line leading to a 30% reduction in the overall time taken for adaptation. 
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Figure 6.1. Passage cycles during adaptation from a monolayer culture to a single-cell suspension 
through the expression of Bcl-2. Two cultures consisting of a non-Bcl-2-expressing control culture 
(22H11) and a cell-line engineered to continuously over-express Bcl-2 (CHO Bcl-2) were set up in 
triplicate. At the start of experimentation the cells were detached from the surface of the tissue 
culture flask. The viable cell number and percentage viability were determined before the cells were 
centrifuged at 90g for 5 minutes and re-suspended in fresh culture medium. All cultures were seeded 
at a cell density of 4×10
5
 cells per ml into a final volume of 100ml using 250ml vented Erlenmeyer 
flasks. The culture was agitated at a rate of 125 rpm at 37◦C in the presence of 5% CO2. Both 
cultures were passaged to 4x10
5
 cells/ml every 72 hours and the viable and total cell numbers were 
recorded (see chapter 2 Materials and Methods). Adaptation was considered successful following the 
return to an equal or better growth and production rate to that observed with the original culture. 
The first 2 passages represent growth in a static environment prior to the initiation of adaptation. 
Error bars are not shown for clarity, but the average standard error of the mean was no more than 
0.2.  
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In addition, Bcl-2-expressing cultures also maintained a significantly higher viability 
during the process of adaptation to either serum supplemented suspension or protein-free 
suspension culture in comparison to the non-Bcl-2 control culture (data not shown). Fig 
6.2 shows the effect of combining Bcl-2-expression with the inducible expression of 
p21CIP1 for either 3, 6, or 9 days at the start of the adaptation process.  
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Figure 6.2. Passage cycles during adaptation from monolayer cultures to single-cell suspension 
through the expression of p21
CIP1
/Bcl-2. Cultures previously grown in static conditions were detached 
from the surface of the tissue culture flask. The viable cell number and percentage viability was 
determined before the cells were centrifuged at 90g for 5 minutes and re-suspended in fresh growth 
medium.  All cultures were seeded at a cell density of 4×10
5
 cells per ml into a final volume of 100ml 
using 250ml vented Erlenmeyer flasks. The culture was agitated at a rate of 125 rpm at 37◦C in the 
presence of 5% CO2. Adaptation was considered successful following the return to an equal or better 
growth and production rate to that observed with the original culture. For each set of experiments, 
four flasks were set. 5mM of Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the culture 
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medium of three of the flasks at the start of experimentation in order to induce p21
CIP1
-expression; 
the other flask was kept as a control (0mM IPTG). Expression of p21
CIP1
 was maintained in the first 
flask for a period of 3 days, the second for 6 days and the third for 9 days. Every 72hrs cultures were 
centrifuged at 90g and re-suspended in fresh culture medium. Flasks in which p21
CIP1
-expression was 
to be maintained had 5mM IPTG added back into the fresh culture medium. <on induced cultures 
were passaged back to 4×10
5
 cells/ml. Following 3, 6, and 9, days of cell cycle arrest, p21
CIP1
-
expression was halted by the removal of IPTG from the culture medium. Each culture was examined 
daily in triplicate via the Trypan blue exclusion method to determine viable and total cell numbers 
(see chapter 2 Materials and Methods). Mean and standard error were calculated from this data and 
the significance determined via t-test analysis. The first 2 passages represent growth in a static 
environment prior to the initiation of adaptation to serum-containing suspension. Error bars are not 
show for clarity but the average standard error of the mean was no more than 0.2. 
 
In all arrested cultures, cellular viability remained high throughout the entire period of 
culture which may be explained by over-expression of the anti-apoptotic Bcl-2 which 
results in a reduction in the rate of cell death normally associated with cell cycle arrest. 
The expression of p21
CIP1
 following the addition of IPTG was confirmed via western blot 
(Fig. 6.3), in both a p21
CIP1
 only control and the p21
CIP1
/Bcl-2-expressing cell-line the 
addition of IPTG resulted in the expression of p21
CIP1
 and lead to cessation of the cell 
cycle. In contrast the addition of IPTG to the negative non-p21
CIP1
-expressing control 
cell-line had no effect on the cell cycle. 
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Figure 6.3. Western blot analysis of p21
CIP1
-expression in p21
CIP1
/Bcl-2-expressing cell-lines. Samples 
were analysed following 96 hours growth as static batch cultures grown in T75 tissue culture flasks 
containing DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf serum 
and 50µM MSX. Each cell-line was cultured either with or without the addition of 5mM IPTG in 
order to induce p21
CIP1
-expression at the start of experimentation. 22H11 was used as a negative 
control as this has not been transfected with p21
CIP1
. 3B2 was used as a positive control as it has 
previously been transfected with p21
CIP1 
(see chapter 2 Materials and Methods). Each well was 
loaded with 30µl of sample which was previously normalised to the same cell density. 
 
The results are in agreement with the findings of the previous chapter, in that increasing 
the time of arrest before releasing cells can reduce the time to adapt cells to grow as 
single cells in suspension culture.  Additionally, improvement in cellular viability appears 
to enhance cell adaptation of p21
CIP1
 cells. Previous studies on p21
CIP1
 alone (Astley et al. 
2007) had found that the expression of p21CIP1 for periods of either 3, 6, or 9 days during 
adaptation to suspension growth resulted in a 12, 23, and 31 percent reductions in 
adaptation time, respectively. In comparison the combined expression of Bcl-2 and 
p21
CIP1
 lead to 44, 53 and 63 percent reductions, respectively. 
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6.4.2. The effect of Bcl-2/p21
CIP1
 over-expression on the ability of a CHO cell-line to 
adapt to protein-free suspension culture 
Adapted serum-supplemented suspension cultures were passaged for a minimum of 4 
passages before being set up as described in the Materials and Methods section of this 
thesis. The results shown in Fig 6.4 demonstrate the effect of Bcl-2-expression on the 
process of adaptation of serum-supplemented suspension cultures to a protein-free 
suspension growth environment, resulting in the overall time taken for adaptation being 
significantly reduced - from 73 days to 46 days (37% reduction). 
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Figure 6.4. Passage cycles during adaptation from serum supplemented culture medium to protein-
free culture medium through the expression of Bcl-2. Two cultures consisting of a non-Bcl-2-
expressing control culture (22H11) and a cell-line engineered to continuously over-express Bcl-2 
(CHO Bcl-2) were set up in triplicate. Both cultures were previously grown as suspension cultures in 
DMEM F12 growth medium supplemented with 10% heat inactivated foetal calf serum and 50µM 
MSX. Cells from mid-exponential phase were harvested and the viable cell number and percentage 
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viability were determined before the cells were washed in warm 1% PBS and centrifuged at 90g for 5 
minutes. The cells were then re-suspended in fresh protein-free medium (ProCHO4) supplemented 
with 50µM MSX. All cultures were seeded at a cell density of 4×10
5
 cells per ml into a final volume of 
100ml using 250ml vented Erlenmeyer flasks (Corning Ltd, UK). The culture was agitated at a rate 
of 125 rpm at 37◦C in the presence of 5% CO2. Both cultures were passaged to 4x10
5
 cells/ml every 
72 hours and the viable and total cell numbers were recorded (see chapter 2 Materials and Methods). 
Adaptation was considered successful following the return to an equal or better growth and 
production rate to that observed with the original culture. The first 2 passages represent growth in a 
static environment prior to the initiation of adaptation. Error bars are not shown for clarity, but the 
average standard error of the mean was no more than 0.2.  
 
 
Figure 6.5 shows the effect of arresting cells for 0, 3, 6, or 9 days.  In this study the 
combined expression of p21CIP1 and Bcl-2 resulted in a 42, 54, and 62 percent decreases, 
respectively, in the time taken for successful adaptation to a protein-free, suspension 
culture. In addition, the overall culture viability remained significantly higher throughout 
the process of adaptation than that observed with the 22H11 control cell-line or in 
cultures expressing only p21
CIP1
. It was again noted that there was a direct correlation 
between the length of time spent in cell cycle arrest and the resulting overall culture 
viability, with cultures experiencing the longest periods of cell cycle arrest exhibiting the 
highest culture viability throughout the process of adaptation.  
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Figure 6.5. Passage cycles during adaptation from serum supplemented culture medium to protein-
free culture medium through the combined expression of p21CIP1/Bcl-2. Cultures previously grown in 
DMEM F12 culture medium supplemented with 10% heat inactivated foetal calf serum and 50µM 
MSX were harvested during mid-exponential phase and the viable cell number and percentage 
viability were determined.  The cells were then washed in warm 1% PBS before being centrifuged at 
90g for 5 minutes. The cells were then re-suspension in fresh protein-free medium (ProCHO4) 
supplemented with 50µM MSX. All cultures were seeded at a cell density of 4×10
5
 cells per ml into a 
final volume of 100ml using 250ml vented Erlenmeyer flasks. The culture was agitated at a rate of 
125 rpm at 37◦C in the presence of 5% CO2. Adaptation was considered successful following the 
return to an equal or better growth and production rate to that observed with the original culture. 
For each set of experiments, four flasks were set up. 5mM of Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added to the culture medium of three of the flasks at the start of experimentation in 
order to induce p21
CIP1
-expression; the other flask was kept as a control (0mM IPTG). Expression of 
p21
CIP1
 was maintained in the first flask for a period of 3 days, the second for 6 days and the third for 
9 days. Every 72hrs cultures were centrifuged at 90g and re-suspended in fresh culture protein-free 
medium. Flasks in which p21
CIP1
-expression was to be maintained had 5mM IPTG added back into 
the fresh culture medium. <on-induced cultures were passaged back to 4×10
5
 cells/ml. Following 3, 6, 
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and 9, days of cell cycle arrest, p21
CIP1
-expression was halted by the removal of IPTG from the 
culture medium. Each culture was examined daily in triplicate via the Trypan blue exclusion method 
to determine viable and total cell numbers (see chapter 2 Materials and Methods). Mean and 
standard error were calculated from this data and the significance determined via t-test analysis. The 
first 2 passages represent growth in a static environment prior to the initiation of adaptation to 
serum-containing suspension. Error bars are not show for clarity but the average standard error of 
the mean was no more than 0.2. 
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6.4.3. The effect of adaptation using Bcl-2 or Bcl-2/p21
CIP1
-expression on culture 
growth and productivity. 
In order to confirm that the process of adaptation had not resulted in a loss of 
proliferation or productivity, culture growth rate and viability for the 22H11 control, Bcl-
2 only and p21CIP1/Bcl-2 cell-lines was analyzed over 15 days following adaptation to 
each of the growth conditions. All cultures exhibited an increase in the overall obtainable 
viable cells (Fig. 6.6) and in the cumulative cell time (CCT) (Fig. 6.7) following 
adaptation to suspension and protein-free growth environments.  
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Figure 6.6. Maximum obtainable viable cell number. Results were determined for each of the cell-
lines during batch culture, when grown as either serum supplemented static, serum supplemented 
suspension or protein-free suspension culture (see chapter 2 Materials and Methods). The standard 
error of the mean was calculated over three replicates and is shown by the error bars. Student’s t-test 
indicated significant differences between the maximum viable cell number obtainable through the 
expression of Bcl-2 or p21
CIP1
/Bcl-2, grown as either static, suspension or protein-free suspension 
when compared to the non-p21
CIP1
/Bcl-2 control (22H11) (p < 0.05). 
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Figure 6.7. Cumulative cell time. Results were plotted to determine the cumulative cell time (CCT) 
for control, Bcl-2 and p21
CIP1
/Bcl-2-expressing cell-lines during growth as either serum supplemented 
static, serum supplemented suspension or protein-free culture conditions (see chapter 2 Materials 
and Methods). Error bars show the standard error of three replicates. Student’s t-test indicated 
significant differences between the cumulative cell times determined for cell-lines expressing Bcl-2 or 
p21
CIP1
/Bcl-2, grown as either static, suspension or protein-free suspension when compared to the 
non-p21
CIP1
/Bcl-2 control  (p < 0.05). 
 
 
In both the Bcl-2 and p21CIP1/Bcl-2 cell-lines the CCT is considerably higher than the 
control cultures in all growth environments, however the expression of p21CIP1 would 
appear to slightly reduce the CCT in comparison to Bcl-2-expressing cultures, this may 
be in part due to an increase in the overall genetic information required to be transcribed 
during each round of replication and may also reflect a slight shift in terms of cellular 
functionality from growth to productivity. The results also clearly show the positive 
effect of Bcl-2 on culture viability in both Bcl-2 and non-induced Bcl-2/ p21
CIP1
 cell-
lines. This increase is not believed to be due to direct stimulation by Bcl-2 itself but is 
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more likely due to the suppression of apoptosis during the early stages of the culture, 
which leads to an increase in the number of dividing cells.  
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Figure 6.8. Specific growth rate following adaptation to growth in suspension and protein-free 
growth environments. Results were obtained during the exponential growth phase of non-induced 
cultures grown either as serum-supplemented static cultures or following adaptation to serum-
supplemented suspension or protein-free suspension (see chapter 2 Materials and Methods). Error 
bars show the standard error of three replicates. Values for P are given between bars demonstrating 
the significance of the increase in specific growth rate following adaptation to each of the growth 
environments. 
 
During the process of adaptation to both suspension and protein-free culture 
environments; Bcl-2 over-expression resulted in increased robustness to the mechanical 
forces within the culture environment, as well as providing protection against nutrient 
deprivation and toxic metabolite accumulation. Interestingly, the results of the specific 
growth rate (Fig. 6.8) shows a significant increase in the specific growth rate of all cell-
lines following adaptation from serum supplemented static to serum supplemented 
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suspension and likewise from serum supplemented suspension to protein-free suspension 
culture. 
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Figure 6.9. Specific production rate following adaptation to growth in suspension and protein-free 
growth environments. Bars show the specific production rate of cultures in which p21
CIP1
-expression 
had been induced and non-induced. Cells were grown either as serum-supplemented static cultures 
or following adaptation to serum-supplemented suspension or protein-free suspension (see chapter 2 
Materials and Methods). Error bars show the standard error of three replicates. Student’s t-test 
indicated significant differences between the productivity of induced and non-induced cultures at 
each condition (p < 0.05). 
 
 
All cultures exhibited an increase in the specific productivity rate following adaptation to 
serum-supplemented suspension (Fig. 6.9); however, a more significant increase was 
observed following adaptation to the protein-free growth environment. Interestingly, the 
expression of Bcl-2 alone did appear to have a significant impact on the specific 
productivity; however, the initiation of cell cycle arrest via the addition of IPTG to the 
p21
CIP1
/Bcl-2 cell-line resulted in a greater increase in specific productivity in all growth 
environments.  
207 
 
6.5. Discussion 
In this study, I have identified a potential role for Bcl-2 in the process of adaptation of 
industrially important cell-lines to chemically defined growth environments. I have 
additionally demonstrated the clear benefit of combining Bcl-2 with periods of cell cycle 
arrest through the inducible expression of p21
CIP1
. 
 
Several studies have reported various findings to the effect of Bcl-2-expression on 
productivity. Itoh et al (1995) reported a seven fold increase in antibody titre; similarly 
Simpson et al (1997) also reported a 38% increase. This study also found that Bcl-2-
expression did result in a slight increase in productivity as compared to the control cell-
line. Cultures expressing both p21CIP1 and Bcl-2 showed a marked increase in 
productivity during the period of cell cycle arrest. In contrast, Fassnacht et al (1998b, 
Tey et al (2000), Tey and Al-Rubeai (2004) reported no such increase in obtainable 
productivity. It is apparent that important factors that contributed to the differences 
between the two set of findings in productivity were the difference in culture duration, 
growth rate, maximum cell number, how quickly the cells were dying and when 
substantial cell death became apparent. 
 
When cultured in large scale for production of biopharmaceuticals mammalian cells can 
easily become susceptible to hydrodynamic forces that trigger the onset of apoptosis (Al-
Rubeai et al 1995), leading to a reduction in product titre and resulting in an increased 
cost. Apoptosis can be triggered by various factors: mechanical, environmental and 
chemical. Bcl-2, an integrated component of the mitochondria membrane, is an important 
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apoptosis regulatory gene, which by maintaining the integrity of the mitochondria 
membrane, is able to prevent the release of cytochrome C into the cytoplasm, thus 
blocking the activation of caspases, and thereby preventing the subsequent initiation of 
apoptosis. It is well established that the over-expression of Bcl-2 can significantly 
improve the robustness of industrially important cell-lines to conditions found within the 
bioprocessing environment, including nutrient limitation, growth arrest, oxygen 
limitation, viral infection and shear stress (Al- Rubeai and Emery 1990, Franek and 
Dolnikova 1991, Mercille and Massie 1994, Singh et al 1994, Mastrangelo et al 1996, 
Mitchell-Logan and Murhammer 1997).  The fact that Bcl-2 allows previously unadapted 
cells to survive in suspension and serum-free culture supports the postulation that this 
protein plays an important role in apoptotic signalling pathways and suggest that Bcl-2 
may also sub-serve more diverse functions beside its death-inhibiting role. One possible 
explanation for the reduced period of adaptation is that adaptability to changes in 
nutritional and physical environment is part of an intracellular defence mechanism that 
can be stimulated by lack of substratum and serum. The reported cell cycle arrest by 
shear stress and nutrient deprivation support the notion that Bcl-2 protection may be 
achieved by prolonging the G1 phase and that this protein plays a key role in optimizing 
cell numbers to suit the prevailing nutrient and physical environment (Simpson et al 
1999).  
 
Previously, it has been shown that the expression of the cyclin dependant kinase inhibitor 
p21
CIP1
 could have a positive impact on the adaptation of CHO cell-lines to suspension 
and serum-free growth environments by halting cell cycle progression in the G1 phase of 
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the cell cycle (Astley et al 2007), thereby improving cellular robustness in response to 
mechanical damage and reducing the requirement for the presence of growth 
factors/complex nutrients present in serum. Combining the positive effect of p21
CIP1
 on 
adaptation with that of Bcl-2 ability to reduce cell death and prolong viability in 
suboptimal condition it is not surprising to observe such a significant decrease in the 
period of adaptation to suspension and protein-free culture.  
 
Interestingly, in this study Bcl-2-expression also resulted in an increase in the overall 
maximum viable cell count obtainable in comparison to the control culture. This increase 
is not believed to be due to direct stimulation by Bcl-2 itself but is more likely due to the 
suppression of apoptosis during the early stages of the culture, which leads to increased 
percentage of dividing cells with consequent accumulation of viable cells. During the 
process of adaptation to both suspension and protein-free culture environments, Bcl-2 
over-expression resulted in increased robustness to the mechanical forces within the 
culture environment, as well as providing protection against nutrient deprivation and 
toxic metabolite accumulation. 
 
In conclusion, the results of this study provide a clear indication of the possible role for 
the combined expression of the anti-apoptotic gene Bcl-2 and of p21CIP1 -induced cell 
cycle arrest in the process of adapting of CHO cell-line to industrial applications. I have 
demonstrated in this study that, through the induction of extended periods of cell cycle 
arrest combined with the over-expression of Bcl-2, it is possible to significantly decrease 
the time required for adaptation of CHO cell-line to both suspension and protein-free 
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growth environments and thereby to enable the swift development of commercial cell-
lines able to meet the demands for higher productivity and longevity whilst withstanding 
the stresses imposed by growth within a chemically defined bio-processing environment. 
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7. General discussion and future perspectives 
 
7.1. Summary of results 
This thesis represents a continuation of our labs previous research into apoptosis and the 
cell cycle. In chapter 3 I was able to demonstrate that it is possible to create a 
multicistronic CHO cell line that is able to express the monoclonal antibody IgG through 
the GS expression system. This cell line was further engineered to express the anti-
apoptotic Bcl-2 gene and the cyclin-dependent kinase inhibitor p21
CIP1
 under the control 
of an inducible expression vector. Following its creation I was then able to successfully 
characterize the growth and productivity profiles of the resulting clones. Each clone was 
also examined for its ability to halt cell cycle progression following the induction of 
p21
CIP1
-expression as well as the anti-apoptotic effect of Bcl-2 when challenged with 
exposure to staurosporine and serum deprivation. Both p21
CIP1
 and Bcl-2-expression 
were additionally confirmed for each of the clones through analysis via western blot. 
Finally the productivity and specific production rates of all clones were determined both 
during periods of p21
CIP1
-expression and during growth without vector expression. This 
allowed me to confirm my previous hypothesis, that cell cycle arrest as a result of 
p21CIP1-expression would indeed result in an increase in productivity and that the 
combined expression of Bcl-2 would not have a negative impact on the overall 
production rate. 
 
In chapter 4 I examined the hypothesis that a relationship exists that is able to link 
p21
CIP1
-induced cell cycle arrest to the previously observed changes in cell size and 
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productivity.  In order to investigate this fully a CHO cell line which expresses the 
monoclonal antibody IgG through the GS expression system was further engineered to 
allow the inducible expression of p21
CIP1 
through the addition of IPTG to the culture 
medium. Using this cell line, it was first confirmed that p21CIP1-expression does in fact 
lead to G1 phase cell cycle arrest. A number of key metabolites were analyzed in both 
induced and non-induced cultures, including glucose and glutamate utilization and lactate 
and ammonia production rates. To further investigate the effect of p21
CIP1
-induced cell 
cycle arrest has on the cells metabolism the total protein and mitochondrial activity was 
also analyzed.  
 
Cell size was examined both via a Malven mastersizer and through the analysis of packed 
cell volume. The results of this study clearly demonstrated an increase in overall cell 
volume, confirming the hypothesis that in p21
CIP1
-induced cultures cell growth may be 
uncoupled from cell division. The increased antibody productivity observed during 
periods of proliferation arrest could be directly correlated to the increase in cell volume 
and total intracellular protein. This is likely to reflect the increase in the protein synthesis 
machinery within the arrested cells. Interestingly it would also appear that a link may 
exist between the rate of glucose utilization and cell volume as both of these were found 
to increase simultaneously during the early stages of the culture. Later on in the culture 
an increase in the rate of glutamate utilization and productivity were also observed in 
cultures expressing p21CIP1, suggesting that glutamate is utilized more readily by arrested 
cells for the process of antibody production and that during periods of cell cycle arrest 
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this process occurs more readily, most likely as a result of the decreased cell density and 
therefore a greater abundance of available glutamate. 
 
In chapter 5 I examined the hypothesis that proliferation arrested CHO cells may be 
adapted to suspension and protein-free growth environments more successfully than cells 
that are proliferating. The theory behind this investigation was that cells in the G2/M 
phases of the cell cycle have previously been shown to be more susceptible to 
hydrodynamic forces due to the associated increase in cell size and weakening of the cell 
membrane prior to cell division (Al-Rubeai et al 1995, Abdul and Al-Rubeai 1997).  I 
therefore hypothesized that arresting cells in the G1 phase of the cell cycle would result 
in improved robustness when exposed to the shear forces of a suspension environment. In 
addition it was theorized that extending the period of cell cycle arrest would reduce their 
requirement for extracellular growth factors, as well as preventing the accumulation of 
extracellular autocrine growth factors. It was also suggested that by preventing cell cycle 
progression cells may be able to utilize the additional time spent in G1 phase arrest to 
repair the resulting genome damage, created through the direct withdrawal of serum, 
prior to cell cycle release. 
  
Adaptation to protein-free culture was also found to occur at a greatly enhanced rate 
during periods of cell cycle arrest, most likely as a result of a reduction in the cells 
requirement for growth factors/complex nutrients that are usually present in the serum as 
these molecules are only essential for the stimulation of cells to enter cell division. 
Interestingly our results also revealed that p21
CIP1
-induced cell cycle arrest was able to 
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limit the formation of aggregates during the process of adaptation; possibly by enhancing 
culture viability and thereby preventing the release of degraded DNA and other cellular 
materials into the medium. It was therefore hypothesized that p21
CIP1 
may play a key role 
in the organization of the extracellular matrix by reducing the expression of extracellular 
adhesion factors. This would in turn reduce multicellular aggregation, which can also 
result in a reduction in viability due to the nutrient and mass transfer limitations within 
the spheroid structure of multicellular aggregates.  
 
The expression of p21
CIP1
 was also found to reduce apoptosis during the process of 
adaptation, most likely as a result of preventing the accumulation of toxic metabolites 
usually associated with cellular overgrowth. To determine if this reduction in apoptosis 
could be further enhanced I engineered a cell-line in which the expression of p21
CIP1
 and 
the expression of the anti-apoptotic gene Bcl-2 could be combined. The results clearly 
demonstrate an improvement in cellular robustness when exposed to mechanical damage 
as well as a reduced requirement for the presence of growth factors/complex nutrients 
present in serum. By combining the positive effect of p21
CIP1
 on adaptation with the 
ability of Bcl-2 to reduce cell death and prolong viability in suboptimal condition it is not 
surprising that we observed a significant decrease in the period of time required for 
successful adaptation to both suspension and protein-free culture.  
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7.2. Recommendations for further work 
 
The work presented in this thesis has the potential to lead to several other studies 
including:  
 
• Genetic profiling of p21
CIP1
-expressing cultures is vital. Through the use of 
molecular biology techniques and post-genomic technologies such as gene 
expression profiling and metabolic profiling, it may be possible to significantly 
improve our understanding of the physiological state of p21
CIP1
-expressing cells.  
Such an ‘inverse engineering approach’ (Bailey et al 1996) would allow us to 
identify alterations in cellular organization that result in the physiological changes 
and increase in productivity observed in this thesis. There are many factors 
including increased transcription, post-translational events, metabolic precursor 
generation and energy generation that may well contribute to the observed 
increase in productivity during periods of cell cycle arrest. The characterization of 
changes to the metabolic pathways and the cells physiology may therefore offer 
additional possibilities for the modulation of the identified pathways to further 
enhance productivity. 
 
• The effect of combining p21
CIP1
 and Bcl-2 expression on the metabolic pathways 
observed in this thesis. As described above, it is likely that the physiological 
changes and increase in productivity observed as a result of the over-expression of 
p21CIP1 occur due to several factors. It has previously been reported that the over-
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expression of Bcl-2 may have a positive impact on culture viability and 
productivity (Itoh et al 1995). In addition its expression has been shown to be 
associated with the cessation of cell proliferation in the G0/G1 phase as well as 
effecting the transition through G2/M (Lopez-Diazguerrero et al 2006). It would 
therefore be interesting to see if the combined expression of p21CIP1 and Bcl-2 
would have an impact on the cells requirements for key nutrients and/or the cells 
physiology and production potential as determined through the use of molecular 
biology techniques.  
 
• The creation of an inducible Bcl-2 or p21CIP1/Bcl-2 expressing CHO cell line in 
which both genes expression may be induced independently. In this study Bcl-2 is 
expressed permanently, something which has previously been shown to have a 
negative effect on the growth rate and productivity of the cell line. Therefore in an 
ideal situation Bcl-2-expression would not be initiated until the cells were in 
danger of undergoing apoptosis in the latter stages of culture. This may also be 
beneficial to the cells metabolic needs as the expression of Bcl-2 unnecessarily 
may well place additional demands on the cell for increased energy metabolism. 
The controlled expression of Bcl-2 may also be beneficial in the adaptation of 
cell-lines to new growth conditions following which its expression may not be 
needed. In this thesis the expression of p21
CIP1 
was under the control of an 
inducible expression vector, this meant that p21
CIP1
-expression could be switched 
on on demand enabling cells to reach an optimum cell density before being 
arrested and thus preventing the associated accumulation of toxic metabolites in 
217 
 
the growth medium, normally associated with cellular over growth. As previously 
described Bcl-2 was expressed permanently, in a combined strategy p21
CIP1
-
expression would be initiated when the cells had reached an optimum density and 
viability and Bcl-2-expression would not be initiated until there was a risk of loss 
of viability and thus productivity. 
 
• The combined expression of p21
CIP1
 and Bcl-2 with a fed batch strategy designed 
to meet the metabolic needs of high producing cell-lines that have been 
highlighted in this chapter. It is believed that productivity could be further 
enhanced in p21CIP1 and p21CIP1/Bcl-2-expressing cell-lines by implementing a 
strategy that would enable the cells to be grown to a high cell density before the 
addition of IPTG and the initiation of feeding, in order to supplement the medium 
with the key nutrients that have been shown to be utilized more readily during 
periods of high production rates. This would be particularly valuable when both 
p21
CIP1
 and Bcl-2 are being expressed as p21
CIP1
 has been shown to increase 
productivity whilst Bcl-2 has been found to reduce apoptosis and therefore extend 
the culture period. Feeding strategies to meet the demands of the arrested culture 
may extend the length of the culture thus further and in doing so result in an 
overall increase in product titre. 
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7.3. Conclusions 
This project has been highly successful in highlighting the possibility for the utilization 
of genetic methods not only for the enhancement of productivity, but also for improving 
the adaptability of CHO cell-lines for use in industrial applications. The results of this 
thesis clearly show that arresting cells in the G1 phase of the cell cycle results in a 
significant increase in productivity. Analysis of key nutrient utilization and cellular 
metabolism indicate that when cell proliferation is halted, cellular growth is able to 
continue independently, resulting in an increase in overall cell volume. This increase in 
cell volume appears to be associated with increased glucose utilization rates; in contrast 
the rate of productivity appears to be linked to an increase in glutamate utilization which 
occurred following the exhaustion of glucose. 
 
Although the exact mechanisms are not clear it is obvious from the observed increase in 
mitochondrial activity, total protein content and nutrient utilization rates that there are 
significant changes to the metabolic pathways that occur as a result of p21
CIP1
-induced 
cell cycle arrest. The identification of these pathways would require genetic analysis 
techniques beyond the scope of this thesis; however this study does provide a very firm 
basis for such studies. The determination of changes in these key metabolic pathways will 
enable the manipulation of existing medium compositions, the formulation of superior 
growth media and feed strategies that will more precisely meet the increased needs of 
high producing proliferation arrested cell-lines. 
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In this thesis I have also successfully developed and tested a novel protocol for the 
adaptation of CHO cells to both anchorage-independent suspension and protein-free 
growth environments, through the use of p21
CIP1
-induced cell cycle arrest. I was able to 
demonstrate that the period of time required for successful adaptation to each of the 
aforementioned growth conditions could be significantly reduced. This highlights the 
possibility that p21
CIP1
 may play additional roles other than the prevention of cell 
division, including reducing the rate of aggregate formation by improving culture 
viability and thus preventing the release of degraded DNA, as well as down-regulating 
the expression of extracellular adhesion factors. When the expression of Bcl-2 was 
combined with periods of cell cycle arrest the results on the rate of adaptation were even 
more dramatic. It would appear that the ability of Bcl-2 to prevent apoptosis improves the 
culture viability and prevents cell death usually associated with the accumulation of toxic 
metabolites. 
 
This thesis has been successful in demonstrating how it is possible to utilize genetic 
techniques for the manipulation of industrially relevant cell-lines in order to not only 
enhance their productivity but also to shorten the period of time required for their 
adaptation to the conditions necessary for the large scale production of 
biopharmaceuticals. In addition analysis of the mechanisms underpinning the resulting 
increase in productivity may help in the discovery of the exact mechanisms and pathways 
through which cellular productivity is achieved. It may also provide identifiable markers 
which can be used for the production and selection of high producing cell-lines. 
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In the future it may well be possible to combine environmental and genetic techniques, 
such as those highlighted by this thesis, in order to produce cell-lines in which the 
specific production rates are higher than those currently obtainable. In addition the ability 
to reduce the time required for successful adaptation will better enable the increasing 
need for protein free production systems to be met. Ultimately this would result in a 
reduction in the overall production times required as well as substantially reducing the 
associated cost. 
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